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Abstract 
Abstract 
Ageing is a complex multi-factorial process, which is characterised by a 
decreased ability of the human body to interact, respond and defend itself 
against numerous stimuli. As average life span continues to increase, it 
becomes increasingly important to understand what impact ageing or disease 
has on physiological functions and the efficacy of interventions such as 
exercise. Cardiac power output (CPO) is the best indicator of overall cardiac 
function (Cooke et al., 1998) and can be measured non-invasively at rest 
(CPOfest) and maximal exertion (CPOmax), enabling the heart's functional 
reserve (CR) to be calculated. The aims of these studies were to use CPO to 
measure changes that occurred as a result of healthy ageing, long-term 
endurance training, and chronic heart failure, and compare these effects in 
men and women. 
After further developing the techniques and protocols to measure CPO, 
seventy healthy men and one-hundred and thirteen women aged nineteen to 
seventy six years were recruited and studied. Healthy ageing resulted in a 
49%, 23% and 22% decrease in V02max, CPOmax and CR respectively in men. 
In marked contrast, there were no significant age-related changes in CPOmax 
or CR in healthy women. Forty-two habitually active men and eighteen women 
were recruited across the same age range. The active men had significantly 
higher CR (-17%-36%) than age-matched sedentary men. In contrast, the 
active women showed no increase in CR over the sedentary women. 
These sex-specific differences in response to ageing and exercise were 
independent of changes in body size. 
Abstract 
The CPOmax and CR of twenty-one male heart failure patients were 
respectively -57% and -64% below that of the healthy sedentary men. 
These results indicate for the first time that healthy ageing has a negative 
impact on CPO in men which can be attenuated by long-term endurance 
training, or made worse by heart failure. Importantly, no decrease occurred in 
CPO in women with ageing, and the cardiac adaptations in response to 
exercise were also less marked. 
Contents 
Abstract 
Contents iii 
List of tables ix 
List of figures ...................................................................................................... 
xi 
Abbreviations xv 
Chapter 1- Introduction 
1.0 Healthy ageing ....................................................................................... 
2 
1.1 Theories of ageing ................................................................................ 
3 
1.2 Age-related changes in aerobic power ............................................ 
1.3 The effect of endurance exercise on aerobic power_____________________ 6 
1.4 Age-related changes in the structure and function of skeletal 
muscle 
1.5 Exercise-induced changes in skeletal muscle function ................ 
10 
1.6 Age-related changes in cardiovascular composition and 
structure 
1.7 Regulation and age-related changes in the control of 
cardiovascular function 16 
1.7.1 Neural regulation of cardiovascular function ................... 
18 
1.7.2 Hormonal regulation of cardiovascular function .............. 
18 
1.7.3 Autoregulation of blood pressure 19 
1.7.4 Age-related changes in the regulation of 
cardiovascular function ....... ...... ......................................... 
20 
1.8 Age-related changes in cardiac function ......................................... 
21 
1.8.1 Age-related changes in resting cardiac function ............. 
22 
1.8.2 Age-related changes in maximum cardiac function........ 24 
1.9 Effects of exercise on cardiac function 27 
1.10 Effects of heart failure 30 
1.11 Cardiac power output--------------------------------------------------------------------------- 33 
1.12 Aims of the study, .......................................................... ....... ---------- 
37 
Chapter 2- Methods 
2.0 Pre-test screening and subject recruitment____________________________________ 40 
2.1 Evaluation procedures ......................................................................... 
41 
2.2 Measurement of body composition ................................................... 
42 
2.3 Measurement of aerobic power and cardiac power output......... 46 
2.3.1 The measurement of V02max ............................................... 
48 
2.3.2 The measurement of resting cardiac function .................. 
52 
2.3.3 The measurement of maximum cardiac function 56 
2.4 Calculations 59 
2.5 Scaling----------------------------------------------------------------------------------------------------- 63 
2.6 Statistical analysis ................................ ................................................ 
65 
Chapter 3- Results: Validity and Reliability of the Equipment 
and Techniques 
3.0 Preliminary studies ............................................................................ ".. 
3.1 The reproducibility of measurements of aerobic power and 
cardiac function . ------------ ------------------------------------------------------------------------ 
68 
68 
iv 
3.2 The impact of recovery time between repeated bouts of 
maximal exercise 
3.3 The possible effects of circadian rhythms on cardiac power 
output 
............................................ 
69 
75 
Chapter 4- Results: The Effects of Healthy Ageing on Aerobic 
and Cardiac function in Men 
4.0 The effects of healthy ageing on cardiac power output in 
sedentary men 80 
4.1 Changes in body mass and aerobic function in sedentary men 80 
4.2 Resting cardiac function in sedentary men_____________________________________ 82 
4.3 Maximum cardiac function in sedentary men_________________________________ 86 
Chapter 5- Results: The Effects of Endurance Training on 
Aerobic and Cardiac function in Men 
5.0 Endurance exercise training in men_________________________________________________ 97 
5.1 The effect of habitual endurance exercise training on aerobic 
power in men. ................................................................ 
99 
5.2 The effect of endurance exercise training on resting cardiac 
function in men 101 
5.3 Changes in maximum cardiac function as a result of 
endurance exercise in men 104 
V 
Chapter 6- Results: The Effects of Heart Failure in Men 
6.0 The impact of a failing heart on overall function 
............................ 
109 
6.1 Changes in aerobic function as a result of heart failure in men. 110 
6.2 The impact of heart failure on resting cardiac function 
................ 
110 
6.3 The impact of heart failure on maximum cardiac function in 
men 115 
Chapter 7- Results: Changes in Aerobic Power and Overall 
Cardiac function in Sedentary Women 
7.0 The effects of healthy ageing in sedentary women ....................... 
119 
7.1 Changes in body mass and aerobic function in sedentary 
women 119 
7.2 Resting cardiac function in sedentary women, ............................... 
121 
7.3 Maximum cardiac function in sedentary women ............................ 
125 
Chapter 8- Results: The Effects of Endurance-Training in 
Women 
8.0 Long-term endurance exercise training in women ........................ 
136 
8.1 Long-term endurance exercise training and aerobic power in 
women __, 
137 
8.2 Long-term endurance exercise training and resting cardiac 
function in women ........................................................... .......... ....... "" 
140 
8.3 Long-term endurance exercise training and maximum cardiac 
function in women-------------- ----------------- ----------------------- ------ ------- 
143 
vi 
Chapter 9- Results: Sex-Related Differences in Body 
Composition and Overall Cardiac Function in Response to 
Ageing 
9.0 The impact of body composition________________________________________________________ 150 
9.1 Changes in body composition as a result of healthy ageing....... 150 
9.2 Allometric scaling of aerobic power__________________________________________________ 151 
9.3 Allometric scaling of resting overall cardiac function____________________ 155 
9.4 Allometric scaling of maximum overall cardiac function. .............. 
158 
Chapter 10 - Discussion 
10.0 Key findings 
............................................................................................ 
165 
10.1 Limitations 167 
10.2 Changes in maximum aerobic and overall cardiac function in 
men 173 
10.2.1 The effects of healthy ageing in men ................................. 
173 
10.2.2 The effects of habitual long-term endurance exercise 
in healthy men 176 
10.2.3 The effects of heart failure in men ...................................... 
180 
10.3 Changes in maximum aerobic and overall cardiac function in 
women 
10.3.1 The effects of healthy ageing in women. ........................... 
182 
10.3.2 The effects of habitual endurance exercise in women... 185 
10.4 Size-independent gender comparison ............................................. 
187 
10.5 Future research 191 
vii 
Chapter 11 - Conclusion 
194 
References 
197 
Appendices 
Subject questionnaire. .......................................................................... 
233 
2 Subject consent form .......................................................................... 
246 
3 Peer reviewed communications 248 
viii 
List of Tables 
1 Treadmill protocol 
-. -"_. ----. "_. "_-- 49 
2 The coefficients of variability in resting and maximal 
measurements of aerobic power and cardiac function 70 
3 Respiratory gas values during three maximal exercise tests, 
with different length of recovery intervals 
4 Measures of overall cardiac function, blood flow and blood 
pressure generation during three maximal exercise tests, with 
different length of recovery interval 
5 Measurement of CPO, blood flow and blood pressure at rest 
and maximal exercise in the morning and afternoon____________________ 78 
6 Anthropometric characteristics of endurance-trained and 
sedentary men 98 
7 The effects of healthy ageing and endurance-exercise in men 
on resting measures of blood flow and blood pressure 
______________ 
103 
8 The effects of healthy ageing and endurance exercise in men 
on maximum measures of blood flow and blood pressure.......... 105 
9 Anthropometric characteristics of male healthy control group 
heart failure patients 
............................................................................. 
111 
10 Resting blood flow and blood pressure in healthy males and 
heart failure patients ............................................................................. 
114 
11 Maximum blood flow and blood pressure in healthy males and 
heart failure patients ................................ .. _. --............ 
116 
12 Anthropometric characteristics of endurance-trained and 
sedentary women 
ix 
List of Tables Continued... 
13 The effects of ageing and long-term endurance exercise on 
resting blood flow and blood pressure in women .......................... 
142 
14 The effects of ageing and endurance-training on maximum 
measures of blood flow and blood pressure in women________________ 144 
15 Correlation of maximal aerobic power to body size and 
composition ............................................................................................ 
154 
16 Correlations between resting overall cardiac function and 
body size and composition. ................................................................. 
157 
17 Correlations between maximum cardiac function and 
functional reserve capacity to body size and composition.......... 160 
X 
ist of Ficu 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Effects of ageing on the total number of ventricular myocyte 
nuclei in the human heart 14 
Mechanisms that augment cardiac output in healthy humans 
and heart failure patients 
............................................................... "..... 
32 
Schematic diagram illustrating the changes in cardiac power 
output as a result of ageing and ischaemic damage 
.................... 
35 
Dual-energy X-ray absorptiometry unit (DEXA)............................. 
DEXA scan 45 
DEXA results from a typical healthy male subject 
........................ 
45 
Measurement of blood pressure using auscultation method 
during incremental exercise 51 
Resting rebreathing valve 53 
An example of a satisfactory resting capnograph 
......................... 
55 
Headgear used to support the weight of rebreathing valve and 
bag during exercise 
.............................................................................. 
57 
An example of a satisfactory maximum capnograph 
.................... 
60 
Changes in aerobic function in men as a consequence of 
healthy ageing. 
....................................................................................... 
81 
The effect of healthy ageing on resting overall cardiac 
function in men 83 
The effects of healthy ageing on resting blood flow generation 
in men 84 
The effects of healthy ageing on resting blood pressure 
generation in men ................................................................................. 
85 
XI 
List of Figures Continued... 
16 The effect of ageing on systemic vascular resistance at rest..... 87 
17 Age-related changes in maximum overall cardiac function......... 88 
18 Healthy ageing and its effects on maximum blood flow 
genera tion-------------"--"------------ 
"-"----------- ............. --------------... ----------"---" 
89 
19 The effects of healthy ageing on maximum blood pressure 
generation ............................................................................................... 
91 
20 Age-related changes in systemic vascular resistance at 
maximal exertion in sedentary men .................................................. 
92 
21 The effect of ageing on maximum arteriovenous oxygen 
difference in healthy men .................................................................... 
93 
22 Age-related changes in cardiac functional reserve in healthy 
men 
23 Maximum aerobic power in age-matched sedentary and 
endurance-trained men .................................. "-------------------"----"- -"-----"" 
100 
24 The effects of healthy ageing and endurance exercise on 
resting and maximum cardiac power output in men ..................... 
102 
25 Changes in overall cardiac functional reserve as a 
consequence of ageing and endurance exercise .......................... 
107 
26 Changes in aerobic function as a consequence of heart failure 112 
27 Changes in overall cardiac function in men as a consequence 
of heart failure .................................. .................................. ............... 
113 
28 Changes in aerobic function in women as a consequence of 
healthy ageing. ....................................................................................... 
120 
XII 
List of Figures Continued... 
29 The effects of fifty-six years of healthy ageing on resting 
overall cardiac function in women 
................................ 
122 
30 The effects of healthy ageing on resting blood flow in women... 123 
31 Ageing and its effects on resting blood pressure in women,....... 124 
32 Resting systemic vascular resistance and the age-related 
change in sedentary women 
------------------------------------------------------------"- 
126 
33 Maximum overall cardiac function in sedentary women 
between nineteen and seventy-six years of age. 
........................... 
127 
34 The effects of ageing on maximum blood flow generation in 
women 
------------------------------------------ 
128 
35 Age-related values of maximum blood pressure in sedentary 
women ----------------""---... _................... ----.......... ------------------------------"----"------" 
130 
36 The effect of healthy ageing on systemic vascular resistance 
at maximum aerobic power in sedentary women__________________________ 131 
37 The effect of ageing on maximum arteriovenous oxygen 
difference in healthy women ............................................................... 
132 
38 Cardiac functional reserve in women between nineteen and 
seventy-six years of age,.. ..................... 
39 Maximum aerobic power in age-matched sedentary women 
and female athletes . ------"--------- ------------------"--------""-------.... -------" "-------" 
139 
40 The effects of healthy ageing and long-term endurance 
exercise on cardiac power output in women .................................. 
141 
41 Overall cardiac functional reserve in sedentary and 
endurance-trained women ......... -- "-----" . ................. ""---- ....... --"----... 
146 
XIII 
List of Figures Continued... 
42 Maximum arteriovenous oxygen difference in age-matched 
sedentary and athletic females .......................................................... 
147 
43 Changes in body composition as a consequence of healthy 
ageing ...................................................................................................... 
152 
44 The effect of appropriate scaling on the maximum aerobic 
power of healthy men and women 
45 Resting overall cardiac function allometrically scaled for 
changes in lean body mass in healthy men and women ............. 
159 
46 Maximum overall cardiac function allometrically scaled for 
changes in lean body mass in healthy men and women_____________ 161 
47 Sex and age-related changes in cardiac functional reserve....... 163 
XIV 
Abbreviations 
ATP Adenosine triphosphate 
a-v O2diff Arteriovenous oxygen difference 
a-v 02diffmax Maximum arteriovenous oxygen difference 
BMC Bone mineral content 
BMI Body mass index 
BSA Body surface area 
Caco2 Arterial concentration of carbon dioxide 
Ca 2+ Calcium ions 
CHD Coronary heart disease 
CO2 Carbon dioxide 
CPO Cardiac power output 
CPOmax Maximum cardiac power output 
CPOrest Resting cardiac power output 
CR Cardiac functional reserve 
C -V C02 Venous concentration of carbon dioxide 
CVD Cardiovascular disease 
DEXA Dual-energy X-ray absorptiometry 
DNA Deoxyribonucleic Acid 
DBPmax Diastolic blood pressure measured at V02max 
DBPrest Resting diastolic blood pressure 
ECG Electrocardiogram 
FM Body fat mass 
HRmax Maximum heart rate 
HRrest Resting heart rate 
HRT Hormone replacement therapy 
xv 
Abbreviations Continued... 
IGF Insulin-like growth factor 
Km/h Kilometres per hour 
LBM Lean body mass 
MAPmax Mean arterial blood pressure '/o2max 
MAPrest Resting mean arterial blood pressure 
MGF Mechano-growth factor 
MI Myocardial infarction 
NYHA New York Heart Association 
N2 Nitrogen gas 
PegC02 Equilibrium of carbon dioxide pressure 
PETCO2 End tidal pressure of carbon dioxide 
P -V C02 End venous pressure of carbon dioxide 
Qmax Maximum cardiac output 
Qrest Resting cardiac output 
RER Respiratory exchange ratio 
SBPmax Systolic blood pressure measured at V02max 
SBPrest Resting systolic blood pressure 
SVmax Maximum stroke volume 
SVlmax Maximum stoke volume index 
SVrest Resting stroke volume 
SVRmax Maximum systemic vascular resistance 
SVRrest Resting systemic vascular resistance 
TBM Total body mass 
Vco2 Carbon dioxide production 
xv' 
Abbreviations Continued... 
VE Minute ventilation 
Vol Oxygen consumption 
Vo2max Maximum aerobic power 
VT Tidal volume 
VTmax Maximum tidal volume 
xvii 
Introduction 
Chapter 1 
Introduction 
Introduction 
1.0 Healthy Ageing 
In the twenty-first century the average life expectancy of humans is continuing 
to increase, and shows no sign of stopping. Between 1971 and 2001 the 
number of people in the UK over sixty-five years of age grew by 28%. Today 
the over sixty-fives account for 16.6% of the total European population, and 
represent the fastest growing age group. With this trend towards an older 
population it is increasingly important to understand what impact ageing has 
on physiological function, and the role that interventions such as exercise can 
play in promoting a better quality of life. 
Studying the effects of ageing per se is increasingly difficult. This is due to the 
fact that normal ageing is increasingly associated with numerous disease 
processes such as atherosclerosis, diabetes mellitus, coronary heart disease 
(CHD) and obesity. These diseases are intrinsically linked to cellular 
mechanisms (Lakatta, 2002) which are superimposed on the changes which 
occur as a consequence of ageing. Investigating the effects of ageing on 
cardiovascular function is further complicated when you consider that 
cardiovascular disease (CVD) was the biggest single cause of death in the UK 
in 2003, accounting for just under two hundred and thirty three thousand 
deaths. Coronary heart disease (CHD) accounted for more than one-half of 
this total, and is the single biggest cause of premature death (under seventy- 
five years of age) in the UK (Peterson et al., 2005). 
Clearly, to study the effects of ageing per se the ageing process must be 
separated from the various common diseases. Previous studies have often 
failed to adequately do this and as a result have attributed significant changes 
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to ageing, which may in fact be the result of disease processes. In an attempt 
to describe ageing Masoro (2001) stated that ageing should be regarded as a 
synonym for senescence, and defined it as "the deteriorative changes, during 
the adult period of life, which underlie an increasing vulnerability to challenges, 
thereby decreasing the ability of the organism to survive". 
1.1 Theories of Ageing 
Several theories of what causes ageing have evolved in recent years. Today, 
ageing is viewed as an extremely complex multi-factorial process. This notion 
has replaced the traditional concept that a single gene, or deterioration in one 
key body system, was the cause of senesce in human physiological function. 
In a review by Weinert and Timiras (2003), a total of fifteen different theories of 
what causes ageing were highlighted. These theories were separated into four 
distinct categories; evolutionary, molecular, cellular, and system-based. The 
evolutionary theories postulate that ageing results from a decline in the force 
of natural selection. The molecular theories believe that ageing is the result of 
mutations in deoxyribonucleic acid (DNA) and changes in gene expression. 
Cellular theories are based on belief that cells have a limited replicative 
capacity, and that once this capacity has been reached the cells terminally 
arrest and physiological function is altered. This cellular senescence can also 
occur in response to distinct molecular events such as stress-induced 
damage. Finally, the system-based theories of ageing are based on the 
decline of organ systems. This decline in turn limits the ability of the human 
body to control and maintain other systems, and its ability to communicate and 
adapt to the environment in which it lives. All of the systems in human 
body 
are considered indispensable, but the nervous, endocrine and immune 
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systems play key roles in co-ordinating all the other systems of the body, and 
the ability of the human body to interact, respond, and defend itself to both 
external and internal stimuli. 
All of the theories of what causes ageing have a degree of overlap and they all 
agree that ageing is characterised by an in ability to maintain homeostasis, 
and finally death. But, ultimately the precise causes of ageing remain 
unknown. 
This thesis is going to initially focus on what changes occur in aerobic power 
and overall cardiac function as a result of: 
1. Healthy ageing in both sedentary men and women. 
2. Habitually engaging in long-term endurance exercise. 
3. Heart failure. 
1.2 Age-Related Changes in Aerobic Power 
Maximal aerobic power (V02max) is traditionally defined as the maximal rate at 
which oxygen can be taken up and used by the body during exercise (Hill and 
Lupton, 1923). It is widely used in exercise and clinical science to measure 
performance (Shephard, 1984), the effects of training (Bassett and Howley, 
2000) and as a prognostic tool (Osman et al., 2000). It usefulness is based on 
the fact that it is a functional measure that integrates the pulmonary diffusion 
capacity of the lung, cardiac output, the oxygen carrying capacity of blood and 
the ability of the skeletal muscle to extract and utilise oxygen. There has been 
debate surrounding which of these aspects is the limiting factor in determining 
V02max. Exponents such as Bassett and Howley (1997) argue oxygen 
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transport and delivery is the limiting factor, while Noakes (1998) proposes a 
"central governor" theory and believes that skeletal muscle recruitment is the 
limiting factor. 
As with the theories on what causes ageing, there is a degree of overlap in the 
theories concerning what controls or limits Vo2max. The detrimental impact of 
ageing on Vo2max has been known for many years (Astrand et al., 1973). 
Hawkins and Wiswell (2003) conducted a review of the research relating to 
V02max and the effect of ageing. Maximum aerobic power has been found to 
decline from as little as 4% per decade to 12% per decade with increasing 
age. But ageing can have both a direct (mechanistic) and an indirect (an age- 
related decrease in activity levels) influence on Vo2max. It has been proposed 
that ageing which is independent of disuse or disease results in a decrease in 
V02max of approximately 5% per decade (Bortz and Bortz, 1996). 
Previous research has also proved inconclusive in determining if the age- 
related impact on Vo2max is gender specific. The decrease in Vo2maxwas 
found to be comparable in men (Jackson et al., 1995) and women (Jackson et 
al., 1996) between twenty and seventy-years of age. Importantly, they also 
recognised that in both sexes 50% of the observed decrease in 
V02,, 
ax could 
be accounted for by the self-reported decline in activity levels, and 
concomitant decreases in muscle mass. In contrast, in a group of sixty-two 
subjects Stathokostas et al. (2004) found that 
Vo2maxdecreased by 14% in 
men, but only 7% in women per decade. 
5 
Introduction 
1.3 The Effect of Endurance Exercise on Aerobic Power 
Prescribed aerobic exercise provides a stimulus to increase Vo2max (Stromme 
et al., 1977). Some studies have concluded that the ability of the human body 
to increase Vo2max in response to exercise is reduced with increasing age. 
Research by Tanaka and Seals (2003) and Pollock et al. (1987), has 
contested this conclusion. They found that individuals who were sixty years of 
age, or older, retained their ability to increase Vo2max. Malbut et al. (2002) 
supported this conclusion with specific reference to older women (over eighty 
years of age), but found that the same twenty-four week aerobic training 
stimulus was insufficient to significantly improved the Vo2max in men of the 
same age. In contrast, the ability of older individuals to increase their V02max 
was found by Kohrt et al. (1991) to apply to both men and women. These 
researchers attributed that lack of change observed in other studies (Adams 
and DeVries, 1973; Benestad, 1965; Niinimaa and Shephard, 1978; Suominen 
et al., 1977) to be the result of insufficient training stimuli. 
Rogers et al., (1990) found that the Vo2max of master athletes who had a mean 
age of sixty-two year was 50% greater than that of age-matched sedentary 
individuals. But it is important that a sufficient exercise stimulus is maintained 
if the adaptation in Vo2max is to be preserved in spite of increasing age. 
Research by Pimentel et al. (2003) into the effects of exercise and ageing in 
men, and similarly Tanaka et al. (1997) in women, found that between twenty 
and seventy-five years of age exercise significantly increased 
Vo2maxvalues 
when compared to sedentary individuals. However, there was still an age- 
related decline in the Vo2max of endurance-trained individuals. Further, if the 
6 
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training stimulus was withdrawn the rate of decline in Vo2,, was greater in 
the previously trained individuals than in their sedentary counterparts. 
The measurement of Vo2max is widely used because it determines the ability of 
the whole human body to consume and utilize oxygen, integrating many 
different physiological processes which are crucial to the maintenance of 
quality of life. Ageing appears to have a negative impact on Vo2max, but this 
can be offset to a degree by engaging in regular endurance exercise. 
Nonetheless, the changes which occur in Vo2,, as a result of ageing must 
arise from localised changes in the ability of the human body to take up, 
transport and utilise oxygen. Two key components in this are skeletal and 
cardiac muscles. 
1.4 Age-Related Changes in the Structure and Function of 
Skeletal Muscle 
Healthy ageing in humans is well known to be associated with a decline in 
neuromuscular function and performance (Doherty et al., 1993a). This decline 
is characterised by a decrease in skeletal muscle mass which is commonly 
termed sarcopenia, and consequently in skeletal muscle force generation. In 
his review article, Doherty (2003) highlighted the fact that the term sarcopenia 
encompasses the changes which occur in skeletal muscles as a result of 
altered central and peripheral nervous system innervation, hormonal status, 
inflammatory effects, and caloric and protein intake. 
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The average reported age-related decrease in skeletal muscle mass is 
between 20-40% (Doherty, 2003), but greater reductions (over 50%) have 
been reported in individuals who survive past the ninth decade of life (Murray 
et al., 1980). The relative decrease in skeletal muscle force with increasing 
age is similar in both men and women, although the absolute loss is greater in 
men. 
Work which has used electrical stimulation to invoke supra-maximal muscular 
contractions, compared to maximal voluntary contractions has sought to 
determine if age-related decreases in force are the result of reductions in 
central drive. Work looking at the biceps brachii and brachialis (Doherty et al., 
1993b), the adductor pollicis (Phillips et al. 1992) and the tibialis anterior 
(Belanger and McComas, 1981) muscles in humans has established that both 
older men and women were able to fully activate their motor neuron pool 
maximally. It therefore appears that cellular changes which occur within the 
muscle are the major factors which contribute to the reduction in muscle force 
with increasing age. 
Various techniques have been used to determine skeletal muscle cross- 
sectional area in humans in vivo, the most widely used techniques are 
ultrasound, computed tomography and magnetic resonance imaging. 
Studies 
by Young et al. (1985 and 1984) reported decreases of 25-35% in the cross- 
sectional area of the quadriceps muscles in older men and women, when 
compared to young controls. But, as with muscle force the reduction 
in cross- 
sectional area appears to accelerate with increasing age 
(Lexell et al., 1988). 
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Factors which have been postulated as the cause of the age-related 
decreases in muscle cross-sectional area are physiological fibre atrophy which 
is related to decreases in activity levels (Goldspink, 1991), and hormonal 
factors such as a reduced liver and muscle production of the growth factor 
IGF-1 and it spliced variant mechano-growth factor (MGF) (Goldspink and 
Yang, 2001). 
However, the observed age-related reduction in skeletal muscle performance 
is often greater than the reduction in cross-sectional area. Cellular 
mechanisms which also contribute to the loss in performance of skeletal 
muscle with increased age include a decrease in excitation-contraction 
coupling resulting from a decrease in myosin concentration and its decreased 
motility (Hook et al., 1999), and reduced calcium sensitivity and uptake by the 
sarcoplasmic reticulum (Hunter et al., 1999). 
Generally in humans from the seventh decade onwards there is a loss of 
muscle fibres, particularly fast fibres, due in part to the degeneration of the 
motor neurons (Doherty et al., 1993b; Frontera et al., 2000). In addition to 
these changes in fibre number and size, there is a shortening of the remaining 
muscle fibres, and a decrease in angles of pennation. Age-related increases in 
non-muscular tissue (fat and connective tissue) have been reported to be as 
high as 59% and 127% in the quadriceps and hamstrings of healthy men, 
respectively (Overend et al., 1992). The same group has also reported age- 
related increases in the non-muscular tissue within the muscle of the upper 
body, 27% in the arm flexors and 45% in the arm extensor muscles (Rice et 
al., 1989). These changes all contribute towards a reduction in skeletal muscle 
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performance. Furthermore, there is an age-associated increase in tendon 
compliance. With increasing age tendons become less rigid and thus absorb 
more force (Tuite el al., 1997), this inhibits the ability of older people to transfer 
generated muscle force into limb movement. 
1.5 Exercise-Induced Changes in Skeletal Muscle Function 
Skeletal muscle atrophy is recognised by changes in protein turnover 
(Goldspink, 1991). In early postnatal life protein synthesis exceeds protein 
breakdown, the result is a net accumulation and skeletal muscle growth (Lewis 
et al., 1984). In later adulthood the rates of protein synthesis and breakdown 
become equal, resulting in a cessation of the growth of skeletal muscles. If old 
humans become inactive, protein breakdown will exceed protein synthesis and 
skeletal muscles lose protein and atrophy progresses. However, if sufficient 
exercise is undertaken which delivers the appropriate amounts of mechanical 
stress it appears that even older skeletal muscles retain their ability to 
accumulate protein, undergo hypertrophy and improve their overall 
performance (Goldspink, 1991). 
High-resistance, low-repetition training has been shown to increase isometric 
muscle force. In a study by Young et al. (1983) men of thirty years of age and 
women of twenty-three years of age showed that this form of training 
significantly increased quadriceps force generation. There was also a highly 
significant amount of hypertrophy in the trained limbs, but this was insufficient 
to fully explain the functional improvements. Furthermore, there were no 
significant improvements in the untrained contralateral limbs. Similarly, 
increases of 134% and 9.8% have been reported in maximal voluntary 
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contraction and lean muscle cross-sectional area, respectively, following 
twelve weeks of high-resistance strength training in older people aged 
between eighty-five and ninety-seven years (Harridge et al. 1999). Previously, 
neural adaptations and improved co-ordination had been postulated as a 
reason for improvements in muscle performance in older subjects. This was 
not the case in this study. The subjects failed to fully activate their quadriceps 
muscle group both before and after the training intervention, despite the 
adaptation in force-generation. Therefore, it appears that the skeletal muscles 
of older humans do not loose their ability to adapt given a sufficient stimulus or 
increased workload. 
Engaging in high-resistance training on a long-term basis also has a beneficial 
impact on skeletal muscle force and power. Pearson et a1. (2002) examined 
elite master weightlifters, compared to sedentary controls. At all ages the 
weightlifters were significantly stronger. But, importantly the relative declines 
that were observed in both force and power over the course of ageing were 
similar in both groups. Although no anatomical measures were made in this 
study, possible mechanisms that accounted for the increases in power 
exhibited by the trained groups included a greater lean-leg volume, a relative 
increase in the size of Type II muscle fibres, and finally a training adaptation 
towards faster contracting muscle fibres. 
The ability of high-resistance exercise training to restore the cellular 
mechanisms associated with skeletal muscle function in the elderly was 
confirmed by Canepari et al. (2005). This study found that twelve-weeks of 
high resistance training was effective in increasing the velocity of sliding of 
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actin filaments on pure myosin isoforms during contraction in both young 
(between twenty-three and twenty-nine years of age) and elderly (between 
sixty-eight and eighty-two years of age) men. This was despite the training 
having no significant impact on the myosin heavy chain isoform composition in 
the elderly subjects. 
In contrast to the high-resistance activities that have been shown to improve 
skeletal muscle performance, the trained groups who will be the focus of this 
thesis are long-term endurance trained athletes who regularly participate in 
aerobic based activities such as long-distance running. A study by Harridge et 
a/. (1997) compared the skeletal muscle characteristics of fifteen endurance- 
trained individuals who had been maintaining this type of activity from 
adolescence and were at the time of the study between seventy and one- 
hundred years of age. When this group was compared to an age-matched 
group of sedentary individuals there were no significant differences in either 
muscle force or contraction time of the knee extensors. Furthermore, both 
elderly groups showed significant decreases in muscle power and prolonged 
contraction times when compared to a control group of young (twenty-six 
years of age) men. 
Ageing has a significant impact on the structure and function of skeletal 
muscle. Presented with a sufficient mechanical stimulus, it appears that 
skeletal muscles of older humans retain their capacity to adapt accordingly 
(Newton et al., 2002). High-resistance low-repetition exercise appears to be 
effective in providing this stimulus (Pearson et al., 2002). While endurance 
exercise does not improve a muscles ability to generate more force, it does 
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increase its oxidative capacity through the acquisition of more mitochondria 
(Holloszy and Coyle, 1984), and an increase in the number of capillaries per 
muscle fibre (Holloszy, 2001). This ability to improve the oxidative capacity of 
skeletal muscle does not appear to diminish with age (Coggan et al., 1992), 
thereby increasing the need for more oxygen and hence V02, ax. 
1.6 Age-Related Changes in Cardiovascular Composition 
and Structure 
The major function of the heart is to operate as a hydraulic pump. To ensure 
the circulation of blood each ventricular contraction results in blood flow 
(cardiac output; Q) and blood pressure (the hydrostatic pressure exerted by 
the blood against the vessel walls). The blood transports oxygen and nutrients 
that are critical to maintaining the function of all the organs and tissues of the 
human body, and subsequently eliminates the waste products that are 
produced during the physiological processes. 
There are very few studies which have examined the effects of ageing on the 
human heart at a cellular level due to the obvious ethical constraints of 
obtaining human hearts. In two studies by Olivetti et al. (1991 and 1995) 
autopsies were conducted on the preserved hearts of healthy humans within 
twenty-four hours of death. These studies confirmed that the hearts were free 
from overt cardiovascular disease by first examining the medical history of the 
deceased, and then by conducting both macro and micro anatomical analysis. 
In men between seventeen and ninety years of age healthy ageing resulted in 
a loss of 30-36% of the total number of myocytes (Olivetti et al., 1995; Fig. 1). 
This loss was accompanied by a compensatory hypertrophy of the remaining 
13 
Introduction 
Women 
A Left Ventrºcie 
4 
10 y-5.2-0.003x; "-009, p. 0.53 
Z 
K 8 
ai 
. LQ 
6- 
*A 
> 4 " 
""'ý" """ 
L 2 
E c 
z 
0 
0 15 25 35 45 55 65 75 85 95 
C Right Ventricle 
" y. 18-0.0004x; r. 0.03; p-0.82 
0a3 
a Z 
04 
u" 
sot 16 so-'JW* 
ö>t 
E 
=0 
0 15 25 35 45 55 65 75 85 95 
Age, years 
Men 
B Left Ventrtcre 
10 y7-0.043x; r. 0.63: p-0.0001 
8%  
6  ?a  
a   
" ti 2  
0f 
0 15 25 35 45 55 65 75 85 95 
D Right Ventricle 
y"2.5 . 0.014x. x. 0.71. p. 0.0001 3 
2 SOL 
  
0- 
0 15 25 35 45 55 65 75 85 95 
Age, years 
Figure 1- Effects of ageing on the total number of ventricular myocyte nuclei 
in the human heart. 
Figure adapted from Olivetti et al. (1995). 
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contractile cells. But despite this there was still a significant decrease in the 
weight or mass of both the left and right ventricles. In stark contrast there were 
no significant changes in either the number or volume of myocytes in the 
hearts obtained from previously healthy women over the same age range 
(Olivetti et al., 1995). Furthermore, the reduction in sex hormones after the 
menopause had no significant impact on the number or size of myocytes in 
these women. Hence, there are striking sex-related differences in the rate of 
loss or retention of the number of myocytes with ageing. One thing the male 
and female hearts did have in common was a build up of collagen in both the 
right and left myocardium after forty-years of age. This accumulation of 
collagen, together with increases in fat, elastin and lipofusion is required to 
maintain the structural integrity of the heart. 
These changes in myocardial composition have been confirmed in animal 
studies where the loss of myocytes from both the left and right ventricles has 
been observed (Anversa et al., 1990a and 1990b; Nadal-Ginard et al., 2002). 
As in humans there was a reactive hypertrophy of the remaining cells, the 
mean volume has been reported to be increased by 53% and 26% in the left 
and right ventricles, respectively in ageing rats (Anversa et al., 1986). Similarly 
there was a 22% increase in the fraction of collagen contained within the 
myocardium (Anversa et al., 1990b). 
Also, within the conduction system there is an age-related loss of the 
specialized conducting tissue. This is accompanied by increased fibrosis, fat 
infiltration, and the loss of up to 90% of the pacemaker cells within the sinus 
node between twenty and seventy-five years of age (Lev, 1954). 
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The heart and myocardium have been regarded for many years as a 
postmitotic organ, and unlike skeletal muscle it has been regarded as having 
no regenerative capacity. Stem-cell research is now beginning to question this 
traditional principle. Researchers are attempting to harness what appears to 
be a limited self-renewal potential to restore cardiac function after acute and 
chronic cardiac events (Nadal-Ginard et al., 2002; Sussman & Anversa, 2004). 
But it does appear that in men healthy ageing results in a net decrease in the 
total number of myocytes, while in healthy women the number remains 
unchanged. Presumably this sex-related difference represents differences in 
either the rate of myocyte death (by apoptosis and necrosis), and/or the rate of 
myocyte regeneration from endogenous stem-cells in the male and female 
heart. 
Other age-related structural changes that occur within the human heart include 
a shortening of the base-to-apex dimension, this leads to a decrease in the 
size of the left ventricle and a dilation of the left atrium (Henry et al., 1980). 
The thickness of the leaflets of the aortic and mitral valves increases as a 
result of collagen and lipid accumulation (Sahasakul et al., 1988). The 
collagen which makes up the pericardium also becomes thicker and stiffer 
over the course of ageing (Kitzman and Edwards, 1990). 
1.7 Regulation and Age-Related Changes in the Control of 
Cardiovascular 
As well as the age-related changes that occur within the human 
heart, 
changes also occur in the structure of blood vessels and 
in the regulation of 
blood pressure. Several interconnected negative feedback systems control 
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vascular resistance, along with heart rate and stroke volume. The 
cardiovascular centre in the medulla oblongata controls these feedback 
systems along with neural and hormonal feedback. Within the cardiovascular 
centre are numerous neurons, some control vessel diameter (vasomotor 
centre) by stimulating vasoconstriction or vasodilatation, while others stimulate 
or inhibit heart rate and contractility. 
The cardiovascular centre receives input from both higher regions of the brain 
and from sensory receptors. There are three types of sensory receptors that 
provide feedback to the cardiovascular centre. They are: 
1. Proprioceptors which monitor the movements of joints and muscles. 
2. Baroreceptors that are located in the aorta, internal carotid arteries 
and other large arteries which monitor changes in the pressure and 
stretch of the walls of blood vessels. 
3. Chemoreceptors which monitor the concentration of oxygen, carbon 
dioxide and hydrogen in the blood. They are located close to the 
baroreceptors of the carotid sinus and aortic arch. 
Sympathetic output from the cardiovascular system reaches the heart via 
cardiac accelerator nerves, while the opposing parasympathetic stimulation is 
transmitted along the vagus nerves. These opposing signals control heart rate 
and contractility. 
The vasomotor region of the cardiovascular centre sends continual impulses 
to the smooth muscle in the blood vessel walls via vasomotor nerves, thus 
determining vasomotor tone. 
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1.7.1 Neural Regulation of Cardiovascular Function 
Baroreceptor and chemoreceptor reflexes provide the negative feedback 
which determines the neural regulation of blood pressure. When blood 
pressure falls the baroreceptors are stretched less, in response they send 
nerve impulses at a slower rate to the cardiovascular centre, which then 
decreases parasympathetic and increases sympathetic stimulation. The 
consequence is an increase in heart rate and contractility, and an increase in 
the secretion of epinephrine and norepinephrine by the adrenal medulla. This 
results in increases in systemic vascular resistance and blood pressure. 
When blood pressure increases, conversely the baroreceptors send impulses 
at a faster rate. Parasympathetic stimulation increases, while sympathetic 
stimulation is decreased. Heart rate, contractility and cardiac output all decline. 
The rate at which sympathetic impulses are sent along the vasomotor neurons 
is also slowed, which results in vasodilatation and a lowering of systemic 
vascular resistance. 
Chemoreceptors are stimulated to send impulses to the cardiovascular centre 
by hypoxia, increased acidosis or hypercapnia of the blood. In response the 
cardiovascular centre increases sympathetic stimulation to arterioles and 
veins, causing vasoconstriction and an increase in blood pressure. 
1.7.2 Hormonal Regulation of Cardiovascular Function 
Several hormones also play active roles in the regulation of blood pressure 
and blood flow. Epinephrine and norepinephrine are released 
by the adrenal 
medulla. These hormones increase the rate and force of cardiac contraction. 
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They also play a very important role in increasing the blood flow to skeletal 
muscle during exercise by causing the vasoconstriction of arterioles and veins 
in the skin and abdominal region, and the vasodilatation of arterioles in cardiac 
and skeletal muscle. 
When blood volume falls or blood flow to the kidneys is reduced renin is 
secreted into the blood stream. Renin and angiotensin converting enzyme act 
on their substrates to produce the active hormone angiotensin II, which raises 
blood pressure. Antidiuretic hormone can also be released from the posterior 
pituitary gland in response to dehydration or decreased blood volume, 
resulting in vasoconstriction which in turn also increases blood pressure. 
Finally, in terms of the hormonal regulation of blood pressure atrial natriuretic 
peptide is released by the cells in the atria of the heart. Atrial natriuretic 
peptide lowers blood pressure by causing vasodilatation and by promoting the 
loss of salt and water in urine. 
1.7.3 Autoregulation of Blood Pressure 
Autoregulation is the ability a tissue has to adjust its blood flow to match its 
metabolic demand. In tissues such as skeletal muscle, where demand for 
oxygen and nutrients and the removal of waste products can increase by 
tenfold during physical activity autoregulation is critical to increasing blood flow 
through the tissue. 
Two types of stimuli cause autoregulatory changes; the first of these stimuli is 
physical changes. Warming causes vasodilatation, whereas cooling causes 
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vasoconstriction. Smooth muscle in arteriole walls also exhibit a myogenic 
response, contracting more forcefully when stretched and relaxing when 
stretch is reduced. The secondly type of stimuli are chemicals that are 
produced by cells including white blood cells, platelets, smooth muscle cells 
and endothelial cells that alter the diameter of blood vessels. Vasodilators 
include nitric oxide, lactic acid, adenosine, hydrogen and potassium. 
Vasoconstrictors include superoxide radicals, serotonin and endothelins. 
1.7.4 Age-Related Changes in the Regulation of Cardiovascular 
Function 
In healthy individuals there are age-related increases in the afterload which 
resists the flow of blood leaving the left ventricle, and in resting blood 
pressure. These changes are partially caused by the age-related increase in 
vascular resistance. The walls of conduit arteries thicken, and the vessels 
become dilated and elongated. This thickening is the result of a diffuse 
process that has not been fully explained (Lakatta, 1993). Within the vessel 
walls total mucopolysacchardie content (ground substance of the interstitial 
matrix) remains unaltered, chondroitin sulphate and heparin sulphate levels 
increase, while hyaluronate and chondroitin content decreases (Kaplan and 
Meyer, 1960). Within the vascular media there is an age-associated change in 
the distribution of un-stretched collagen, a fragmentation of the internal elastin 
membrane and a relative loss of elastin and glycoprotein content (Lakatta, 
2000). The intimal wall thickness of the carotid artery has been reported to 
increase by two- to three-fold between twenty and ninety years of age (Lakatta 
and Levy, 2003). These age-related changes result in the arterial structure 
20 
Introduction 
becoming less elastic and thus render it less compliant with the advancing 
years. 
As well as the structural changes that occur with ageing that contribute 
towards increases in blood vessel stiffness and blood pressure, the changes 
may also be partly modulated by increases in arterial tonus, such as enhanced 
arterial smooth muscle cell calcium loading in response to a natriuretic 
hormone (Lakatta, 1989). Aged blood vessels also show an increased 
endothelial permeability and reduced nitric oxide-dependant vasodilator 
responsiveness (Taddei et al., 1995). Also there is a reduced vasodilator 
response because of a reduced number and affinity of specific receptors, and 
a reduced vasoconstrictor response (Ferrari et al., 2003). 
There also appears to be an age-related increase in blood pressure during 
exercise. This appears to be partly due to the reduced vasodilatory capacity of 
the arterial tree (Fleg, 1986). There is also an age-related decline in the ability 
of arterial baroreceptors to modulate chronotropic activity. Ferrari et al., 2003 
supported this notion concluding that with ageing, baroreceptor control of 
blood pressure is quantitatively preserved but has a significantly slower time 
course. 
1.8 Age-Related Changes Cardiac Function 
Given all the compositional and structural changes which occur in the heart 
and vasculature as a consequence of ageing there inevitably have to be 
changes in function. 
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In terms of cardiac function, the older human heart has thicker myocardial 
walls, which therefore become less compliant (Labovitz and Pearson, 1987). 
As the leaflets of the aortic and mitral valves become less compliant there is 
an increase in the regurgitation of blood (Sahasakul et al., 1988). The 
senescent heart also exhibits prolonged contraction and relaxation phases 
(Pugh and Wei, 2001). This is the result of a slower action potential thought to 
be caused by a prolongation of calcium transients which results from both a 
slower release and uptake of Cat' by the sarcoplasmic reticulum (Schmidt et 
a/., 2000; Lompre, 1998), and an increase in the expression of slow: fast 
myosin heavy chains (Lakatta, 1999). This slower function of the healthy older 
human heart and its decreased compliance results in an increase in left 
ventricular end-diastolic pressure. This in-turn leads to a reduction in the early- 
passive phase of diastolic filling, such that the heart increases its reliance on 
atrial contraction to augment the late-phase of diastolic filling to maintain left 
ventricle end-diastolic volume. This is illustrated by an increase of up to 40% 
in the time between the aortic valve closing and the mitral valve opening, and 
also a decrease of up to 50% in the peak rate at which blood fills the left 
ventricle in early diastole between twenty and eighty-years of age in both men 
and women (Lakatta, 1993). Overall the heart becomes shorter base-to-apex 
(Henry et al., 1980), as the left atrium dilates, while the left ventricle becomes 
more spherical in shape (Nees et al., 2002). 
1.8.1 Age-Related Changes in Resting Cardiac Function 
At rest the ageing heart adapts well to maintain its function (Pugh and Wei, 
2001). In terms of what effect healthy ageing has on the generation of resting 
blood flow the published research is somewhat equivocal. Some studies have 
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documented a reduction in resting cardiac output (Qrest) equal to 1% per year 
(Brandfonbrener et al., 1955), while others have documented no change 
(Lakatta, 1999; Rodeheffer et al., 1984). The reason for these different 
conclusions can be attributed to different subject inclusion criteria, differences 
in body posture during the measurements and the methods employed to 
measure Qrest. 
Cardiac output is the product of stroke volume and heart rate. Again there is 
some disagreement regarding what impact, if any, healthy ageing has on 
resting stroke volume (SVreSt). The study by Rodeheffer et al. (1984) reported 
a decrease from 85m1 for men in their twenties to 60m1 for men in their 
eighties. Other more recent studies have reported no change in SVrest 
(Lakatta, 1993). Again these discrepancies are the result of the same 
methodological differences that caused different conclusion relating to Orest. 
Resting heart rate (HRrest) also appears to remain largely unchanged with the 
progression of healthy ageing (Fleg et al., 1990). There have been reports of 
decreases in HRrest in both men and women when it has been measured in a 
seated position (Schwartz et al., 1991). This is the result of a prolonged P-R 
interval which reflects the delay at the atrioventricular junction resulting from 
the previously detailed age-related accumulation of fat and collagenous tissue 
(Lakatta, 1993), and secondly from the reduction in the number of pacemaker 
cells in the sinoatrial node (Lev, 1954). 
In the Framington study reported by Kannell et al. (1981) ageing in humans 
was associated with increases in resting systolic blood pressure (SBPt) in 
both men and women. Between the forth and eight decades the increase was 
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25 mmHg in men and 35 mmHg in women. Diastolic blood pressure (DBP. st) 
was reported to plateau by the sixth decade, and then showed a slight 
decrease thereafter. 
Resting cardiac function in healthy humans therefore appears to be well 
maintained in spite of advancing age, given the absence of any pathological 
disease processes. But, at rest the cardiovascular system is operating at only 
a small percentage of its potential. To accurately measure any functional 
changes that are elicited in cardiovascular performance tests must be 
conducted when it is maximally stressed. In healthy humans exercise is the 
most appropriate research tool, and therefore the most widely used technique 
to evoke a maximal response. 
1.8.2 Age-Related Changes in Maximum Cardiac Function 
As previously detailed it has been recognised for many years that ageing 
results in a decrease in Vo2max. This decrease is generally regarded to start in 
the third decade of life, and the rate of the decline is between 5 and 10% per 
decade (Dehn and Bruce, 1972). The decrease in V02max is paralleled by a 
decrease in work capacity, and at sub-maximal work loads the elderly often 
achieve a higher level of oxygen consumption. A major factor which has been 
recognised to contribute towards the age-associated decrease in Vo2max is a 
decline in maximum cardiac output (Q. ). 
Many investigators have demonstrated age-related decreases in Qmax (Ehsani 
et al, 1991; Fleg et al., 1995; Ogawa et al., 1992). However some recent 
studies have cast doubt on this observation, showing Q,. to be maintained in 
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the face of healthy ageing (Rodeheffer et al., 1984; Fleg, 1986). These reports 
have attributed the decreases observed in other studies to be the result of less 
rigorous inclusion criteria which failed to exclude subjects who were suffering 
from covert coronary artery disease, and secondly the invasive methods used. 
Maximum blood flow generation is the product of stroke volume (SVR,. ) and 
heart rate (HRmax). The investigators who have found Qmax to be effectively 
maintained throughout ageing have attributed it to an age-related increase in 
SVmax or stoke volume index (SVImax) (Lakatta, 1993). Whilst not surprisingly, 
those who have reported Qmax to decrease have also reported SVmax and 
SVImax to be maintained or to decrease with ageing (Bogaard et al., 1997; Fleg 
et al., 1995; Ogawa et al., 1992). 
All the studies agree that ageing results in a significant reduction in HRmax, 
which accounts for the majority of the decrease in Qmax" Between the third and 
seventh decade of life Julius et al. (1967) reported HR,,. to decrease by 18% 
(170 to 140 beats per minute), while SVmax fell only 9% (95 to 86 ml). As with 
the age-related decline HRrest the decline in HRmax has been attributed to the 
loss of pacemaker cell within the sinus node (Lev, 1954), but also to a reduced 
responsiveness of the older heart to circulating catecholamines (Fleg et al., 
1985; Kitzman and Edwards, 1990), or possibly to some other intrinsic age- 
related mechanism as yet ill defined (Tanaka et al., 2001). It is generally 
concluded that Qmax declines with ageing, with the majority of this decrease 
attributed to the age-related decline in HRmax, although some studies have 
also shown SV,, ax to decrease but to a lesser extent. With advancing age, 
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therefore, there is an unequivocal increased reliance on the Frank-Starling 
mechanism in the absence of decreased cardio-acceleration. 
Significantly less research has been carried out investigating the age-related 
changes that occur in the generation blood pressure during maximal aerobic 
exercise. Clearly arterial pressures under these conditions will be lower than 
the pressures generated when subjects perform heavy weight-lifting exercise. 
Under these conditions systolic blood pressure can rise to in excess of 480 
mmHg, and diastolic to over 350 mmHg (MacDougall et al., 1985). This is due 
the mechanical compression of the blood vessels, combined with the potent 
pressor and Valsalva responses. 
At V02max Ogawa et al. (1992) reported significant age-related increases in 
maximal systolic (SBPmax), diastolic (DBPmax) and mean arterial (MAPmax) 
blood pressures. Furthermore the age-related increases in blood pressure 
were greater in women. In their twenties women had a lower SBPmax and 
MAPmax than their male counterparts, while the trend was reversed above sixty 
years of age. Stratton et al. (1994) reported that SBPmax, DBPmax and MAPmax 
were all higher in men who were over sixty years of age, when compared to 
healthy men who were under thirty-two years of age. In contrast, work 
reported by Rodeheffer et al. (1984) found no significant age-related increases 
in any of the measures of blood pressure at Vo2max. 
There appears to be much conflicting evidence pertaining to what impact 
ageing has on cardiac function. This is especially true when concentrating on 
maximum cardiac function. Many of these contradictions result from differing 
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subject populations, their inclusion or exclusion criteria, and the methods 
employed. This includes the emphasis on measuring blood flow and not 
overall cardiac function (i. e. cardiac power output; CPO). 
1.9 Effects of Exercise on Cardiac Function 
As previously described (section 1.3) engaging in long-term endurance 
exercise can have a beneficial effect of Vo2max. Importantly, in a society which 
is becoming increasingly sedentary it appears the ability to increase Vo2max is 
not blunted with age. Although the upper ceiling of adaptation is reduced, the 
rate of improvement in response to a sufficient stimulus does not decrease 
with advancing age (Paterson, 1992). This applies to both men and women 
(Seals et al., 1984). 
There is some debate though surrounding whether the mechanisms which 
adapt and contribute towards an increased Vo2max are sex specific. Stratton et 
a/. (1994) reported that previously sedentary young and older men retain their 
capacity to improve cardiac function. This has been supported by numerous 
studies which have concluded that men have the ability to adapt cardiac 
function in response to endurance exercise. Specifically, improvements in left 
ventricular systolic function (Ehsani et al., 1991) and left ventricular filling rate 
(Spina et al., 1996) have been reported. It has also been reported that men 
also increase their maximum arteriovenous oxygen difference (a -v O2difff). 
While some studies have found women have a similar capacity to improve 
their cardiac function (McCole et al., 1999; Sullivan et al., 1991), others have 
found that women in contrast to men exhibit no improvements in either Q or 
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SVmax. Their ability to improve Vo2, r,. in response to endurance exercise is 
therefore solely attributable to an improved a -v O2diffmax (Ehsani et al., 2003; 
Spina et al., 2000; Spina et al., 1993). But the question of what impact long- 
term endurance training has on CPO has not yet been addressed. 
As well as inducing Vo2max values which can be twice that of their sedentary 
counterparts, master athletes also have reduced levels of subcutaneous fat. 
The increased levels of peripheral oxygen extraction are the result of greater 
Type I muscle fibre hypertrophy and the augmentation of oxidative muscle 
enzymes (Lakatta, 1993). But, several studies have attributed the endurance 
exercise-induced improvements in aerobic power mainly to increases in Qmax 
(Lakatta, 1994). For example, Ogawa et a!. (1992) estimated that 88 to 99% of 
the training-induced increase in Vo2max was the direct result of increases in 
Qmax. 
An augmentation in SVmax is the major cause for increases in Qmax, because 
exercise training has been found to have no significant effect on the age- 
related decline in HRmax. Stratton et al. (1994) reported a 17% increase in 
SVmax in men aged between twenty-four and eighty-two years of age after only 
six months of exercise training. Gledhill et al. (1994) and Zhou et al. (2001) 
found similar increases in SVmax which were the result of increases in 
ventricular filling and emptying in endurance trained athletes. Furthermore, 
Stratton et al. (1994) also found that an increase in ejection fraction occurred 
in spite of an exercise-induced increase in SBPmax. They concluded this 
increase in blood pressure could be the result of an increase in myocardial 
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contractility. This increase in contractility has been contested by other 
researchers (Ehsani, 1987), but several echocardiography studies have found 
exercise-induced increases in left ventricular hypertrophy and chamber size in 
both old (Heath et al., 1981; Douglas and O'Toole, 1992) and young (George 
et al., 1999; Whyte et al., 2004) males and females. However, these 
echocardiography measurements were conducted under resting conditions, 
and as a result do not directly relate to contractility, and are poor reflections of 
what happens in the dynamic state i. e. during exercise. 
Another mechanism which could explain the exercise-induced augmentation in 
SVmax is a decrease in arterial stiffness. Exercise has been shown to blunt the 
age-associated increases in carotid pulse pressure and pulse wave velocity in 
older endurance-trained athletes (Vaitkevicius et al., 1993). From a structural 
standpoint exercise has been shown to increase the elastin content, and 
reduce the calcium content of the elastin in the walls elastic arteries. From a 
non-structural context exercise has been shown to be effective at increasing 
vascular-endothelial-dependant vasodilatation (Seals, 2003) thus decreasing 
systemic vascular resistance (SVR) and allowing increases in Amax and SVmax 
to be achieved more easily. 
Finally, if individuals have participated in endurance based training, and as a 
result have augmented their aerobic and cardiovascular function, it is critical 
that they maintain the same levels of activity if they wish to maintain these 
beneficial adaptations. Studies by Pimentel et al. (2003) and Tanaka and 
Seals (2003) have found that as with Vo2max endurance-trained individuals 
have higher cardiac functional capacities. But, if the exercise stimulus is 
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withdrawn the rate of decline is greater than that which is associated with 
ageing alone. As a result of this detraining effect, previously trained individuals 
quickly loose all of the cardiac and aerobic benefits, and become 
indistinguishable from their long-term sedentary contemporaries. 
1.10 Effects of Heart Failure 
Heart failure is one of the cardiology's most difficult concepts to grasp 
(Williams et al., 2005). Often the term is used to characterise a heart that is 
failing, but it symptoms are not uniform. Most commonly, from a cardiac 
prospective individuals who are suffering from heart failure have a 
dyssynchrous myocardial contraction. As a result, the heart fails to produce 
sufficient hydraulic power to supply the tissues of the body with oxygen, and 
therefore normal levels of function cannot be maintained. 
Early classical symptoms of heart failure include breathlessness (dyspnoea) 
and fatigue (Ekman et al., 2005). A key manifestation and principal symptom 
of heart failure is exercise intolerance which is often the cause of many 
patients seeking medical care; the degree to which exercise tolerance is 
limited is a key prognostic indicator (Francis et al., 2001). 
In severe cases the functional impairment which results from heart failure may 
be manifested at rest. But to fully appreciate the impact of heart failure as with 
ageing and exercise the effects must be measured accurately and under 
conditions of maximal stress. It is here that the inadequacy of the heart's 
reserve capacity is only fully exposed and truly quantifiable. 
30 
Introduction 
Heart failure patient's have a much lower aerobic power than healthy 
individuals. Middle aged patients typically achieve a Vo2max of 10 to 20 
ml/kg/min, in comparison to the 30 to 40 ml/kg/min achieved by healthy age- 
matched individuals. This is the result of inadequate blood flow reaching the 
skeletal muscles, and muscle wasting through inactivity (Wilson et al., 1984). 
The cardiac output of heart failure patients has been reported to be only one- 
half of that of a healthy but sedentary individual when measured at maximal 
exertion. This is the result of both a stroke volume which as well as being 
decreased at rest can only be increased moderately up to between 50 and 65 
ml, compared with the 100 ml that is achieved by healthy subjects (Pir a et al., 
2003). 
The reduced ability of heart failure patients to increase their stroke volume is 
the result of a left ventricle that is already dilated at rest, and has no remaining 
capacity to augment preload or ejection fraction in response to the exercise 
stimulus (Sullivan and Cobb, 1992). The failure to increase left ventricle 
ejection fraction results from a combination of impaired intrinsic contractility, 
reduced ß-adrenergic responsiveness, and elevated systemic vascular 
resistance (Pina et al., 2003; Fig. 2). 
As a result heart failure patients rely on increases in heart rate to enhance 
cardiac output in response to an exercise stimulus. Although the initial 
increases in heart rate in response to exercise are often very similar to those 
seen in healthy individuals (Sullivan and Cobb, 1992) the heart rate reserve 
capacity is vastly decreased. This is because typically the resting heart rate of 
a heart failure patient is already elevated. 
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Figure 2- Mechanisms that augment cardiac output in healthy humans and 
heart failure patients 
Flow diagram showing how healthy people (A) without heart failure, and 
patients (B) with heart failure increase cardiac output. 
C. O indicates cardiac output; HR, heart rate; SV, stroke volume; EDV, end- 
diastolic volume; and ESV, end-systolic volume. 
Figure adapted from Pina et al. (2003). 
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In the United Kingdom approximately one in every five deaths in men and one 
in every six in women is the result of heart failure. The economic cost exceeds 
£7.9 billion per year. Heart failure therefore has numerous negative 
cardiovascular, aerobic and economic implications. It was for these reasons 
that the investigators decided to study individuals who were suffering from the 
condition. It represents the negative end of the spectrum in terms of its 
cardiovascular and activity implications, and therefore makes a good contrast 
to the effects of healthy ageing, and long-term endurance training. 
1.11 Cardiac Power Output 
It is apparent that numerous studies have been conducted on the effects of 
ageing, exercise, or heart failure on the individual indices of cardiac function, 
such as Q, SV, blood pressure and or ventricular dynamics. Furthermore, 
some investigators have correctly recognised the validity of measuring cardiac 
reserve capacities by testing cardiac function at both rest and when maximally 
stimulated (Lakatta, 1993). But none of these studies have reported changes 
which occur in overall cardiac function. 
The major function of the heart is to operate as a hydraulic pump. It converts 
adenosine triphosphate (ATP) into kinetic energy to maintain the circulation of 
blood (Tan, 1991). Without this energy the circulation would cease and 
hypoxia would quickly occur in all the tissues of the human body. The potential 
of the heart to generate external work depends on its ability to create blood 
flow and blood pressure. Both are equally important in maintaining the 
circulation of blood. It was the recognition of this fact that lead Tan (1987) to 
develop the term cardiac power output (CPO), and develop its measurement. 
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Furthermore, it illustrates that when previous studies have only measured 
either the blood flow or blood pressure generation they have failed to measure 
overall cardiac function. 
The measurement of CPO was developed within clinical cardiology (Tan, 
1986). It is calculated as: 
CPO (Watts) = (Q x MAP) x K, 
where 6 is cardiac output (1/min), MAP is mean arterial pressure (mmHg), and 
K the constant conversion factor (2.22 x 10-3) into watts. 
Furthermore, CPO can be measured at rest (CPOrest), and when the heart is 
maximally stressed (CPOmax). The functional cardiac reserve (CR) can then be 
calculated from the following equation, 
CR = CPOmax - CPOrest" 
The technique was first applied when assessing the prognosis of heart failure 
patients. Invasive measurement methods were employed, and dobutamine 
infusion was used to illicit maximal cardiac stress (Tan, 1986). It was 
concluded that patients who had a CPOmax of less than one watt, and hence a 
small CR, had a poor change of surviving more than one year. 
A further study by Tan and Littler (1990), again using invasive measurement 
techniques and dobutamine induced stress, also supported the use of CPO as 
a prognostic tool in patients who were suffering from acute cardiogenic shock, 
the majority of whom had suffered myocardial infarctions (MI). The effect of 
one or more MI on CPO and CR is illustrated in figure 3. 
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Figure 3- Schematic diagram illustrating the changes in cardiac power output 
as a result of ageing and ischaemic damage. 
The dashed blue line represents resting cardiac power output (CPOrest) and 
the sold blue line represents predicted maximal cardiac power output 
(CPOmax). Cardiac functional reserve (CR) is the difference between the two 
lines and is represented by the hatched area. 
Cardiac reserve can be negatively affected by ageing, or more dramatically by 
a myocardial infarction (MI) and damage to the myocardium. 
When CPOmax and CPOrest become indistinguishable the long-term prognosis 
of the heart failure patient is very poor. In extreme conditions when CPOmax 
falls below the previous basal CPOrest value a state of cardiogenic shock 
ensues, which is rapidly followed by death unless drastic interventions (e. g. 
surgery) are successful. 
Figure adapted from Goldspink et al. (2003). 
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Roul et al. (1995) were the first to employ CPO when inducing stress through 
exercise rather than a pharmacological approach. Again they concluded that 
CPO had strong prognostic value, but as with previous studies (Tan, 1986 and 
1987; Tan et al., 1989; Tan and Littler, 1990) they were employing an invasive 
measurement technique. A further study by Bain et al. (1990) supported the 
prognostic power of CPO, and further emphasised the need for measures to 
be made at maximal exertion. 
These previous studies all employed invasive techniques for the measurement 
of Q. Subsequently Cooke et al. (1998) developed and employed a non- 
invasive method based on carbon dioxide rebreathing to measure Q. This was 
validated by comparison to previous studies which had employed an invasive 
methodology (Astrand et al., 1964). Theses investigators concluded that CPO, 
and the subsequent calculation of CR, was the best objective indicator of 
overall cardiac function. Furthermore, they found that CPO could be measured 
reproducibly during peak exercise and that it was strongly correlated to 
V02max 
and exercise capacity. 
Recently CPO (Tan, 1991) has been described as the best overall indicator of 
cardiac performance, and its prognostic power in terms of measuring cardiac 
function has shown to be greater than that of Vo2max (Nicholls and Reilly, 
2001). Yet the application of CPO is still mainly confined to use in the clinical 
environment, where it is used as a prognostic tool in the diagnosis 
(Cotter et 
al., 2003) and treatment (Marshall et al., 2001) of patients with 
impaired 
cardiac function. 
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1.12 Aims of the Study 
The overall aim of these studies was to use CPO for the first time to measure 
what impact healthy ageing, long-term endurance exercise and heart failure 
have on overall cardiac function in a large number of both men and women. 
These subjects represent a cross-section of the community, and enable sex- 
related comparisons to be made with ageing and exercise training. 
Given the cross-sectional nature of the studies, a number of preliminary 
studies had to be conducted first to ensure the data collected was accurate 
and meaningful. 
The objectives of the preliminary studies were: 
1. The validation of the automated equipment to be used to analyse 
respiratory gases. 
2. Test the reproducibility of the measurements of cardiac function to 
ensure that they were reliable. 
3. Determine what the recovery period must be between multiple bouts 
of maximal exercise, to ensure a true maximal state is elicited for 
meaningful measurements of CPO. 
4. Investigate whether circadian rhythm affects the measurement of 
CPO, and if it does determine what the most appropriate time of day 
is to conduct the measurements. 
After these preliminary studies had been concluded, focus moved to the 
collection of physiological data for interpretation. A large number of subjects 
were carefully recruited, screened and selected to ensure any conclusions 
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drawn from the data were meaningful and accurate. The studies were carefully 
designed with the following objectives in mind: 
I. Measure the effects of ageing on Vor,.,.,, CPO t and CPOR,.,, in 
healthy sedentary men and women. 
2. Make a meaningful body size and composition independent 
comparison between men and women to determine if healthy ageing 
similarly affected Vo2max, CPO and CR in the two sexes. 
3. Measure and compare what impact engaging in endurance exercise 
has on Vo2max, CPO and CR in long-term endurance trained men 
and women. 
4. Determine what quantifiable effect NYHA class III and IV heart 
failure has on Vo2max, CPO and CR when measured non-invasively. 
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2.0 Pre-Test Screening and Subject Recruitment 
Before beginning the study ethical approval was granted from Liverpool John 
Moores University ethics committee for all the procedures involved. 
Subjects were recruited from Merseyside and the surrounding area. After 
expressing an interest in taking part in the study, subjects completed a 
questionnaire initially detailing their health status and medical history (App. 1). 
Completed questionnaires were examined, and subjects were rejected based 
on the following medical criteria; any history of cardiovascular disease, 
including coronary heart and coronary artery disease, a history of hypertension 
[defined as a resting blood pressure > 140/89 mmHg (Williams et al., 2004)], 
diabetes mellitus, or significant clinical obesity as defined by a body mass 
index (BMI) above 35 kg/m2. Individuals who were consuming any prescribed 
medication or food supplements known to affect cardiovascular or respiratory 
function were also refused entry into the study, as were all tobacco smokers. 
The second part of the questionnaire addressed the volunteers past and 
current activity levels. Individuals were asked to detail the frequency, duration 
and intensity of all activities that they participated in, including all recreational 
and structured exercise. If any discrepancies were found, or questions were 
not satisfactorily answered a further interview was used for clarification. Any 
individual who reported doing less than ninety minutes of exercise per week 
(none of which was structured) was regarded as having a sedentary lifestyle 
based on this self-reporting basis. 
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The female version of the questionnaire contained a section relating to the 
volunteers hormonal status, e. g. menstrual cycle where applicable, and all 
forms of contraception and hormone replacement therapy. 
Finally, a group of patients with heart failure were studied. From an initial 
medical assessment it was determined that all were suffering from NYHA 
class III and IV heart failure. Class III or moderate heart failure patients are 
comfortable at rest, but less than ordinary physical activity in these patients 
causes fatigue, palpitations, dyspnoea, or angina pectoris. Class IV patients 
are suffering severe heart failure and have an inability to carry out any 
physical activity without discomfort. They exhibit symptoms of cardiac 
insufficiency at rest, and if any physical activity is undertaken, discomfort is 
increased (Bennett et al., 2002). Following completion of the tests all of these 
patients were scheduled to undergo surgery at Liverpool Cardiothoracic 
Centre to install bio-ventricular pacemakers. Due to their medical condition all 
of these patients were being treated with various beta-blockers, diuretics, 
spirolactones, and ACE-inhibitors to help maintain their heart function. Hence, 
they were treated as an entirely separate group as they did not adhere to the 
strict health criteria of the earlier populations. 
2.1 Evaluation Procedures 
All of the performance tests were conducted in the exercise 
laboratories at 
Liverpool John Moores University. The temperature of the laboratories was 
maintained around 20°C, and humidity between 
40 and 60%. Subjects 
reported for each test at least three-hours postprandial, 
having avoided the 
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consumption of caffeine for at least three-hours, and having abstained from all 
strenuous physical exertion for twenty-four-hours. 
Before arriving at the university all the volunteers were sent a full description 
of the test battery. On arrival a further verbal explanation was given of all the 
procedures and any questions were answered. Each individual then signed a 
consent form (App. 2) and testing began. 
2.2 Measurement of Body Composition 
First, height and weight were measured using a Harpenden stadiometer and 
Avery balance beam scales, respectively. 
Whole, and regional, body composition was measured using Dual-Energy X- 
ray Absorptiometry (DEXA). Previous validation has proven this technique to 
be accurate in both sexes and across a wide age range (Kohrt, 1998). Its 
accuracy is unaffected by race, athletic status or musculoskeletal development 
(Prior et al., 1997). 
The DEXA unit (Hologic Inc, Horizon Park, Levensesteenweg, Belgium) 
consists of a bed, underneath which a collimated two-dimensional X-ray fan 
beam originates. Above the bed are detectors that measure the transmitted 
beams after attenuation by the different constituents of the human body (Fig. 
4). The scanner and bed is controlled by a dedicated computer and software 
(Delphi A S/N 70719) which also allows the subject's body to be divided into 
various sub regions via the identification of anatomical landmarks (Fig. 5). 
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Before measuring the body composition of each subject the DEXA was 
calibrated. Firstly a phantom spine was scanned; this ensured the accuracy of 
the system when measuring bone content, and the clarity of the captured 
images. Secondly, a synthetic phantom containing known quantities of lean 
and soft tissue was scanned; this was used to guarantee the accuracy of the 
system with respect to these constituents. 
Each subject was instructed to remove all metal appendages (jewellery, 
under-wired bras, clothes with zips etc) before lying on the bed. The subjects 
were positioned, and secured with non-reflective polystyrene blocks to ensure 
they did not move during scanning. Once initiated the bed and the source of 
the X-ray fan beam move in opposite directions in unison, scanning the entire 
subject area in three minutes. The degree of the X-ray attenuated by the 
subject's body is recorded. Within each region, as well as the whole body, 
DEXA can quantify total body mass (TBM), fat mass (FM), bone mineral 
content (BMC), and lean body mass (LBM). These can subsequently be 
calculated as percentages of body mass (Fig. 6). 
44 
Methods 
Figure 5- DEXA scan. 
The scan illustrates the image used to identify the anatomical landmarks, and 
subdivide the regions of the body. 
DXA Results Summary: 
Region 
I 
BM C 
(g) 
Fat 
(9) 
Leaz 
(9) 
Leai+BM C 
(g) 
Total Mass 
(9) 
/ Fat 
L Am 237.57 911.0 3775.0 4012.6 4923.6 18.5 
R Arm 249.90 936.2 3989.6 4239.5 5175.7 18.1 
Trunk 948.62 5802.0 34016.1 34964.7 40766.7 14.2 
L Leg 606.32 2632.1 11255.1 11861.5 14493.5 18.2 
R Leg 636.25 2649.5 11864.1 12500.3 15149.9 17.5 
S'ubtata1 2678.67 12930.8 64899.8 67578.5 80509.3 16.1 
Head 627.09 1090.5 3779.6 4406.7 5497.2 19.8 
Total 3305.76 140213 686793 71986.2 860065 16.3 
TBAR2460 
Figure 6- DEXA results from a typical healthy male subject. 
The DEXA quantifies the compositional elements of the whole body and it sub- 
regions. 
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2.3 Measurement of Aerobic Power and Cardiac Power 
Output 
The practical testing of maximal aerobic power (V02max) and cardiac power 
output (CPO) was separated into three distinct stages to ensure that accurate 
and representative results were recorded. The stages were: 
1. An incremental treadmill exercise test to exhaustion to determine 
V02max" 
2. The measurement of resting CPO. 
3. The measurement of maximal CPO. 
Subjects were fitted with a 12-lead electrocardiogram (ECG; Cardio-Perfect, 
Welch Allyn, Skaneateles Falls, NY, USA) for the duration of all three stages. 
Respiratory gases were measured continuously on a breath-by-breath basis 
using a Medgraphics® CPX/D system (Medgraphics corporation, St. Paul, 
Minnesota, USA). 
The CPX/D system consists of a flow analyser, and a gas concentration 
analyser, these are fully integrated with the 12-lead ECG via a standalone 
personal computer using BREEZEXTM software. The reported accuracy of the 
system is ± 0.1%, with a response time of less than less than 100 
milliseconds. 
The flow analyser draws gas via a pneumotachograph (preVentTM) and a 
double lumen umbilical cord fitted directly to a mouthpiece. One lumen of the 
umbilical cord houses a small resistive element which generates a pressure 
drop as gas flow passes across it. The pressure differential across the 
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resistive element is proportional to the flow of gas in the pneumotachograph, 
thus flow volume is measured. 
The gas analyser uses a vacuum to draw a respiratory gas sample through a 
sample line that is also fitted to the mouthpiece. The gas sample passes 
through a drying cartridge and into the analyser. Oxygen concentrations are 
measured using an electrical voltage, this causes movement of the 02 
molecules. The molecules are then measured as they pass a patent zirconia 
fuel cell, and are compared to a reference gas sample. 
The carbon dioxide (C02) concentration of the same respiratory gas sample is 
also measured using an infrared analyser. Carbon dioxide absorbs more 4.3 
, um wavelength infrared light than any other gas. The amount of light absorbed 
by the sample is again compared to a reference sample, and the amount of 
C02 contained within was quantified. 
From these measures we derived oxygen consumption (Vo2), carbon dioxide 
production (Vco2), minute ventilation (VE), tidal volume (VT), and end tidal 
pressure of carbon dioxide (PETco2). 
Prior to each test the flow and gas modules were calibrated. Ambient 
temperature, barometric pressure, and relative humidity were recorded. A 
three-litre syringe was used to replicate five full respiratory cycles, these 
cycles were performed at varying rates to test the accuracy of the flow module. 
The gas module was then calibrated using both reference (21 % 02, and 
balance NO and calibration (12% 02,5% CO2, balance NO gases. 
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2.3.1 The Measurement of Vo2max 
The main objectives of this first stage were to accurately measure the 
subject's Vo2max, their ability to generate blood pressure, and their exercise 
tolerance. It also provided a quantitative measure of their health status, and 
confirmed the information gathered from the questionnaire. 
Subjects completed an incremental treadmill exercise test. The protocol was a 
further modified version of the Bruce protocol (Bruce, 1971). The first two 
minutes acted as a warm-up and familiarisation period for those subjects who 
were unaccustomed to using treadmills. The speed for the first minute was 2.2 
kilometres per hour (km/h), and the gradient was 50. This increased to 2.7 
km/h and 100 gradient in the second minute. After the warm-up period 
increments of 0.5 km/h and 1° gradient occurred at regular one minute 
intervals until volitional exhaustion (Table 1). The decision to employ 
intermediate increments in both speed and gradient with increased regularity 
was based on the findings of Porszazs et al. (2003) and Myers et al. (2000). 
This research recommended these modifications be made to the standard 
Bruce protocol to elicit a linear increase in Vol, to ensure the accurate 
measurement of V02max, and to guarantee the test lasts an appropriate 
duration. This protocol was employed for all subjects. 
The subject's respiratory gases were sampled continuously throughout the 
test. Subjects were considered to have achieved Vo2max when two of the 
following three criteria were met: 
1. A plateau in Vol, despite a further increase in workload. 
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Stage Duration (minutes) Speed (km/h) Incline (°) 
1 0: 00-1: 00 2.2 0 
2 1: 00 - 2: 00 2.2 0 
3 2: 00-3: 00 2.7 5 
4 3: 00 - 4: 00 2.7 10 
5 4: 00-5: 00 3.3 11 
6 5: 00 - 6: 00 4 12 
7 6: 00 - 7: 00 4.8 13 
8 7: 00-8: 00 5.5 14 
9 8: 00-9: 00 6.2 15 
10 9: 00 - 10: 00 6.8 16 
11 10: 00 - 11: 00 7.4 17 
12 11: 00 - 12: 00 8 18 
13 12: 00-13: 00 8.4 19 
14 13: 00 - 14: 00 8.8 
20 
15 14: 00 - 15: 00 9.2 
21 
16 15: 00 - 16: 00 9.6 
22 
Table 1- Treadmill Protocol. 
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2. A heart rate within 10 beats per minute of their age predicted 
maximum (i. e. 220 - age). 
3. An respiratory exchange ratio (RER) equal or greater than 1.10. 
Heart rate was derived from the ECG, which was monitored throughout the 
test by a qualified cardiologist. Any exercise-induced ischaemia or arrhythmia 
indicating abnormal cardiac function was considered grounds for the early 
termination of the test, and subsequent exclusion of the subject from further 
testing. 
Blood pressure was taken manually from the brachial artery using a mercury 
sphygmomanometer and stethoscope. The subject's arm was raised and 
supported at the level of the heart during each recording (Fig. 7). The first 
measurement was taken before beginning the test. During the exercise blood 
pressure was taken initially at two minute intervals, the frequency of the 
measurement increased towards volitional exhaustion to ensure maximal 
blood pressure was recorded. A final recording was taken immediately post 
exercise. If any abnormal changes in blood pressure were detected, once 
again the test was terminated and the subject excluded from further analysis. 
Abnormal changes in blood pressure are for example, a failure of systolic 
blood pressure to increase with increasing workload, or an excessive increase 
in response to exercise (American College of Sports Medicine, 2000). 
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Figure 7- Measurement of blood pressure using auscultation method during 
incremental exercise. 
51 
Methods 
2.3.2 The Measurement of Resting Cardiac Function 
The purpose of this second stage was to measure resting cardiac output 
(Qrest) and mean arterial blood pressure (MAPrest). The Collier (1956) method 
was implemented to measure end venous pressure of carbon dioxide (P vco2). 
Previous research has proved this method to be most accurate CO2 
rebreathing technique for measuring Qrest (Auchinloss eta!., 1980, Franciosa 
et al., 1976, Zeidifard et al., 1972). 
Subjects reported to the laboratory and the 12-lead ECG was re-attached, 
they sat down and were fitted with a mouthpiece and nose-clip. The subject 
stayed in this relaxed position for a minimum of five minutes, during which 
respiratory gases and the ECG were monitored continuously. 
Attached to the mouthpiece were the respiratory gas sample lines, and a Hans 
Rudolph three-way rebreathing valve (Model 2870 series). A preVentTM 
pneumotachograph was attached to the outflow route of the valve, while a five- 
litre anaesthesia bag, which acted as a C02 rebreathing bag was attached to 
the remaining channel. The valve allowed the researcher to manual redirect 
the subjects breathing from atmospheric air, to breathing the gas mixture in 
the bag. The weight of this equipment was fully supported from the treadmill 
structure (Fig. 8). The mouthpiece was used in preference to the face mask as 
it is less cumbersome for the subject, and could be more quickly fitted and 
removed. 
When a stable baseline was achieved, blood pressure was measured using 
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1,1 
2 
°3 
Figure -8 Resting rebreathing valve. 
Key 
1. Cord supporting weight of the equipment. 
2. Three-way rebreathing valve. 
3. Five-litre anaesthesia rebreathing bag. 
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the manual auscultation method. The anaesthesia bag was filled with a 
medical grade mixture of 10% C02,35% 02 and balance N2; the volume 
corresponding to double the subjects VT. 
After another brief moment to allow the respiration and heart rate to stabilise 
the investigator switched the rebreathing valve at the end of a tidal breath, this 
redirected the air flow towards the rebreathing bag. The subject was instructed 
to take a deep inspiratory breath, inhaling the full volume of gas from the 
rebreathing bag. This ensured the gas mixed well with the alveolar gas. The 
rebreathing manoeuvre continued until a plateau in Vco2 was observed on the 
CPX/D screen, or for a maximum of 15 seconds. After this time recirculation of 
C02 in the blood occurs and invalidates any further results. Once complete, 
the valve is retracted so the subject could inhale atmospheric air once again. 
A satisfactory capnograph plot (Fig. 9) would clearly illustrate: 
" Good mixing of the rebreathing gas with the alveolar gas. 
"A CO2 equilibrium occurring after 3 respiratory cycles, and within 15 
seconds. 
" The CO2 equilibrium lasting for a minimum of 2 additional respiratory 
cycles. 
" Appropriate volume of the rebreathing gas mixture. 
" Appropriate breathing rate of circa 30 breaths per minute. 
If these criteria were not met the measure was discarded and the cause of any 
error remedied. 
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Figure 9- An example of a satisfactory resting capnograph. 
Key 
1. Start of rebreathing. 
2. Third breath after start of rebreathing. 
3. Plateau in the inspired and expired CO2. 
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A minimum of three minutes was allowed to pass between each 
measurement, this ensured that the subject had washed out any residual CO2 
from the previous rebreathing manoeuvre. Once the subjects heart rate and 
respiratory gases had returned to the predetermined baseline values, the 
procedure was repeated until at least three accurate measures had been 
collected. The average of these measures was taken as being representative 
of QreSt. The whole process took approximately thirty minutes. 
2.3.3 The Measurement of Maximum Cardiac Function 
Finally, in stage three the focus moved to the measurement of maximum 
cardiac output (Qmax)" This time the subjects were fitted with a facemask which 
encompassed the entire region from the bridge of the nose to the jawline. A 
soft gel was applied around the perimeter of the facemask which moulded to 
the subject's facial contours to ensure an air tight seal. A specialised adaptor 
(Hans Rudolph) allowed the face mask to be attached to the same three-way 
valve (Hans Rudolph), and anaesthesia bag, as employed at rest. The weight 
of the mask and rebreathing value was now supported by a perspex head gear 
(Hans Rudolph, Model 2785 Series; Fig. 10). This lightweight structure allowed 
the subject to exercise freely, without it the weight of the rebreathing value 
would have dislodged the facemask during exercise. 
Subjects completed a two minute warm-up period, thereafter increments were 
made in both speed and gradient until the subject once again achieved their 
Vo2max, as determined during stage one. The frequency and magnitude of the 
increments was tailored slightly for each subject to ensure that the test lasted 
an appropriate duration to elicit their maximal oxygen consumption (Myers et 
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Figure - 10 Headgear used to support the weight of rebreathing valve and bag 
during exercise. 
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al., 1991) and cardiac output (McCo{e et al., 2001). 
This time the Defares (1958) exponential method of C02 rebreathing was 
employed to measure maximal cardiac output. This method uses the 
exponential rise of Pco2 towards asymptote to calculate P vco2, and the Fick 
(1870) equation to calculate Qmax (Fig. 11). The Defares method was chosen 
because it provides an accurate and reliable measure of Qmax under 
conditions of exercise stress (Ferguson et al., 1968). It has proven to be highly 
reproducible (Cade et al., 2004), and is applicable to individuals of all ages 
(Beekman et al., 1984). Importantly it causes less distress to the individual at 
the point of maximal exertion than alternative methods (Jones, 1988). 
The rebreathing gas mixture in the anaesthesia bag was 4% CO2,35% 02 and 
balance N2 on this occasion, the volume was equal to the subjects maximal VT 
as determined during stage one. When the subject achieved their V02max, the 
directional valve was manually switched at the end of a respiratory cycle. This 
ensured that the subject inhaled the full volume of rebreathing gas. The 
rebreathing manoeuvre took a maximum of ten seconds, during which the 
subject continued to exercise. The valve was then retracted, and the subject 
was allowed to breath atmospheric air whilst the exercise intensity was 
reduced. A minimum of three minutes recovery time was then allowed to 
ensure the elimination of all the inhaled gases. During this time, subjects were 
encouraged to continue exercising but at a reduced intensity to facilitate the 
recovery process. Once the washout process had been completed the process 
was then repeated. If a discrepancy of more than one litre per minute was 
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present between the first two measure of max the process would be repeated 
a third time. 
A satisfactory maximum capnograph (Fig. 11) clearly illustrates: 
" The systematic discarding of the PETco2 recorded at the end of the first 
breath. This is done as there is insufficient time for the adequate 
mixing of alveolar gas and the mixture from the anaesthesia bag (da 
Silva et al., 1985) 
"A minimum of three respiratory cycles within eight seconds. 
" The discarding of any breaths recorded after eight seconds, i. e. after 
this time recirculation of C02 invalidates any measurement (Laszlo, 
2004). 
The PETC02 from the remaining breaths is then analysed using the iterative 
technique of Heigenhauser et al. (1978). This procedure minimizes the 
variance of the points around the least squares regression line, and plots the 
Qmax after twenty seconds. 
2.4 Calculations 
Cardiac power output (expressed in Watts) is the only non-invasive method 
that can be used to test overall cardiac function at rest (CPOrest) and maximal 
(CPOmax) exertion in humans in vivo. It integrates both blood flow and blood 
pressure, and is calculated from the equation described by Cooke et al. 
(1998), 
CPO = (Ox MAP) x K, 
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Figure 11 - An example of a satisfactory maximum capnograph. 
Key 
1. Discarded PETco2 recorded at the end of the first breath. 
2. Respiratory cycles occurring within eight seconds. 
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where Q is cardiac output (1/min), MAP is mean arterial pressure (mmHg), and 
K the constant conversion factor (2.22 x 10-3) into watts. 
When CPO has been measured at rest and at maximal exertion it is possible 
to calculate the functional cardiac reserve (CR) from the following equation, 
CR = CPOmax - CPOrest" 
The measurement of 6 is based on the indirect version of the Fick (1870) 
equation, 
Vcot 
Q= 
C VC02 - CaCO2 
where C vco2 and Caco2 are the venous and arterial concentrations of CO2 
(mmHg), respectively. 
The Vco2 component of the Fick (1870) equation is obtained from the 
measurement of respiratory gases. The C vco2 was determined by measuring 
the partial pressure of CO2 in the venous blood (P vco2 mmHg). The P vco2 
was determined using the Collier (1956) equilibrium method of rebreathing 
C02, and the Defares (1958) exponential method of CO2 rebreathing at rest 
and maximal exertion, respectively. These methods were chosen as they 
minimise the effect of ventilation heterogeneity, and required less subject co- 
operation than alternative non-invasive rebreathing techniques (Barazanji et 
al., 1996). 
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The CaC02 was derived from the partial pressure of C02 in the arterial blood. 
This was estimated from the end-tidal Pco2 (PETco2), assuming normal lung 
function using the equation of Jones (1988), 
Paco2 = 5.5 + 0.90 PETco2 - 0.0021 VT, 
where VT is tidal volume (ml BTPS), and PETco2 is the average of the last 30 
seconds measured from the expired gases prior to performing the rebreathing 
manoeuvre. 
When converting partial pressures to content, two assumptions are made. 
First the haemoglobin concentration is 15 g/100ml, and second that the arterial 
oxygen saturation is greater than 95% during rebreathing (Jones, 1988). 
To ensure an accurate measure of P vco2 from the equilibrium of Pco2, Jones 
(1988) recommends the use of a "downstream correction" factor. This 
accounts for the lung-to-artery circulation time (Jones et al., 1969), and was 
integrated within the BREEZEXTM software as follows: 
P vco2 (mm Hg) = Pegco2 - (0.24 x Pegco2 - 11) 
where Pegco2 is the equilibrium Pco2 before correction. 
Both the Fick (1870) equation and the Jones (1988) conversion equations 
were incorporated in the CPX/D system. The system also has the capability to 
perform both Collier (1956) and Defares (1958) manoeuvres for CO2 
rebreathing, and integrating the measures with the continuous respiratory gas 
analysis and ECG. 
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Mean arterial pressure is used in the calculation of CPO because it represents 
the average pressure throughout the entire cardiac cycle. It is calculated using 
the equation of Meaney et al. (2000), 
MAP = DBP + 0.412 (SBP - DBP), 
where SBP is systolic and DBP diastolic blood pressure, measured in mmHg. 
In 1846 Poiseuille described the factors which govern pulsatile flow (Smith and 
Kampine, 1990). By transposing Poiseuille's original equation an equation for 
calculating systemic vascular resistance (SVR) was derived, 
SVR = (80 x MAP) /Q, 
where MAP is mean arterial pressure in mmHg, Q is cardiac output in I/min, 
and 80 is the conversion factor to dynes/sec/cm5. 
Finally, after measuring Q and Vol it is possible to rearrange the Fick 
equation, and calculate arteriovenous oxygen difference (a -vO2 diff), 
a-VO2diff=Vo2 
0 
where Vol is oxygen consumption measured in ml/min, and Q is cardiac 
output in I/min, the resultant a--O2 diff is millilitres of oxygen per litre of blood 
(mI/I). 
2.5 Scaling 
It has been established that body size significantly affects some aspects of 
cardiac function (Collis et al., 2001). Therefore, to accurately allow direct 
comparisons of cardiac function between different groups (e. g. male versus 
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female, athletic versus sedentary) the effects of body size must be allowed for. 
The most appropriate way is to implement a curvilinear allometric scaling 
technique (Batterham et al., 1999). 
First a Pearson's product correlation is conducted to establish measure of 
body dimension (e. g. height, weight, BMI etc) has the strongest impact on the 
measurement of cardiac function. The two variables are then transformed 
using natural logarithms (base e) to account for any deviations from a linear 
relationship. 
The basic linear relationship equation is, 
y= a +bx+e, 
where b is the gradient of the line of best fit, a the y-axis intercept, and E the 
additive residual error. 
The allometric equation is, 
y= ax'E, 
where y is the value of physiological interest (e. g. cardiac output), x is the 
measure of body dimension (e. g. weight) ,a is the proportional coefficient, and 
b is the power function. 
This allometric equation can be logarithmically transformed and the data can 
then be entered into the following equation: 
log y= log a+x log b+ log e 
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The equation is then solved and the b exponent derived by removing the 
interaction term. If the relationship between the physiological variable and the 
measure of body dimension were perfectly linear then b= 1.0. The 
physiological variable is then powered to the derived b exponent and becomes 
a measurement that is independent of body size. 
Once any two populations of interest have been analysed the resultant cardiac 
measurement can then be plotted over the range of ages. If two populations 
are plotted alongside each other, significant differences in the slope of the 
regression lines can be sought, and any residual differences will be the result 
of ageing, and are not confounded by differences in body size. 
2.6 Statistical Analysis 
The male and female sedentary subjects were independently separated into 
decade age groups, 20 - 29,30 - 39 years etc. The American College of 
Sports Medicine (2000) publishes percentiles for the Vo2max for each group, 
and categorizes fitness accordingly. Rather than arbitrarily applying these 
criteria to our population, percentiles were calculated based on the data that 
was collected. Any individual who achieved a Vo2max in the top twenty-five 
percent, when compared to their age-matched peers, was excluded from 
further analysis. This ensured that when the affects of healthy ageing were the 
focus, only healthy sedentary subjects were included in the analysis. 
The normality of the distribution of the data was initially tested using 
Kolmogorov-Smirnov test. Thereafter, normally distributed data was then 
analysed using parametric tests. 
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To compare data between specified groups one-way and multi-way analysis of 
variance (ANOVA) was employed. When using a one-way ANOVA, a Tukey 
HSD post-hoc test was used to identify significant differences. Where a multi- 
way ANOVA was employed, Bonferroni's post-hoc test was used. 
Pearson's product-moment correlation coefficient was used to test for 
relationships between variables. Where a relationship was confirmed, linear 
regression analysis was used to measure the change in the dependent 
variable per unit change in the independent variable. On graphs the rvalues 
and the equations from which they are derived are presented. In the caption 
the F ratio is given, with the associated degrees of freedom and level of 
significance. 
Linear regression was also employed to test for differences in relationships. 
Where more than one dependent variable was measured using the same units 
(i. e. resting and maximal cardiac output), the variables are plotted against a 
single independent variable (e. g. age). A linear line of best fit was then applied 
to each data set. If the r values are significant, and there is no overlap in the 
confidence intervals associated with each regression line, it was concluded 
that the slopes of the lines, and consequently the relationships, are 
significantly different. 
The level of statistical significance was arbitrarily set at P<0.05, but where a 
stronger significant difference was found the resulting P value is shown. 
66 
Results 
Chapter 3 
Results 
Validity and Reliability of the 
Equipment and Techniques 
67 
Results 
3.0 Preliminary Studies 
Before beginning the collection of data to measure the physiological impacts of 
ageing, exercise, and heart failure three preliminary studies were conducted. 
These studies were designed to test the validity and reliability of the 
equipment, and the reproducibility of the proposed techniques to be used 
throughout these large projects. 
3.1 The Reproducibility of Measurements of Aerobic Power 
and Cardiac Function 
To conduct a cross-sectional study and accurately examine changes in any 
given physiological function it is critical that the measurements made are not 
subject to excessive variation that might lead to inaccurate conclusions being 
drawn. Previous research has reported intra-individual day-to-day variations in 
the measurement of Vol by automated gas analysis systems. These 
variations range from 3% (Miles et al., 1994) to as high as 12% (Versteeg and 
Kippersluis, 1989). Macfarlane (2001) highlighted the importance of 
recognising that such variations include both biological and technical 
variability. 
Twenty-five subjects (seventeen males, and seven females) were recruited to 
test the variability within the chosen measurement techniques. They 
represented a broad cross-section of the subjects to be tested in the principle 
projects, e. g. the effects of healthy ageing and long-term endurance exercise. 
All were aged between twenty-three and sixty-nine years, and ranged from 
healthy sedentary individuals to elite veteran athletes. The subjects completed 
68 
Results 
stage one of the protocol to measure Vo2max (see Methods section 2.3.1). 
Stages two and three to measure CPOrest (see Methods section 2.3.2) and 
CPOmax (see Methods section 2.3.3) were repeated on two occasions, 
separated by a minimum of seven days. 
The coefficients of variation for the measurements of Vol, CPO and Q, both at 
rest and during maximal exercise, are shown in Table 2. 
The total day-to-day and subject-to-subject variability in the measurements of 
Vol, CPO, and 0 were all less than five percent both at rest and at maximal 
exercise. These are significantly less than the commonly accepted level of 
10% total variation. They also signify that the chosen techniques were highly 
reproducible. Consequently, any recorded differences greater that these 
variations could confidently be attributed to significant changes in physiological 
mechanisms. 
3.2 The Impact of Recovery Time between Repeated Bouts of 
Maximal Exercise 
Once the validation of the equipment had been completed, the focus moved to 
the design of the protocol. This protocol was originally devised for measuring 
cardiac performance in heart failure patients where it was necessary to 
complete all the measurements i. e. V02max, CPOrest and CPOmax, in a single 
visit to the hospital laboratory. This necessitated a recovery period of only 
thirty minutes between the bouts of exhaustive exercise. Although the 
measurements of blood pressure returned to baseline values within this time 
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Coefficient of Variability (%) 
Resting Measures 
Oxygen Consumption 2.46 
Cardiac Power Output 4.46 
Cardiac Output 4.15 
Maximal Measures 
Oxygen Consumption 3.47 
Cardiac Power Output 2.20 
Cardiac Output 2.33 
Table 2- The coefficients of variability in resting and maximal measurements 
of aerobic power and cardiac function. 
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interval changes in other factors such as respiratory gases, which could 
conceivably affect the measurement of CPO, were not measured. 
Previous research has concluded that successive bouts of heavy aerobic 
exercise causes hypoxaemia and disturbs the exchange of pulmonary gases 
for at least thirty minutes after the cessation of exercise (Caillaud et al., 1996). 
Although a prior bout of heavy exercise has no effect on Vol kinetics, it is 
associated with a suppression of the Vol slow component and Vco2 (Burnley 
et al., 2000). The impact of an acute prior bout of heavy exercise on overall 
cardiac function is not known. If the impact is not significant, then it would be 
preferable from a purely practical standpoint to continue completing all stages 
of the testing protocol in a one visit to the laboratory. If a significant impact 
does occur then an appropriate recovery time will need to be incorporated into 
the protocol. 
To examine the effects of different recovery periods on the measurements of 
respiratory gases, haemodynamics and CPO, thirteen male subjects with a 
mean age of 21.8 ± 0.7 years were recruited. First CPOrest was measured, this 
was followed by the standard Vo2max test. The measurement of CPOmax was 
then conducted twice, first after a thirty minute recovery period, then again 
after a twenty-four hour recovery period. 
Resting CPO for this group of males was 1.26 ± 0.1 Watts. The values for the 
respiratory gases analysed during the three bouts of maximal exercise are 
presented in Table 3. All of the gas values measured after the thirty minute 
recovery period were significantly suppressed, with the exception of 
PETco2max. 
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VO2max Test Recovery Time 
30 minutes 24 Hours 
VO2max(1/min) 4.1 ±0.2 3.9±0.2* 4.0±0.2 
V02max (ml/kg/min) 52.8 ± 2.5 49.5 ± 2.0 * 51.4 ± 2.6 
VCO2max(1/min) 4.9±0.2 3.9±0.2* 4.3±0.2*t 
RERmax 1.2 ± 0.03 1.0 ± 0.02 * 1.1 ± 0.02 * 
VTmax(I/min) 2.9±0.1 2.4±0.1 * 2.6±0.1 
PETC02max 38.0 ± 1.0 35.4 ± 1.1 37.2 ± 1.2 
Table 3- Respiratory gas values during three maximal exercise tests, with 
different length of recovery intervals. 
Data are presented as means ± standard error of the mean. 
Significant differences between the values were tested using an ANOVA with 
repeated measures and Bonferroni post-hoc test, where appropriate. 
*P<0.05 significant difference when compared to initial Vo2max test. 
tP<0.05 significant difference when compared to the test conducted after a 
thirty minute recovery period. 
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This illustrates that a thirty minute rest period is insufficient to accurately 
measure aerobic power after a previous acute bout of heavy aerobic exercise. 
However, following a twenty-four recovery period there were no significant 
difference in V02max, VTmax, or PETC02max, when compared to the initial test. 
Although a significant suppression in Vco2max remained in comparison to the 
first Vo2max test, this difference was reduced as a consequence of the 
prolonged recovery period. 
When maximal overall cardiac function was measured, there were no 
significant differences irrespective of the rest period between the bouts of 
maximal exercise (Table 4). This was also true of the individual components of 
blood flow (i. e. SVmax and HRmax) and blood pressure (SBPmax and DBPmax; 
Table 4). 
The overall trend for higher values to be attained following a twenty-four hour 
recovery period after an acute bout of maximal exercise, coupled with the 
feedback from the subjects who found completing two bouts of maximal 
exercise in close succession particularly difficult, convinced us of the merits of 
a prolonged recovery period. Therefore, a minimum twenty-four hour recovery 
period was integrated between stages one (V02max test) and three (the 
measurement of CPOmax). We believe this improves the original protocol, 
which was designed for diagnosing heart failure. 
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V02max Test Recovery Time 
30 minutes 24 Hours 
CPOmax (Watts) 6.0 ± 0.3 6.2 ± 0.3 
Qmax (1/min) 23.6 ± 0.9 24.9 ± 1.0 
SVmax (ml/beat) 123.3 ± 4.5 131.1 ± 5.4 
HRmax (bpm) 188.2 ± 2.4 191.9 ± 2.8 190.2 ± 2.6 
MAPmax(mmHg) 113.2±2.4 111.9±2.3 112.2±2.3 
SBPmax (mmHg) 197.1 ± 6.7 197.2 ± 6.2 198 ± 5.9 
DBPmax (mmHg) 52.1 ± 2.6 52.2 ± 2.8 52.2 ± 2.8 
CR (Watts) 4.7±0.2 5.0±0.3 
Table 4- Measures of overall cardiac function, blood flow and blood pressure 
generation during three maximal exercise tests, with different length of 
recovery interval. 
Data are presented as means ± standard error of the mean. 
Significant differences between the values were tested using an ANOVA, with 
repeated measures where appropriate. 
There were no statistically significant differences between any of the 
measures when compared to the initial V02max test, or as a result of different 
recovery periods between the bouts of acute exercise. 
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3.3 The Possible Effects of Circadian Rhythms on Cardiac 
Power Output 
The variations that occur over twenty-four hours in circadian rhythm are known 
to be reflected by changes in core body temperature, the peak occurring at 
16: 30, and the lowest point at 04: 30 (Reilly et al., 1997). Previous research 
has suggested that variations include changes in resting cardiac output 
(Cugini et al., 1991), heart rate (Reilly et al., 1984) and diastolic blood 
pressure (Deschenes et al., 1998). It is has also been suggested that these 
variations persist following bouts of intense and exhaustive exercise (Cabri et 
al., 1988). Similarly a time-related variation in the occurrence of cardiovascular 
events that require clinical interventions has been established (Muller, 1999). 
Such time of day variations in Q and blood pressure could conceivably affect 
measurements of CPO, because they are integral components of overall 
cardiac function. However, the previously reported changes were measured 
either at rest, or following bouts of exercise, and the variables were not 
measured at maximal exertion. Therefore, it was important to establish if 
circadian rhythms have a significant effect on both CPOrest and CPOmax. If a 
significant impact of time of day occurs then it will be necessary to remove any 
confounding effects by standardising the time at which tests are conducted on 
each individual. 
Ten male subjects, with a mean age of 21.5 ± 1.2 years, were recruited to 
determine if circadian rhythms effected the measurement of CPO. Stage one 
of the standard protocol was initially conducted to measure Vo2max. Following 
a break of a week the subjects returned to perform stages two and three, i. e. 
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to measure CPOrest and CPOmax at two different times of day. The first of these 
tests was performed at 04: 30, and the second at 16: 30. These times were 
selected to reflect the trough and peak of circadian rhythm. The order in which 
the tests were performed was randomly assigned to the subjects, and the 
appointments were separated by a minimum of forty-eight hours. 
The measurements of CPO were made following the standard protocol with 
one minor addition. Rectal probes were used to record the core body 
temperature as this is known to reflect circadian variations. 
Indeed core temperature was 37.0°c ± 0.01 and 37.5°c ± 0.01 in the morning 
and afternoon respectively; the difference between these values was highly 
significant (P < 0.01). This difference of approximately 0.5°c remained 
following a bout of maximal exercise, i. e. 37.5°c ± 0.1 in the morning 
compared to 37.9°c ± 0.01 in the afternoon (P < 0.01). 
Maximal aerobic power was unaffected by the time of day at which it was 
measured. This is clearly illustrated by the lack of any significant differences 
when comparing the mean V02max attained at 04: 30 (i. e. 41.6 ± 3.5 ml/kg/min) 
and 16: 30 (i. e. 44.9 ± 1.7 ml/kg/min). In addition, neither of these values 
differed significantly from the Vo2max measured a week earlier (i. e. 45.0 ± 1. 
ml/kg/min). 
Despite the significant differences in core body temperature which confirmed 
the impact of a circadian rhythm, no significant differences were found in any 
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of the measures of cardiac function. A lack of change was evident in both the 
resting and maximal measures (Table 5). 
None of the measures were close to approaching significance levels shown by 
the high P values in Table 5. These results indicate that CPO was not affected 
by circadian rhythms, and could therefore be measured with confidence at any 
time of day. This has obvious practical implications, especially given the large 
number of subjects involved in the forthcoming studies investigating the effects 
of healthy ageing, exercise training and heart failure on overall cardiac 
function. 
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Time Of Day 
04: 30 16: 30 P value 
Cardiac Power Output (Watts) 
Resting 0.97 ± 0.1 1.1 ± 0.0 0.24 
Maximum 5.6 ± 0.5 5.8 ± 0.3 0.73 
Cardiac Output (1/min) 
Resting 4.7 ± 0.3 5.6 ± 0.3 0.52 
Maximum 22.8 ± 1.1 22.9 ± 1.0 0.94 
Heart Rate (bpm) 
Resting 62.8 ± 2.9 67.2 ± 3.2 0.31 
Maximum 185.6 ± 2.3 189.8 ± 2.7 0.25 
Stroke Volume (ml/beat) 
Resting 76.4 ± 5.6 84.2 ± 3.5 0.26 
Maximum 123.3 ± 6.5 121.2 ± 5.9 0.81 
Mean Arterial Pressure (mmHg) 
Resting 91.4 ± 2.9 88.5 ± 1.8 0.40 
Maximum 113.7 ± 3.0 113.3 ± 2.9 0.92 
Systolic Blood Pressure (mmHg) 
Resting 116.1 ± 3.8 117.9 ± 2.3 0.70 
Maximum 194.7 ± 5.4 194.6 ± 5.2 1.00 
Diastolic Blood Pressure (mmHg) 
Resting 74.1 ± 2.8 67.9 ± 2.7 0.13 
Maximum 57.1 ± 2.7 56.4 ± 2.3 0.86 
Cardiac Reserve (Watts) 4.6 ± 0.5 4.7 ± 0.3 0.88 
Table 5- Measurement of CPO, blood flow and blood pressure at rest and 
maximal exercise in the morning and afternoon. 
Data are presented as means ± standard error of the mean. 
There were no statistically significant differences in any of the physiological 
variables as a result of the time of day, as determined by the two extreme 
times of 04: 30 and 16: 30. 
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4.0 The Effects of Healthy Ageing on Cardiac Power Output 
in Sedentary Men 
After completing the questionnaire (App. 1), stress test and screening process, 
sixty-nine healthy sedentary males, ranging in age from nineteen to seventy- 
six years were included in the subsequent analysis, investigating the impact of 
healthy ageing on overall cardiac function. 
4.1 Changes in Body Mass and Aerobic Function in 
Sedentary Men 
Total body mass (TBM), body mass index (BMI) and body surface area (BSA) 
were 82.0 ± 1.3 kg, 26.4 ± 0.4 kg/m2 and 2.0 ± 0.0 m2 respectively. There were 
no significant changes (P > 0.1) in any of these measures in men over the 
course of healthy ageing. 
Resting oxygen consumption( V02rest) showed a significant (P < 0.01) linear 
decrease in over this age range. This decrease was equivalent to 16% in both 
absolute (Fig. 12a), and relative terms (Fig. 12b) after normalisation for total 
body mass. 
Maximal aerobic power showed a much stronger correlation, and a greater 
decrease as a consequence of healthy ageing than V02rest. In absolute terms 
V02max declined significantly (P < 0.0001) by 1834 ml/min (49%) over the fifty- 
seven years studied (Fig. 12a). Neither the rate of decline, nor the strength of 
the correlation changed if this measure was reported relative to total body 
mass (Fig. 12b). 
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Figure 12 - Changes in aerobic function in men as a consequence of 
healthy ageing. 
Resting Vol (Q) expressed in (A) absolute terms (F (1,67) = 11.1, P< 
0.001), and (B) relative to total body mass (F (1,67) = 8.5, P<0.01) were 
both significantly correlated to age. 
Maximum Vol ( ) expressed in (A) absolute terms (F (1,67) = 163.4, P< 
0.0001), and (B) relative to total body mass F (1,67) = 162.4, P<0.0001) 
were also significantly correlated to age. 
The strength of the correlation and the rate of decrease were both 
significantly greater in the maximum measures, as opposed to the resting 
measures. 
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When compared to the normative values for the aerobic power of healthy men 
published by the American College of Sports Medicine (2000) these results 
confirm that the cohort used in this study to assess the impact of ageing were 
sedentary and healthy. Furthermore, given the significant declines in both 
V02rest and Vo2max similar decreases in cardiac function would be anticipated. 
4.2 Resting Cardiac Function in Sedentary Men 
Resting CPO in healthy men showed a significant (P < 0.0001) linear decline 
between nineteen and seventy-six years of age (Fig. 13). The total decrease in 
CPOrest over the fifty-seven years studied was 27%. 
In terms of resting blood flow generation, Quest decreased significantly (P < 
0.0001) by a total of 41 % between nineteen and seventy-six years of age (Fig. 
14a). The decrease in resting stroke volume was also significant (P < 0.0001), 
and of a similar magnitude (38%; Fig 14b). The mean resting heart rate for the 
entire group was 68 ± 1.3 bpm, and did not change significantly (P > 0.07; Fig. 
14c). Therefore, it appears that the reduced resting stroke volume was solely 
responsible for the decrease measured in cardiac output. 
The changes in resting blood pressure generation measured over the course 
of healthy ageing were in the opposite direction to the changes that were 
measured in blood flow generation. There were significant 10% increases in 
MAPrest (P < 0.01), SBPrest (P < 0.001) and DBPrest (P < 0.05) between 
nineteen and seventy-six years of age (Fig. 15). 
Resting systemic vascular resistance (SVRrest) also increased significantly 
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Figure 13 - The effect of healthy ageing on resting overall cardiac function 
in men. 
Resting cardiac power output showed a significant (F (1,67) = 22.0, P< 
0.0001) linear correlation to healthy ageing between nineteen and 
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Figure 14 - The effects of healthy ageing on resting blood flow generation 
in men. 
Resting cardiac output (A) (F (1,67) = 54.4, P<0.0001), and stroke 
volume (B) (F (1,67) = 41.9, P<0.0001) both decreased significantly 
while resting heart rate (C) (F (1,67) = 0.1, P>0.7) showed no significant 
change as a consequences of healthy ageing in men. 
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Figure 15 - The effects of healthy ageing on resting blood pressure 
generation in men. 
Resting mean arterial (A) (F (1,67) = 9.8, P<0.01), systolic (B) (F (1,67) 
= 12.4, P<0.001) and diastolic (C) (F (1,67) = 4.6, P<0.05) blood 
pressures all increased significantly with healthy ageing. 
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(P < 0.0001; Fig. 16). The magnitude of the increase (74%) over the fifty- 
seven year period studied was the biggest increase in any of the variables at 
rest. As SVR represents the resistance to blood flow within the systemic 
circulation this big increase as a consequence of healthy ageing helps to 
explain the decrease measured in SVrest and the increase in MAP. t. 
4.3 Maximum Cardiac Function in Sedentary Men 
Although age-related changes occurred in cardiac function under resting 
conditions, these represent small changes relative to the functional reserve of 
the normal heart. Hence, to establish the true affects of ageing, the heart 
needs to be maximally stressed, thereby enabling the impact of ageing on 
overall functional reserve capacity (CR) to be established. 
Healthy ageing had a much greater impact on maximal overall cardiac function 
(CPO,,, a. ). Between nineteen and seventy-six years of age CPOmax significantly 
(P < 0.0001) decreased by 20% (approximately 0.02 Watts per year; Fig. 17). 
This rate of decline in CPOmax was much greater than the decrease in CPOrest 
over the same period in the same individuals. This is illustrated by the 
significant difference in the slopes of the regression lines in Figures 13 and 17. 
Maximum blood flow generation also showed significant reductions over the 
age range studied. Maximum Q (Fig. 18a) decreased by 32% (P < 0.0001). 
This decrease of 0.13 I/min/year was considerably greater than the decrease 
of 0.04 I/min/year in Qrest (Fig. 14a), and was the result of significant (P < 0.05) 
age-related reductions in both SVmax (Fig. 18b) and HRmax 
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Figure 16 - The effect of ageing on systemic vascular resistance at rest. 
Resting systemic vascular resistance increased significantly (F (1,67) = 
47.1, P<0.0001) as a result of healthy ageing in men between nineteen 
and seventy-six years of age. 
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Figure 17 - Age-related changes in maximum overall cardiac function. 
Maximum cardiac power output decreased significantly (F (1,67) = 19.2, 
P<0.0001) between the ages of nineteen and seventy-six years in 
healthy men. 
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generation. 
There were significant decreases in maximum cardiac output (A) (F (1, 
67) = 57.6, P<0.0001), stroke volume (B) (F (1,67) = 6.6, P<0.05) and 
heart rate (C) (F (1,67) = 153.6, P<0.0001) in healthy men. 
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(P < 0.0001; Fig. 18c). However, the 23% decrease in HRmax was greater than 
the 13% decrease SVmax. 
Over the same fifty-seven years maximum mean arterial blood pressure 
(MAPma, () increased by 14% (P < 0.0001; Fig. 19a). There were however no 
significant changes (P > 0.8) in the SBPmax (Fig. 19b), with the mean for the 
entire group being 196 ± 2.0 mmHg. The increase in MAPma. was therefore 
entirely the result of the significant (P < 0.0001) 53% increase in DBPmax (Fig. 
19c). 
As with SVRrest, SVRmax showed a very strong positive correlation (P < 0.0001) 
to healthy ageing (Fig. 20). The increase over the age range studied was 68%, 
and was the largest increase in any individual variable. 
Between nineteen and seventy-six years of age Vo2max decreased by 51 
(Fig. 12) in healthy sedentary men. Over the same period, and in the same 
subjects CPOma., also decreased by 20% (Fig. 17). Unsurprisingly, given the 
role that the cardiac pump plays in determining aerobic power these two 
measures were positively correlated (r = 0.657, P<0.01). 
However, 57% of the age-related reduction in Vo2max still remains 
unaccounted for. Therefore maximal arteriovenous oxygen difference 
(a -V 02diffmax) was calculated. This showed a significant 
(P < 0.0001) 24% 
reduction in peripheral extraction of oxygen over the fifty-seven years of 
ageing (Fig. 21). 
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Figure 19 - The effects of healthy ageing on maximum blood pressure 
generation. 
Maximum mean arterial (A) (F (1,67) = 15.6, P<0.0001), systolic F (1, 
67) = 0.0, P>0.8) and diastolic (C) (F (1,67) = 28.6, P<0.0001) blood 
pressure in healthy men. 
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Figure 20 - Age-related changes in systemic vascular resistance at 
maximal exertion in sedentary men. 
Maximum systemic vascular resistance (F (1,67) = 71.8, P<0.0001) 
showed a strong linear increase as a result of healthy ageing in men. 
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Figure 21 - The effect of ageing on maximum arteriovenous oxygen 
difference in healthy men. 
Maximum arteriovenous oxygen difference showed a significant linear 
decrease (F (1,67) = 42.8, P<0.0001) between nineteen and seventy-six 
years of age. 
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This study shows that healthy ageing in men results in a significant reduction 
in maximum aerobic power. Resting overall cardiac function also declines, but 
importantly maximum overall cardiac function decreases to a much greater 
extent. 
At rest and maximal exertion there were significant reductions in the 
generation of blood flow, but theses were opposed by age-related increases in 
the generation of blood pressure. The net impact in these sedentary men was 
a significant (P < 0.0001) 20% decrease in the maximal pumping capacity of 
the healthy heart, but also a 25% (P < 0.001) reduction in its overall functional 
reserve capacity (Fig. 22). This means that at all ages studied CPOfeSt (Fig. 
13) was operating well within the reserve capacity, and furthermore that CR 
was well maintained between nineteen and seventy-six years of age. 
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Figure 22 - Age-related changes in cardiac functional reserve in healthy 
men. 
Cardiac functional reserve [CR = CPOmax (Fig. 18) - CPOrest (Fig. 14)] 
showed a significant (F (1,67) = 11.4, P<0.001) linear decline between 
nineteen and seventy-six years of age in healthy but sedentary men. 
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5.0 Endurance Exercise Training in Men 
Given the detrimental impact of healthy ageing on overall cardiac function in 
sedentary men (see chapter 4), male subjects who participated regularly in 
endurance exercise were recruited from various clubs in North-West England. 
The aim was to determine whether habitual participation in endurance 
exercise could attenuate the age-related deterioration in cardiac function. 
All of the subjects conformed to the health guidelines imposed on the 
sedentary groups (section 2.0). Fifteen young (mean age of 19.6 ± 0.8 years) 
highly-trained individuals were recruited from a local rugby academy and the 
John Moores University student population, all participated in structured 
exercise training sessions at least four times per week. Twenty-eight long-term 
veteran athletes were also recruited. These active individuals were 
distinguished by their participation in four training sessions per week during 
which they covered on average thirty-two miles. Additionally, they had been 
training for at least eighteen years, and all were still competing in various 
distance events. Four age-matched (at approximately twenty, fifty, sixty and 
seventy years of age) sub-groups were extracted from the healthy sedentary 
male population to allow a meaningful comparison. 
The anthropometric data for all groups are presented in Table 6. The main 
significant differences were in the amount of body fat. The absolute amount of 
body fat was lower in all the athletic groups, in comparison to their age- 
matched sedentary peers. These differences were statistically significant 
(P < 
0.05) at twenty, fifty and sixty years of age. This difference was again evident 
when fat mass was expressed as a percentage of 
total body weight (BF): all of 
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Sedentary 
Age (Years) 20.4 ± 0.3 49.8 ± 1.0 58.6 ± 0.8 70.1 ± 1.0 
n 18 89 13 
Height (cm) 178.8 ± 2.2 174.5 ± 2.0 172.3 1.9 175.0 ±1.2 
Total Body Mass (kg) 80.5 ± 2.6 82.1 ± 3.5 82.9 ± 3.3 81.4 3.5 
Body Mass Index (kg/m) 25.1 ± 0.6 27.1 ± 1.5 27.9 ± 0.8 26.5 ± 1.0 
Body Surface Area (m) 1.99 ±0 1.97 ±0 1.96 ±0 1.97 ±0 
Fat Body Mass (kg) 16.4 ± 1.4 21.0 ± 2.4 22.4 ± 1.7 t 21.1 ± 1.5 
% Body Fat 19.7 ± 1.0 25.1 ± 1.9 t 26.8 ± 1.4 t 25.3±1.1 t 
Lean Body Mass (kg) 62.4 ± 1.63 58.5 ± 1.4 58.0 ± 2.0 58.5 ± 1.9 
Athletes 
Age (Years) 19.6 ± 0.8 49.5 ± 0.8 57.3 ± 0.7 67.8 ± 1.4 
n 15 13 9 6 
Height (cm) 180.8 ± 1.3 172.3±2.0t 172.9±1.8t 175.6±4.5 
Total Body Mass (kg) 80.1 ± 2.4 72.7 ± 3.8 72.8 ± 2.6 71.9 ± 2.8 
Body Mass Index (kg/M2) 24.5 ± 0.7 24.4 ± 1.0 24.4 ± 0.7 24.6 ± 1.3 
Body Surface Area (m) 2.00 ±0 1.85 ± 0.1 t 1.86 ±0 1.83 ±0 
Fat Body Mass (kg) 11.4 ± 7.5 * 12.6 ± 1.9 * 12.6 ± 1.8 * 13.7 ± 1.3 
%BodyFat 13.8±0.7* 16.5±1.6* 16.7±1.8* 19±1.4* 
Lean Body Mass (kg) 66.7 ± 1.5 57.1 ± 2.2 t 58.0 ± 1.4 t 55.6 ± 2.0 t 
Table 6- Anthropometric characteristics of endurance-trained and sedentary men. 
Data are presented as means ± standard error of the mean. 
* Significant differences (P < 0.05), when comparing age-matched sedentary and 
athletic men. 
t Significant differences (P < 0.05), compared to 20-year old sedentary men. 
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the athletic men had much lower BF in comparison to the sedentary age- 
matched counterparts (P < 0.05). The BF also increased significantly (P < 
0.05) in the older sedentary men, compared with the younger twenty-year old 
sedentary group. No significant differences were found in lean body mass, and 
while total body mass was lower in the older active groups compared to the 
sedentary groups, these differences were not statistically significant. 
Therefore, the endurance-training regime had prevented the age-related 
accumulation of fat that was measured in the sedentary men. 
5.1 The Effect of Habitual Endurance Exercise Training on 
Aerobic Power in Men 
Each group of athletes had a significantly (P < 0.0001) higher V02max than 
their age-matched sedentary counterparts (Fig. 23). In percentage terms the 
training-related adaptations were 25%, 45%, 52%, and 58% at twenty, fifty, 
sixty and seventy years of age, respectively. Furthermore, the V02max of all 
the veteran athletes did not differ significantly from that of the twenty year old 
sedentary group. This illustrates that engaging in long-term endurance 
exercise can effectively attenuate the impact that fifty years of healthy ageing 
has on maximum aerobic power. Nonetheless, even in the highly-trained men 
V02max still decline significantly (P < 0.0001) by 29% (16.4 ml/kg/min) between 
twenty and seventy years of age (Fig. 23). 
The allometric scaling process was employed to minimise any effect of body 
size on Vo2max, and in an attempt to improve the precision and interpretation 
of the data. However, after completing the scaling process the same 
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Figure 23 - Maximum aerobic power in age-matched sedentary and 
endurance-trained men. 
Maximum aerobic power of sedentary ( ), and endurance- trained men (") 
of twenty, fifty, sixty and seventy years of age. 
Data are presented as means ± standard error of the mean. 
* Significant differences (P < 0.05) when comparing age-matched sedentary 
and athletic men. 
t Significant differences (P < 0.05) compared to either sedentary or trained 
twenty-year old men. 
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significant differences remained between the active and inactive groups, as 
were shown by the relative measures in Fig. 23. 
5.2 The Effect of Endurance Exercise Training on Resting 
Cardiac Function in Men 
There were no significant differences in the CPOrest between any of the groups 
of men, irrespective of their activity status (Fig. 24). There were however some 
statistically significant differences between these groups in the individual 
components of resting blood flow and blood pressure generation (Table 7). As 
shown earlier (section 4.2) Qrest decreased over the course of healthy ageing 
in the sedentary men. This trend was unaffected by long-term endurance 
exercise, as Qrest also decreased with advancing years in the trained men. 
Also, there were no age-matched differences between any of the inactive and 
active groups in Qrest. While there was no age-related change in HRrest, long- 
term endurance exercise significantly (P < 0.05) lowered HRrest by -23% in the 
fifty, sixty and seventy-year old veteran athletes, compared to their age- 
matched sedentary counterparts. However, these changes were balanced by 
higher SVrest in all the groups of male athletes, although there was still an age- 
related decline. 
Long-term endurance exercise had no significant impact on resting MAP, SBP, 
or DBP. Thus, the trend towards small age-related increases in resting 
blood 
pressure in men remained irrespective of activity status. 
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Figure 24 - The effects of healthy ageing and endurance exercise on resting 
and maximum cardiac power output in men. 
Square symbols depict values for sedentary men and circles athletes. Open 
and solid symbols represent values measured at rest and maximum 
exercise, respectively. 
Data are presented as means ± standard error of the mean. 
* Significant differences (P < 0.05) when comparing age-matched sedentary 
and athletic men. 
t Significant differences (P < 0.05) compared to either sedentary or trained 
twenty year-old men. 
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5.3 Changes in Maximum Cardiac Function as a Result of 
Endurance Exercise in Men 
Considering the training related increase in V02max (Fig. 23) which clearly 
results from engaging in long-term endurance exercise, and the role the heart 
plays in determining aerobic power, a similar increase in CPOmax might be 
anticipated. Maximum CPO was higher in all the groups of athletes in 
comparison to their age-matched sedentary counterparts. The increase was 
statistically significant (P < 0.01) at twenty (28%) and fifty (26%) years of age. 
Nonetheless, the CPOmax of the veteran athletes still declines with increasing 
age, and indeed at a steeper rate compared to that observed in the sedentary 
men (Fig. 24). 
The individual components of CPOmax i. e. maximum blood flow and blood 
pressure generation are shown in Table 8. As with CPOmax, Qmax was higher in 
all the groups of trained men, in comparison to the age-matched inactive 
controls. This training adaptation equated to increases of between 16 and 
26%, and reached statistical significance (P < 0.05) when the twenty and fifty 
year old age-matched groups were compared. Nonetheless Amax still declined 
with ageing in the athletic population. But, despite this Amax was still the same 
or higher in all the groups of veteran athletes when compared to the much 
younger twenty-year old sedentary men. 
In contrast, habitually engaging in aerobic exercise had no significant effect on 
HRmax, which still declined with increasing age irrespective of activity status. 
Thus the training-related increase in blood flow generation was attributable 
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to an increase in SVmax (Table 8). Indeed, the SVmax of the seventy-year old 
endurance trained men was still higher than that of the sedentary men fifty 
years their junior. 
The data on the generation of maximum blood pressure is also shown in Table 
8. The long-term endurance training had no significant impact on any of the 
measurements of maximum blood pressure. 
The cumulative effect of these changes is that the endurance-trained males at 
all ages have a higher overall cardiac functional reserve capacity (Fig. 25). But 
there is an age-related decline in CR irrespective of either a sedentary or 
active lifestyle. Furthermore, the decline in CR is greater with the advancing 
years in the trained men. At twenty-years of age the exercise-induced 
improvement in CR is 1.7 Watts, diminishing to 0.6 Watts at seventy years of 
age. But the CR of the seventy-year old veteran athletes is still only 0.2 Watts 
below that of twenty-year old sedentary men. 
In summary; when men regularly engage in long-term endurance exercise 
CPOrest is unaffected, while the training elicits clear adaptations in both Vo2max 
and CPOmax. These adaptations translate into all the athletic men having 
higher functional cardiac reserves, when compared to healthy sedentary age- 
matched counterparts. In both cases CR decreases with age, but the rate of 
decrease is greater in the trained men. 
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Figure 25 - Changes in overall cardiac functional reserve as a consequence of 
ageing and endurance exercise. 
Overall cardiac function reserve of sedentary ( ), and endurance- trained men 
(") of twenty, fifty, sixty and seventy years of age. 
Data are presented as means ± standard error of the mean 
* Significant differences (P < 0.05) when comparing age-matched sedentary 
and athletic men. 
t Significant differences (P < 0.05) compared to either sedentary or trained 
twenty-year old men. 
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6.0 The Impact of a Failing Heart on Overall Function 
Studying the effects of heart failure provides an extreme contrast to the hearts 
of endurance trained athletes, which have been conditioned through 
endurance exercise over many years, i. e. physiological versus the patho- 
physiological changes. Indeed, this is one of the strengths of using CPO and 
CR, i. e. it allows you to determine whether the heart is operating well or poorly 
as a hydraulic pump. 
The decision was taken to measure CPO in heart failure patients as it would 
provide an ideal opportunity to determine the minimum baseline of human in 
vivo physiological function. Secondly, testing these patients would also add 
further validity to the use of CPO by testing the techniques sensitivity. 
Twenty-one male patients (NYHA class III and IV) were recruited and 
completed the full testing protocol. Within one week of completing the tests all 
the patients underwent surgery to have bio-ventricular pacemakers implanted 
in an attempt to improve the performance of their hearts, and hence their 
quality of life. 
As detailed in section 2.0 each patient was undergoing individualised 
treatment with various drugs in an attempt to prevent any further deterioration 
in their condition prior to surgery. The most commonly used drugs were 
various beta-blockers, diuretics, spirolactones, ACE-inhibitors and aspirin. 
The mean age of the heart failure patients was 68.1 ± 1.8 years, but their ages 
ranged from forty-six to eighty years. To allow the effects of the patho- 
109 
Results 
physiological disease to be accurately quantified, an age-matched (mean age 
of 67.9 ± 1.3) group of seventeen sedentary healthy males was extracted from 
the earlier collected data and used as a control group. The age range of this 
group was the same as that of the heart failure patients. The anthropometric 
characteristics of both groups are shown in Table 9. 
6.1 Changes in Aerobic Function as a Result of Heart Failure 
in Men 
When compared to the control group, the Vo2rest of the heart failure group was 
significantly (P < 0.05) higher (14%), but without being outside the normal 
range (Fig. 26a). When maximally stimulated the Vo2max of the heart failure 
group was significantly (P < 0.0001) lower. Indeed, it was 45% below that of 
the healthy control group (Fig. 26b). These significant differences remained 
whether the measures were reported in absolute terms, or relative to total 
body mass. Therefore, it is apparent the process of heart failure had 
significantly compromised the aerobic power of the patients. 
6.2 The Impact of Heart Failure on Resting Cardiac Function 
At 0.6 ± 0.0 Watts the CPOfest of the heart failure patients was significantly (P 
< 0.05) below (30%) that of the control group (Fig. 27a). In terms of blood flow 
generation Qrest was 11 % (P < 0.05) below the mean of the healthy male 
group. This was entirely attributed to a lower SVrest (17%), although this failed 
to reach the level of statistical significance because there was no difference in 
HR rest between the groups 
(Table 10). 
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Healthy Control Group Heart Failure Patients 
n 17 21 
Age (years) 67.9+-1.3 68.1 ± 1.8 
Height (cm) 174.4 ± 1.2 170.7 ± 1.6 
Total Body Mass (kg) 82.3 ± 3.1 84.4 ± 3.2 
Body Mass Index (kg/m) 27.0 ± 0.8 28.9 ± 0.9 
Body Surface Area (m) 2.0 ± 0.0 2.0 ± 0.0 
Table 9- Anthropometric characteristics of male healthy control group heart 
failure patients. 
Data are presented as means ± standard error of the mean. 
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Figure 26 - Changes in aerobic function as a consequence of heart failure. 
Resting (A) and maximum Vol (B) values are expressed in absolute terms 
for both the healthy sedentary male control group ( ), and heart-failure 
patients (o). 
Data are presented as means ± standard error of the mean. 
Significant differences (* P<0.05; ** P<0.0001) between the control and 
heart failure groups. 
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Figure 27 - Changes in overall cardiac function in men as a consequence 
of heart failure. 
Resting CPO (A), maximum CPO (B) and overall function reserve (C) 
values for the healthy sedentary control group ( ), and the group of male 
heart-failure patients (o). 
Data are presented as means ± standard error of the mean. 
Significant differences (* P<0.001; ** P<0.0001) between the control and 
heart failure groups. 
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Healthy Control Group Heart Failure Patients 
Q (1/min) 4.1 ± 0.2 3.2 ± 0.2 
HR (BPM) 72.2 ± 3.0 70.1 ± 2.9 
SV (ml) 57.2 ± 3.3 47.6 ± 4.6 
MAP (mmHg) 96.1 ± 1.7 86.6 ± 2.1 ** 
SBP (mmHg) 125.3 ± 2.5 116.9 ± 3.0 
DBP (mmHg) 75.7 ± 2.0 65.3 ± 2.0 ** 
Table 10 - Resting blood flow and blood pressure in healthy males and heart 
failure patients. 
Data are presented as means ± standard error of the mean. 
Significant differences (* P<0.05; ** P<0.01) between the control and heart 
failure groups. 
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Resting mean arterial blood pressure was 1 0% (P < 0.01) lower in the heart 
failure group (Table 10), as a consequence of a 14% depression of DBPrest (P 
< 0.01). 
6.3 The Impact of Heart Failure on Maximum Cardiac 
Function in Men 
As with aerobic power, the effects of heart failure on overall cardiac function 
become even starker when examined at maximal stimulation. The CPOrnax of 
the heart failure group was 57% below that of the healthy sedentary men (P < 
0.0001; Fig. 27b). 
The generation of maximum blood flow was significantly impaired by the 
disease process. Maximum cardiac output was 47% (P < 0.0001) below that of 
the healthy sedentary men (Table 11). This large suppression in Qmax in the 
heart failure patients was the result of significant (P < 0.01) decreases in both 
HRmax (23%) and SVmax (28%). 
The ability of the heart failure patients to generate blood pressure was also 
severely impaired. Over the entire cardiac cycle MAPmax was 20% (P < 
0.0001) below that of the healthy controls (Table 11). This was mainly due to 
the significant (P < 0.0001) 26% decrease in SBPmax. While DBPmax did show 
a trend to be lower in the heart failure patients, this was not statistically 
significant (P > 0.05). 
Hence, both resting and maximum overall cardiac function decreased 
significantly as a consequence of heart failure. 
The impact of the disease was 
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Healthy Control Group Heart Failure Patients 
Q (1/min) 16.6 ± 0.6 8.8 ± 0.7 ** 
HR (BPM) 155.1 ± 3.4 119.3 ± 5.6 ** 
SV (ml) 107.2 ± 3.2 77.7 ± 8.1 
MAP (mmHg) 125.6 ± 2.6 100.4 ± 2.4 ** 
SBP (mmHg) 197.2 ± 3.5 145.1 ± 4.2 ** 
DBP (mmHg) 75.4 ± 3.6 69.1 ± 2.1 
Table 11 - Maximum blood flow and blood pressure in healthy males and heart 
failure patients. 
Data are presented as means ± standard error of the mean. 
Significant differences (* P<0.001; ** P<0.0001) between the control and 
heart failure groups. 
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greater on CPOmax than CPOrest. The result was that the overall cardiac 
functional reserve of these heart failure patients was only 1.3 ± 0.1 Watts (Fig. 
27c). This is significantly (P < 0.0001) below (64%) the CR of a healthy 
sedentary male. Furthermore, these patients only have 30% of the reserve 
capacity that was measured in the healthy seventy year old endurance-trained 
males (section 5.3). With a CR of only 1.3 Watts it is apparent the impact of 
the disease has hugely compromised the hearts ability to operate as a 
hydraulic pump, and sustain a good quality of life. 
By comparing a range of men from the very active endurance trained, to those 
suffering from heart failure, it has been possible to examine the different 
impacts physiological and pathophysiological processes have on the overall 
reserve capacity of the male human heart. The effectiveness of an individual's 
heart in pumping blood around the body has a huge impact on their ability to 
cope with the demands of daily life. Focus will now move to determine what 
impact ageing has on overall cardiac function in healthy women, and the 
effects of endurance-exercise. 
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Chapter 7 
Results 
Changes in Aerobic Power and Overall 
Cardiac function in Sedentary Women 
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7.0 The Effects of Healthy Ageing in Sedentary Women 
One hundred and thirteen healthy sedentary women, between nineteen and 
seventy-six years of age were recruited, and consequently used to assess the 
effects of healthy ageing on overall cardiac function. Forty-seven of these 
women between nineteen and forty-nine years of age were pre-menopausal, 
five between forty-three and forty-nine years of age were peri-menopausal, 
and the remaining sixty-one between forty-five and seventy-six years of age 
were post-menopausal. Within the pre-menopausal group twenty-one (45%) 
were taking oral contraceptives, and twelve of the post-menopausal women 
(20%) were on hormone replacement therapy. 
7.1 Changes in Body Mass and Aerobic Function in 
Sedentary Women 
Total body mass (TBM) and body surface area (BSA) did not change 
significantly (P > 0.05) as a result of fifty-seven years of healthy ageing in this 
large group of women. The mean values were 68.0 ± 1.0 kg and 1.7 ± 0.0 m2 
respectively. In contrast, body mass index (BMI) did increase significantly (P < 
0.01) by 14%, ranging from 17.9 to 34.5 kg/m2. 
Resting oxygen consumption (V02rest) in both absolute terms (Fig. 28a) and 
relative to total body mass (Fig. 28b) did not change significantly between 
nineteen and seventy-six years of age. In contrast, Vo2max declined 
significantly (P < 0.0001) in both absolute terms (Fig 28a) and relative to total 
body mass (Fig. 28b). The reduction in V02max was 40%, both in absolute and 
relative terms, and equated to a total decrease of 878 ml/min over the 
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Figure 28 - Changes in aerobic function in women as a consequence of 
healthy ageing. 
Resting Vol () expressed in (A) absolute terms (F (1,111) = 2.6, P> 
0.1), and (B) relative to total body mass (F (1,111) = 2.2, P>0.1) did not 
change significantly over fifty-six years ageing. 
In contrast both Vo2max (") expressed in (A) absolute terms (F (1,111) = 
78.6, P<0.0001), and (B) relative to total body mass F (1,111) = 106.8, P 
< 0.0001) declined significantly over the same period in the same 
subjects. 
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fifty-seven year period studied. 
A similar reduction in cardiac function might be anticipated in these women 
given the decrease in aerobic power which occurred over the course of 
healthy ageing. 
7.2 Resting Cardiac Function in Sedentary Women 
Resting CPO did not change significantly (P > 0.1) in healthy but sedentary 
women between nineteen and seventy-six years of age (Fig. 29). The mean 
CPOrest for the entire group was 0.8 ± 0.0 Watts. 
Despite the lack of any significant change in CPOrest, Orest did show a 
significant (P< 0.01) 23% decrease (Fig. 30a). As HRrest (Fig. 30c) did not 
change significantly (P > 0.2) over the same period in these subjects (mean 
HRrest was 69.5 ± 0.9 bpm), the reduction in Qrest was ascribed entirely to the 
significant (P < 0.05) 19% reduction in SVrest (Fig. 30b) The decreases in Qrest 
and SVrest were statistically significant, but the absolute magnitude of the 
change over the fifty-seven year period was very small, 1.0 I/min and 11.5 ml 
Quest and SVrest, respectively. 
In these sedentary women, all of the components of resting blood pressure 
increased significantly as a consequence of ageing. Over the entire cardiac 
cycle MAPrest increased (P < 0.0001) by 16% between nineteen and seventy- 
six years of age (Fig. 31 a). Over the same period SBPrest also increased 
significantly (P < 0.0001) by 25% (Fig. 31 b). Although the increase 
in DBPrest 
was less (9.1 %), it was still significant (P < 0.01) over the same period 
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Figure 29 - The effects of fifty-six years of healthy ageing on resting 
overall cardiac function in women. 
Resting CPO (F (1,111) = 1.9, P>0.1) showed no correlation to healthy 
ageing in these sedentary women, between nineteen and seventy-six 
years of age. 
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Figure 30 - The effects of healthy ageing on resting blood flow in women 
80 
Resting cardiac output (A) (F (1,111) = 10.3, P<0.01), and stroke volume 
(B) (F (1,111) = 4.6, P<0.05) decreased significantly while resting heart 
rate (C) (F (1,111) = 1.3, P>0.2) showed no significant change between 
nineteen and seventy-six years of age. 
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Figure 31 - Ageing and its effects on resting 
blood pressure in women. 
Resting MAP (A) (F (1,111) = 27.3, P<0.0001), 
SBP (B) (F (1,111) = 
61.1, p<0.0001) and DBP (C) (F (1,111) = 
8.2, P<0.01) all increased 
significantly as a consequences of 
healthy ageing. 
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(Fig. 31c). 
With the progression of healthy ageing SVRrest significantly (P < 0.0001) 
increased in these sedentary women. The escalation in the resistance to blood 
flow was 64% or 1013 dynes/s/cm5 between nineteen and seventy-six years of 
age (Fig. 32), and helps to explain why Qrest (Fig. 30a) and SVrest (Fig. 30b) 
decreased, whilst MAPrest (Fig. 31 a) increased in these women with the 
advancing years. 
7.3 Maximum Cardiac Function in Sedentary Women 
The lack of a significant change in CPOfeSt in healthy women is interesting, but 
not surprising given the lack of an age-related change in Vo2rest (Fig. 28). 
However, the lack of a significant change (P > 0.3) in CPOmax over the same 
age-range (Fig. 33) is very important, and was unexpected given the 40% 
reduction in Vo2max (Fig. 28). The mean CPOmax for the entire group of 
sedentary healthy women was 4.07 ± 0.07 Watts. 
Despite this lack of any change in overall cardiac function as a result of ageing 
in healthy women, there were significant changes in the two component parts 
of CPOmax, i. e. blood flow and blood pressure. In terms of maximum blood 
flow, Qmax decreased significantly (P < 0.0001) by 26% (Fig. 34a). The SVmax 
of these women did not change significantly (P > 0.1), the mean SVmax for the 
group was 87.6 ± 1.2 ml (Fig. 34b). Therefore, the significant (P < 0.0001) 
19% decrease in HRmax (Fig. 34c), which equates to a reduction of 0.6 beats 
per year was the main reason for the decline of °max. 
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Figure 32 - Resting systemic vascular resistance and the age-related 
change in sedentary women. 
Resting systemic vascular resistance (F (1,111) = 19.7, P<0.0001) 
showed a strong linear increase as a result of healthy ageing in women. 
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Figure 33 - Maximum overall cardiac function in sedentary women 
between nineteen and seventy-six years of age. 
Maximum cardiac power output did not change significantly (F (1,111) _ 
0.8, P>0.3) as a result of healthy ageing in women. 
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Figure 34 - The effects of ageing on maximum blood flow generation in 
women. 
Maximum cardiac output (A) (F (1,111) = 37.5, P<0.0001), stroke volume 
(B) (F (1,111) = 2.2, P>0.1), and heart rate (C) (F (1,111) = 84.9, P< 
0.0001) were measured between nineteen and seventy-six years of age in 
healthy women. 
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Significant increases (P < 0.0001 -P<0.05) in MAP,, a (26%; Fig. 36a), 
SBPmax (9%; Fig. 36b) and DBPmax (63%; Fig. 36c) occurred between nineteen 
and seventy-six years of age. This adaptation in blood pressure generation 
opposes the decrease in blood flow over the same age-range. The decrease 
in Qmax as with the decrease in Qfest is partly the result of a significant (P < 
0.0001) increase in SVRmax (Fig. 36). The magnitude of the SVRmax increase 
was 75% in these women. 
Hence, by directing more of its pumping energy into pressure generation, as 
opposed to flow generation, the CPOmax of the healthy female heart remains 
unchanged over most of its adult life span. 
Given the 40% decrease in Vo2max (Fig. 28), but the lack of any change in 
CPOmax (Fig. 33), there is an unexplained discrepancy between the central 
(cardiac) pumps maintained function, and a reduced ability to consume 
oxygen with advancing age in healthy women. When the a-V O2diffmax was 
calculated it showed a significant (P < 0.0001) 17% decline in these healthy 
women (Fig. 37). This illustrates that healthy ageing in women has an adverse 
effect on the ability of skeletal muscles to extract and consume oxygen. And 
together with the age-related decline in Qmax (Fig. 34a) explains why healthy 
ageing results in a reduced exercise capacity. 
So, between nineteen and seventy-six years of age no significant changes 
occur in either resting aerobic function (Fig. 28), or resting overall cardiac 
function (Fig. 29) in healthy women. Maximal aerobic power does however 
decrease dramatically (Fig. 28) over the same age range. But, while Qmax 
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Figure 35 - Age-related values of maximum blood pressure in sedentary 
women. 
Maximum mean arterial (A) (F (1,111 = 44.7, P<0.0001), systolic (B) (F 
(1,111) = 4.7, P< 0.05) and diastolic (C) (F(1,111 = 83.1, P< 0.0001) 
blood pressures all increased significantly as a consequence of healthy 
ageing in women. 
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Figure 36 - The effect of healthy ageing on systemic vascular resistance 
at maximum aerobic power in sedentary women. 
Systemic vascular resistance at Vo2max (F (1,111) = 72.6, P<0.0001) 
showed a strong linear increase as a result of healthy ageing in women 
between nineteen and seventy-six years of age. 
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Figure 37 - The effect of ageing on maximum arteriovenous oxygen 
difference in healthy women. 
Maximum arteriovenous oxygen difference a -v02 diff declined 
significantly (F (1,111) = 13.21, P<0.0001) in healthy women between 
nineteen and seventy-six years of age. 
This value was calculated from the measurement of Vol and Q. 
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(Fig. 34a) also declines, there is a concomitant increases in MAPmax (Fig. 35a) 
which helps to effectively maintain maximal overall cardiac function (Fig. 33). 
With both CPOfeSt and CPOmax being effectively maintained in women, there 
was no significant deterioration (P > 0.5) in the overall functional reserve 
capacity (CR) of the female heart (Fig. 38). Hence, the healthy female heart 
appears to be resistant to the effects of ageing, at least between nineteen and 
seventy-six years of age. 
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Figure 38 - Cardiac functional reserve in women between nineteen and 
seventy-six years of age. 
Cardiac function reserve determined as CPOmax - CPOrest (see Figs. 34 
and 30) showed no significant (F (1,111) = 0.3, P>0.5) change in healthy 
women. 
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The Effects of Endurance-Training 
in Women 
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8.0 Long-Term Endurance Exercise Training in Women 
The healthy female heart appears to be remarkably resilient, maintaining it 
overall function in the face of ageing (see chapter 7). However, the question of 
what impact long-term endurance training has on overall cardiac function in 
women has not been previously studied. 
Three groups of female athletes were recruited; they were approximately 
twenty-five, fifty and sixty years of age and were compared to healthy but 
sedentary age-matched women. Only active females who trained and 
competed on a regular basis were chosen. Unfortunately, the total number of 
recruits that met our stringent selection criteria was less, this being due to the 
fact that there are less active females than males, especially in the older age 
ranges. 
All of the athletes who were recruited were still competitive in various distance 
events. In the twenty-five year old age group some individuals were of national 
or international competition standard. All of these younger athletes covered 
forty-one miles per week, and had been training for, on average, thirteen 
years. All the women in the two older age groups (fifty and sixty years of age) 
were recruited from athletics clubs across Merseyside. The fifty year old age 
group covered thirty-six miles per week, and had been training for an average 
of twenty years. The sixty year old age group still covered twenty-nine miles 
per week, and had been training for, on average, fourteen years. These 
volumes of exercise were in marked contrast to the sedentary women who 
engaged in less than ninety minutes of exercise (both structured and 
recreational) per week. Also, by only recruiting women who completed these 
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high volumes of endurance training, it also ensured a meaningful comparison 
could be made to the male athletes, i. e. the training stimulus was as 
comparable as possible. 
The anthropometric data for the groups is presented in Table 12. The 
percentage of total body weight which was fat was significantly (P <0.0001) 
lower in all the athletic groups in comparison to their age-matched sedentary 
counterparts. Furthermore, the sixty year old veteran athletes had a lower 
body fat percentage than the twenty-five year old sedentary group. In all the 
other anthropometric respects the sedentary and trained women were 
comparable. 
8.1 Long-Term Endurance Exercise Training and Aerobic 
Power in Women 
As expected, engaging in long-term endurance training had a significant 
impact on Vo2max (Fig. 39). Each of the three groups of endurance-trained 
women had significantly (P < 0.0001) greater aerobic power than the 
sedentary age-matched groups. The adaptations were 81%, 60% and 64% at 
twenty-five, fifty and sixty years of age, respectively. Furthermore, the fifty and 
sixty year old athletic female groups had a significantly (P < 0.05) greater 
V02max than the sedentary twenty-five year old group. These changes 
illustrates that engaging in long-term endurance exercise has a positive effect 
on Vo2max, despite the confounding influence of healthy ageing. These 
significant differences between active and sedentary women remained 
whether aerobic power was reported in absolute terms, per kilogram of total 
body mass, or scaled to lean body mass. But, healthy ageing still resulted in a 
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Sedentary 
Age (Years) 25.7 ± 0.7 48.1 ± 0.5 60.8 ± 0.5 
N 18 13 37 
Height (cm) 167.1 ± 1.5 164.0 ± 1.9 159.1 ± 0.9 t 
Total Body Mass (Kg) 63.4 ± 1.6 68.7 ± 3.2 67.3 ± 1.3 
Body Mass Index (Kg/M2) 22.8 ± 0.6 25.5 ± 1.1 26.5 ± 0.5 t 
Body Surface Area (m) 1.7 ± 0.0 1.7 ± 0.0 1.7 ± 0.0 
Fat Body Mass (Kg) 18.4 ± 0.8 23.0 ± 2.2 24.4 ± 0.8 t 
% Body Fat 28.9 ± 0.8 32.8 ± 1.8 36.0 ± 0.6 t 
Lean Body Mass (Kg) 42.6 ± 1.0 43.4 ± 1.5 40.9 ± 0.7 t 
Athletes 
Age (Years) 26.8 ± 1.1 50 ± 1.0 60.8 ± 2.5 
N 6 8 4 
Height (cm) 164.9 ± 1.4 162.2 ± 2.8 163.2 ± 3.1 
Total Body Mass (Kg) 56.0 ± 2.6 61.2 ± 2.6 63.4 ± 4.4 
Body Mass Index (Kg/M2) 20.6 ± 0.8 23.3 ± 0.9 24.0 ± 2.3 
Body Surface Area (m) 1.6 ± 0.0 1.7 ± 0.0 1.7 ± 0.0 
Fat Body Mass (Kg) 9.5±1.4* 16.4±1.8t 16.5±2.6 
% Body Fat 16.7±1.7* 26.4±2.0*t 25.7±2.4*t 
Lean Body Mass (Kg) 44.2 ± 1.8 42.6 ± 1.4 44.6 ± 2.2 
Table 12 - Anthropometric characteristics of endurance-trained and sedentary 
women. 
Data are presented as means ± standard error of the mean. 
* Significant differences (P < 0.05) when comparing age-matched sedentary and 
athletic women. 
t Significant differences (P < 0.05) compared to either sedentary or trained twenty- 
five year old women. 
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Figure 39 - Maximum aerobic power in age-matched sedentary women and 
female athletes. 
The maximum aerobic power sedentary ( ) and long-term endurance- 
trained women (") of twenty-five, fifty and sixty years of age. 
* Significant differences (P < 0.05) when comparing age-matched sedentary 
and athletic women. 
t Significant differences (P < 0.05) compared to either sedentary or trained 
twenty-five year old women. 
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significant (P < 0.0001) 32% reduction in the Vo2max of the athletic women, 
between twenty-five and sixty years of age (Fig. 39). 
8.2 Long-Term Endurance Exercise Training and Resting 
Cardiac Function in Women 
There were no significant (P > 0.6) discriminatory differences in CPOrest 
between any of the female groups (Fig. 40). The measurements showing the 
age- and training-related changes in resting blood flow and blood pressure are 
presented in Table 13. 
Resting cardiac output exhibited a decreasing trend with increasing age in 
both the sedentary and trained women. This change was not significant (P > 
0.05) in the sedentary women, but was significant (P < 0.05) when comparing 
the youngest and oldest endurance trained groups. All of the trained groups 
had a lower HRrest than their age-matched sedentary counterparts. However, 
the differences only reached statistical significant (P < 0.05) at twenty-five and 
sixty years of age. In the twenty-five year old athletes SVrest was significantly 
(P < 0.05) increased by 44%, thus compensating for the decline in HRrest and 
maintaining Qrest" In contrast, there were no significant (P > 0.9) age-matched 
differences in SVrest at either fifty or sixty years, and an age-related decrease 
in SVreSt was evident in both the sedentary and trained women. 
Training induced no meaningful changes in resting blood pressure generation 
(Table 13). In the athletic populations MAPrest, SBPrest and DBPrest all showed 
similar increasing trends with age, as was evident in the sedentary women. 
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Figure 40 - The effects of healthy ageing and long-term endurance exercise 
on cardiac power output in women. 
Square symbols depict values for sedentary women and circles athletes. Open 
and solid symbols represent values measured at rest and maximum exercise, 
respectively. 
Data are presented as means ± standard error of the mean. 
There were no statistically significant (P > 0.05) differences between any of 
the measurements of CPO, when comparing any of the sedentary or trained 
groups at rest, or at maximal exertion. 
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As mentioned previously CPOfeSt represents only a small proportion of the 
overall cardiac reserve. Hence, changes at rest might be expected to be small 
and not discriminate between very different populations. 
8.3 Long-Term Endurance Exercise Training and Maximum 
Cardiac Function in Women 
Unexpectedly and very interesting there were no significant (P > 0.05) 
changes in the CPOmax of long-term endurance trained women, compared with 
the sedentary controls (Fig. 40). This lack of any adaptation to the training 
stimulus is perhaps surprising given the marked adaptation in Vo2max in the 
same subjects (Fig. 39). Also, the lack of a training induced adaptation in 
CPOmax in the very active women is in stark contrast to the changes seen in 
the equivalent male populations (Fig. 24), despite the fact that both sexes 
were engaging in comparable exercise protocols, and therefore receiving a 
similar training stimulus. While there did appear to be a small increase (17 %) 
in CPOmax in the twenty-five year old female athletes, this difference was not 
statistically significant (P > 0.05) when compared to the age-matched 
sedentary women. 
In terms of maximum blood flow generation, Amax was higher in all the trained 
groups of women, when compared to the age-matched sedentary groups. 
However, these differences only reached statistical significance (P < 0.05) at 
twenty-five years of age (Table 14). There was also a significant (P < 0.05) 
age-related decline in Qmax in both the trained and sedentary women. The 
higher Qmax values measured in the athletic groups were the result of positive 
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adaptations in SVmax in response to the training stimulus (Table 14). Maximum 
stroke volume was higher in all the trained groups, but again the difference 
was only statistically significant when comparing the youngest age-matched 
groups. There were no age-matched differences in HRmax, which decreased 
with increasing age in both the active and sedentary women (Table 14). 
As with the resting measures of blood pressure (Table 13), training had no 
effect on any of the measures of blood pressure at maximum exercise (Table 
14). Hence, MAPmax still increased with age in both populations, regardless of 
their activity lifestyles. 
The impact of these changes (both significant and non-significant) was that all 
the athletic groups had higher cardiac functional reserves than their age- 
matched sedentary counterparts (Fig. 41). These increases though were not 
statistically significant (P > 0.05), and equated to only 25%, 21 % and 8% at 
twenty-five, fifty and sixty years of age, respectively in women. 
To explain how the endurance trained women could increase their Vo2max by 
up to 81 % in comparison to their age-matched sedentary counterparts, despite 
there being very little significant adaptations in Qmax and CPOmax, maximum 
arteriovenous oxygen differences (a -V O2diffmax) were calculated. In response 
to the long-term endurance training stimulus the a -V 02diffmax increased 
significantly (P < 0.0001) in all three of the trained groups of women, 
compared to the age-matched sedentary groups (Fig. 42). The magnitude of 
the increase was 33%, 29%, and 48% at twenty-five, fifty and sixty years of 
age, respectively. Furthermore, engaging in long-term endurance exercise 
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Figure 41 - Overall cardiac functional reserve in sedentary and endurance- 
trained women. 
Overall cardiac functional reserve of sedentary ( ) and long-term endurance- 
trained women (") of twenty-five, fifty and sixty years of age. 
Data are presented as means ± standard error of the mean. 
There were no statistically significant (P > 0.05) differences between any of 
the measurements of CR when comparing any of the sedentary or trained 
groups. 
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Figure 42 - Maximum arteriovenous oxygen difference in age-matched 
sedentary and athletic females. 
The a -V 02diffmax of age-matched sedentary ( ) and long-term endurance 
trained women ("). 
This value was calculated from the measurement of Vol and Q. 
* Significant differences (P < 0.05) when comparing age-matched sedentary 
and athletic women. 
t Significant differences (P < 0.05) compared to either sedentary or trained 
twenty-five year-old women. 
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prevented any age-related decrease in a -vO2 diffmax, illustrated by the fact that 
the fifty and sixty year old athletes had significantly (P < 0.0001) higher a -v02 
diffmax values than the younger sedentary (twenty-five year old) women. 
Participating in long-term endurance exercise was effective in increasing the 
aerobic power of these women (Fig. 39). Despite this there were no 
statistically significant changes (P > 0.05) in either CPOmax (Fig. 40) or CR 
(Fig. 41), as a result of healthy ageing or endurance-exercise training. This is 
in marked contrast to the training induced adaptation measured in men 
(chapter 5), where substantial changes in the overall function were observed 
in response to a comparable exercise stimulus. 
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Chapter 9 
Results 
Sex-Related Differences in Body 
Composition and Overall Cardiac 
Function in Response to Ageing. 
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9.0 The Impact of Body Composition 
The effect of healthy ageing on overall cardiac function therefore seems to 
differ between the two sexes. Healthy women maintain cardiac function, while 
in stark contrast over the same period the overall capacity of the male heart 
decreases significantly. Hence, it seemed appropriate to study these sex- 
related differences in more detail. 
Clearly there are distinct differences in body size and composition between 
men and women, these dissimilarities need to be taken into account when 
comparing potential sex-related differences in cardiac function. Sex specific 
changes also occur in body mass and composition (Starling, 2001) as a 
consequence of ageing. Therefore, some of the reported changes in the 
dynamic functions e. g. Vo2max and CPO could be the result of changes in body 
composition rather than ageing per se. 
Of the original cohort one-hundred and sixty-eight individuals (fifty-seven men, 
and one-hundred and eleven women, between nineteen and seventy-six years 
of age) had their body composition measured using DEXA, and were therefore 
included in this analysis for sex-related difference in relation to ageing. 
9.1 Changes in Body Composition as a Result of Healthy 
Ageing 
In the males total body mass (TBM), body mass index (BMI) and body surface 
area (BSA) did not change significantly (P > 0.1) between nineteen and 
seventy-six years of age. The mean values for these measures were 83.0 ± 
1.3 kg, 26.7 ± 0.4 kg/m2 and 2.0 ± 0.0 m2 respectively. Most importantly there 
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were significant changes in body composition (Fig. 43). Between nineteen and 
seventy-six years lean body mass (LBM) decreased by 9% in healthy men, but 
this did not reach the level of statistical significance (P > 0.05) (Fig. 43a), while 
total body fat (FM) significantly (P < 0.05) increased by 29% (Fig. 43b). 
Similarly, in the women there were no significant changes in TBM or BSA; the 
mean values were 68.2 ± 1.0 kg and 1.7 ± 0.0 m2 respectively. However, BMI 
in the sedentary females did increase significantly (P < 0.01) by 16% over the 
age-range studied. The age-related changes in the body composition of the 
sedentary women were very similar to those seen in the sedentary men (Fig. 
43). Between nineteen and seventy-six years of age LBM significantly (P < 
0.05) decreased by 11 % (Fig. 43a), and FM increased (P < 0.05) by 31 % (Fig. 
43b). The rate of the age-related changes in body composition was 
comparable in both the sedentary men and women. This is represented by the 
slopes of the trendlines in Figure 43. 
Finally, at all points of the age continuum the men had greater amounts of 
LBM (Fig. 43a), and smaller amounts of FM (Fig. 43b) in comparison to the 
age-matched women. 
9.2 Allometric Scaling of Aerobic Power 
For many years differences in body mass between men and women have 
been recognised and normalised accordingly. However, allometric scaling 
allows changes in dynamic physiological functions to be investigated 
independently of changes in both body size and crucially composition. By 
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Figure 43 - Changes in body composition as a consequence of healthy 
ageing. 
Lean body mass (A) showed a no significant change with ageing in men 
( ) (F (1,55) = 3.8, P>0.05), but did show a significant negative 
correlation to age in women () (F (1,109) = 6.1, P<0.05). 
Total body fat (B) increased significantly with healthy ageing in both men 
( ) (F (1,55) = 4.4, P<0.05), and women () (F (1,109) = 6.7, P<0.05). 
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controlling the impact of body composition as well as mass, it is possible to 
make more meaningful direct comparisons between data from men and 
women, and hence investigate if healthy ageing affects cardiac and aerobic 
exercise function differently. 
The first step in allometric scaling is to distinguish which measure of body size 
or composition is the most appropriate to scale. Using Pearson's product 
correlation the variable with the strongest relationship, and thus confounding 
influence, is identified and subsequently allowed for. 
Absolute Vo2max (1/min) correlated significantly to all the measures of body size 
and composition (Table 15); the strongest correlation was to LBM, followed by 
BSA and height, ahead of TBM, FM and BMI. This suggests Vo2max should be 
scaled to lean body mass, which makes good physiological sense as skeletal 
muscle consumes the greatest amount of oxygen during exercise. 
The allometric equation (y =a xbE) was then applied to derive the most 
appropriate b exponent (b = 1.38). This was then used to control the 
confounding influence that changes in LBM have on Vo2max in healthy men 
and women. 
Maximum aerobic power declines significantly (P < 0.0001) in both men and 
women as reported earlier (chapters 4.1 and 7.1). However, by plotting the 
absolute measurements of Vo2max for both men and women on a single graph, 
the sex-specific changes that occur over the course of healthy ageing can be 
investigated. Doing this revealed a significant difference in the rate at which 
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Correlation to VO2max (1/min) 
Height (cm) 0.754** 
Total Body Mass (kg) 0.643** 
Body Mass Index (kg/M2) 0.174* 
Body Surface Area (m) 0.755** 
Fat Mass (kg) -0.179* 
Lean Mass (kg) 0.861 ** 
Table 15 - Correlation of maximal aerobic power to body size and 
composition. 
Pearson's product rvalues are shown for the correlation of absolute V02max 
and the various measures of body size and composition. 
* Correlation significant at P<0.05 
`* Correlation significant at P<0.01 
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Vo2max decreased between nineteen and seventy-six years of age. The 
aerobic power of healthy men declines at a greater rate than that of healthy 
women (Fig. 44a). By simply dividing Vo2max by total body mass (Fig. 44b) the 
interpretation of the data does not change. Both sexes both still experience an 
age-related decline in aerobic power, and the decline is still greater in men. 
But, by allometrically scaling the data to the most appropriate measure of body 
composition (in this case LBM) the difference in Vo2ma, between the sexes is 
effectively removed (Fig. 44c). Furthermore, although Vo2max still significantly 
(P < 0.0001) declines in both sexes as a consequence of healthy ageing, the 
rate of the decline is the same in both men and women, equating to a 37% 
reduction in men, and a 30% reduction in women between nineteen and 
seventy-six years of age. 
9.3 Allometric Scaling of Resting Overall Cardiac Function 
In a similar manner resting overall cardiac function was correlated to the same 
measures of body size and composition (Table 16). 
Resting CPO showed the strongest correlation to LBM (Table 16). Significant 
correlations in order of strength also existed between CPOrest and BSA, TBM 
and height. Resting CPO showed no significant correlation to FM. This 
therefore confirmed that CPOrest should be scaled to LBM. This allowed the 
effects of healthy ageing on CPOrest to be accurately interpreted independently 
of any influence of body size, and a meaningful direct comparison to be made 
between healthy men and women. 
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Figure 44 - The effect of appropriate scaling on the maximum aerobic power 
of healthy men and women. 
The maximum aerobic power of healthy men ( ) and women ( ). 
A. Absolute measure (1/min) 
Men (F (1,55) = 100.07, P<0.0001) 
Women (F (1,109) = 71.65, P<0.001) 
B. Normalised to total body mass (ml/kg/min) 
Men (F (1,55) = 132.54, P<0.0001) 
Women (F (1,109) = 111.34, P<0.001) 
C. Allometrically scaled for the influence of lean body mass 
Men (F (1,55) = 80.23, P<0.0001) 
Women (F (1,109) = 42.79, P<0.001) 
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Correlation to CPOrest (Wafts) 
Height (cm) 0.396** 
Total Body Mass (kg) 0.415** 
Body Mass Index (kg/M2) 0.197* 
Body Surface Area (m) 0.451 ** 
Fat Body Mass (kg) -0.016 
Lean Body Mass (kg) 0.507** 
Table 16 - Correlations between resting overall cardiac function and body 
size and composition. 
Pearson's product rvalues are shown for the correlation of resting CPO and 
to the various measures of body size and composition. 
* Correlation significant at P<0.05 
** Correlation significant at P<0.01 
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In terms of the CPOrest, the derived b exponent was b=0.64. Nevertheless, the 
scaling of CPOrest does not change the overall conclusions drawn from the 
non-scaled data. In men CPOrest still significantly (P < 0.05) declined by 17% 
between nineteen and seventy-six years of age (Fig. 45). While in women, 
CPOrest still remained unchanged (P > 0.6) over the course of healthy ageing 
(Fig. 45). 
9.4 Allometric Scaling of Maximum Overall Cardiac Function 
Finally, the allometric process was applied to the measures of maximum 
overall cardiac function and overall cardiac reserve. These two measures were 
again correlated to the same measures of body size and composition to 
distinguish which was the most appropriate measure to scale (Table 17. 
Both CPOma, and CR were also most strongly correlated to LBM (Table 17). 
As with CPOfest, CPOmax and CR showed weaker correlations to BSA, TBM 
and height, in rank order. Both CPOmax and CR showed no significant 
correlation to FM. As a result, the measures of maximum overall cardiac 
function and overall reserve capacity should also be scaled to LBM. 
The b exponent derived from the allometric process to normalised the changes 
that occur in CPOmax for the changes in LBM was b=0.73. 
By calculating a body size-independent measure of CPOmax the difference 
between the sexes in early adulthood is significantly reduced (Fig. 46). 
However, there is still a significant sex-based difference in the age-associated 
preservation of CPOmax" In men a significant (P < 0.01) 22% decline in CPOmax 
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Figure 45 - Resting overall cardiac function allometrically scaled for 
changes in lean body mass in healthy men and women. 
The CPOrest of men ( ) and women O was allometrically scaled to 
normalise the changes which occur as a result the age-related decline in 
lean body mass. 
The derived exponent was b=0.64. 
As a result CPOrest still decreased significantly (F (1,55) = 6.1, P<0.05) 
in men, in contrast there was no significant (F (1,109) = 0.3, P>0.6) 
change in healthy women between nineteen and seventy-six years of age. 
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Correlation to 
CPOmax (Watts) 
Correlation to 
CR (Watts) 
Height (cm) 0.538** 0.496** 
Total Body Mass (kg) 0.600** 0.559** 
Body Mass Index (kg/M2) 0.311 ** 0.294** 
Body Surface Area (m) 0.640** 0.594** 
Fat Body Mass (kg) 0.023 0.029 
Lean Body Mass (kg) 0.695** 0.642** 
Table 17 - Correlations between maximum cardiac function and functional 
reserve capacity to body size and composition. 
Pearson's product r values are shown for the correlation of maximum CPO 
and CR to the various measures of body size and composition. 
* Correlation significant at P<0.05 
** Correlation significant at P<0.01 
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Figure 46 - Maximum overall cardiac function allometrically scaled for 
changes in lean body mass in healthy men and women. 
The CPO,,,,,,, of men ( ) and women () was allometrically scaled to 
isolate the changes that occur directly as a result of healthy ageing, 
independent of the concomitant declines in lean body mass. 
The derived exponent was b=0.73. 
As a result CPOmax still decreased significantly (F (1,55) = 10.24, P< 
0.01) in men. In contrast there was no significant (F (1,109) = 0.7, P>0.4) 
change in healthy women between nineteen and seventy-six years of age. 
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still occurs between nineteen and seventy-six years of age (Fig. 46). In 
contrast there was no significant (P > 0.4) age-related change in healthy 
women (Fig. 46). At forty-four years of age the maximum overall capacity of 
the male and female hearts (now unaffected by the influence of changes in 
body composition) converged, and they became indistinguishable (Fig. 46). 
After this age point the decrease in the CPOmax of the male heart continued, 
while the female heart continued to successfully retain its maximum overall 
function. 
Functional cardiac reserve (CR) is derived by subtracting CPOrest from 
CPOmax. After calculating CR the allometric scaling process was applied, the 
resulting body size-independent measures of CR are illustrated in Fig. 47. The 
derived b exponent was b=0.76. After normalising for the effect of body 
composition it became apparent that the effects of healthy ageing on CR are 
also sex-dependant. In early adulthood the healthy male heart has a higher 
CR than the healthy female heart. But, with advancing years the size- 
independent CR of the male heart declined significantly (P < 0.05) by 19% 
(Fig. 47). In contrast, the female heart showed no such decline (P > 0.3) 
between the ages of nineteen and seventy-six. As a result the hearts of 
healthy men and women became functionally indistinguishable at forty-five 
years of age. Furthermore, the size-independent reserve capacity of the heart 
of a healthy seventy-six year old female is the same as that of a healthy 
nineteen year old. 
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Figure 47 - Sex and age-related changes in cardiac functional reserve. 
The overall cardiac functional reserve capacity (CR) of healthy men and 
women were allometrically scaled to normalise the effects of any body 
composition differences. 
The derived exponent was b=0.76. 
The CR of men ( ) (F (1,55) = 5.5, P<0.05) declined significantly as a 
consequence of healthy ageing. In contrast the CR of the female group 
() did not change significantly (F (1,109) = 1.2, P>0.2) between 
nineteen and seventy-six years of age. 
0.4 
0.3 
0.2 
0.1 
r? y=-0.00x+0.22 r=0.30 
p 
0 U- op 
7 y=0.00x+0.18 r=0.11 
0.0 
163 
Op 
Z O__ 
Discussion 
Chapter 10 
Discussion 
164 
Discussion 
10.0 Key Findings 
The major novel findings of this thesis were that: 
1. Healthy ageing has a sex-specific impact on overall cardiac function. 
The CPOmax and CR of the healthy male heart declined by 20% and 
25%, respectively, between nineteen and seventy-six years of age. 
In contrast there were no changes in the healthy female heart over 
the same period. 
2. The effects of habitual long-term endurance-training are also 
different between men and women. Athletic males exhibit a 25% to 
58% adaptation in Vo2max, a 16% to 28% increase in CPOmax and a 
17% to 33% improvement in CR when compared to age-matched 
sedentary men. Endurance-trained women of similar ages despite 
showing greater adaptations in Vol (60% to 81 %) do not 
significantly improve either their CPOmax or CR. 
3. The above age- and sex-related changes are independent of the 
concomitant changes in body size and composition, particularly 
when scaled allometrically to LBM. 
This work represents the first time that cardiac power output (CPO) which 
measures both blood flow and blood pressure simultaneously, has been 
employed to measure overall cardiac function in healthy populations of this 
size. Previous work has refined and developed the concept of CPO, but this 
work represents a major progression in its application, especially outside the 
clinical domain. 
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The experimental protocols and the procedures were carefully designed, and 
rigorously tested before the recruitment of any subjects to ensure the accuracy 
and reliability of the collected data. The protocol for measuring CPO was 
refined to ensure true resting and maximal states were obtained on repeated 
occasions (coefficients of variability were 2.2% to 4.5%), and a novel but 
reliable technique was developed to allow blood pressure to be measured at 
maximum aerobic exertion. 
All of the healthy subjects underwent a rigorous screening process to ensure 
their previous and current medical status was not affected by any overt or 
covert disease processes, and to quantify all previous and current levels of 
activity. This process of screening involved both qualitative and quantitative 
techniques, specifically an initial questionnaire, which was followed by 
telephone and face-to-face interviews, and finally an ECG stress test. For this 
reason approximately only one in every three applicants to the study was 
eventually included in the final data analysis. This process represents an 
improvement on most previous studies into ageing where less robust 
screening may have admitted subjects with cardiovascular problems, or 
contravening medications. 
The male heart failure patients were also screened thoroughly. All were long- 
term patients of Broadgreen Cardiothoracic Centre, and they all possessed 
numerous symptoms of chronic heart failure which was confirmed via ECG, 
echocardiography and blood screening. After completing the testing protocol 
all underwent exacting surgery to implant bio-ventricular pacemakers in an 
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attempt to synchronise the activity of their ventricles, improve their long-term 
prognosis and their quality of life. 
The thorough screening process ensured that the conclusions based on the 
data collected from the healthy subjects were valid, accurate, and less likely to 
be misinterpreted as a result of any superimposed disease processes, e. g. 
CHD and CVD. It also allowed distinct populations to be dissected from each 
other, and the results for these subpopulations to be meaningfully compared. 
10.1 Limitations 
Despite all of the attempts to ensure the accuracy and applicability of the data 
there are a number of limitations which must be recognised when interpreting 
the results of this study. 
Firstly and most crucially the cross-sectional nature of the study design must 
be recognised. This was unavoidable given the logistical constraints, but the 
ideal when studying the effects of ageing would be to employ a longitudinal 
design, which examined and re-examined the same subjects over a long time 
frame. As a result of using a cross-sectional design Masoro (2001) highlights 
the two major confounding influences. Firstly, the physiology of the different 
generations within the cohort may have been affected differently by 
psychosocial changes which have evolved with time in society. And secondly, 
as a result of selective mortality it is possible that our older individuals do not 
represent a true cross-section of society, but rather specifically a hardy sub- 
section (via their genetic disposition or lifestyle) who have aged well. 
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With advancing age it becomes increasingly difficult to delineate healthy 
ageing from disease, as disease processes are an inevitably linked with 
ageing, but this study employed what Masoro (2001) terms a reductionist 
approach. Furthermore, all of our healthy subjects were community dwellers, 
and were not recruited from long-term care facilities as has been the case in 
previously studies (Masoro, 2001). As a result, all of the subjects in this study 
were still fully exposed to modern society, and to any psychosocial or 
physiological changes that may occur as a result. 
With regard to the pre-stress test screening, we found that some subjects 
falsified details when they knew the nature of study that they were applying to 
join. Generally though via the interviews, interacting with the volunteers and 
the quantitative measurements (i. e. the ECG and Vo2max) individuals who had 
not truthfully or satisfactorily completed the entire pre-test questionnaire were 
detected. There was often a considerable mismatch between an individual's 
concept of their activity levels, and their measured Vo2max. 
The equipment used throughout the study was extensively tested and 
validated before starting the collection of data. Macfarlane (2001) recognised 
that there are no universal guidelines stipulating the accuracy which 
automated gas analysis systems must achieve. Validation studies encompass 
both the day to day variability within the machine and its operator, and the 
physiological variability inherent in human subjects. It is concluded that we 
have the utmost confidence in the accuracy of our measurements of 
respiratory gases, with low coefficients of variance of 2.2% to 4.5%. These are 
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much better than most other studies which have reported coefficients -10% 
(Gore et al., 2003; Matthews et al., 1987; Miles et al., 1994). 
To measure cardiac output at rest and at maximal exertion the Collier (1956) 
and Defares (1958) methods using carbon dioxide rebreathing were 
employed. These techniques were chosen as they are clearly much less 
restricting on the subject, particularly when exercising. The accuracy of carbon 
dioxide rebreathing has been validated by previous studies (Beekman et al., 
1984; Cade et al., 2004; Cooke et el., 1998; Gabrielsen et al., 2002; Russell et 
al., 1990) against invasive thermodilution techniques, and compared to 
acetylene rebreathing (Laszlo, 2004; Tordi et al., 2004; Warburton et al., 
1999). Also, the accuracy of infra-red analysers when measuring carbon 
dioxide has been validated (Barazanji et al., 1996). From a purely scientific 
prospective it would be preferable to be able to directly measure the resting 
and maximal cardiac output of the healthy human heart invasively, but this 
was not ethically or technically possible in this study. The chosen non-invasive 
techniques were validated by testing their reliability and reproducibility before 
the collection of data for physiological interpretation began. Furthermore, 
previous work has validated the use of CPO using invasive measurements of 
both blood flow and blood pressure (Tan, 1986). 
As recommended by Sun et al. (2000) before performing a measure of cardiac 
output, either at rest of maximal exertion, numerous physiological variables 
were observed e. g. Vol, Vco2, VE, PETco2 and heart rate. This ensured that at 
rest the subject was full relaxed, that any carbon dioxide inhaled during a 
previous measure had been fully washed out, and that the subject was not 
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suffering from any stress-induced physiological changes. When exercising, 
before measuring cardiac output all subjects had to attain maximal values for 
all the physiological variables. This ensured that each subject was fully 
exerting themselves, and not suffering unduly or performing in a way that 
would invalidate the measurement, e. g. hyperventilating. The rebreathing 
period was adjusted appropriately to avoid the impact of recirculation (Sowton 
et al., 1968), and a suitable recovery period was allowed between bouts of 
maximal exercise to avoid an exercise induced suppression of Vco2 (Burnley 
et al., 2000). 
The use of stethoscopes and sphygmomanometers to measure blood 
pressure has been previously validated against invasive measurements of 
blood pressure (Henschel et al., 1954; Hossack et al., 1982; Nagle et al., 
1966). Invasive measurements with indwelling arterial lines were not a viable 
alternative in this study. When using an ergometer there are inherent 
difficulties in the measurement of blood pressure using an auscultation 
method. These are the result of ergometer noise and the movement of the 
subject (Robinson et al., 1988). After much practise and the development and 
refinement of a technique where the arm of the subject was elevated, 
supported, and arm motion minimized we effectively overcame these 
obstacles. This technique allowed systolic and diastolic blood pressures to be 
measured accurately and with confidence both at rest and at maximal 
exertion. 
In total over two-hundred and forty different individuals completed the full 
testing protocol and were included in the final data analysis. This is a 
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substantial number on which to base our conclusions, but as with all studies a 
higher number of subjects would have been ideal. This is particularly true 
when looking at the female cohort. Some studies have found that hormonal 
changes as the result of menstrual cycle phase, the menopause, oral 
contraceptives or hormonal replacement therapy (HRT) can significantly affect 
aerobic function (Casazza et al. 2002; Lynch et al., 2002; Redman et al., 2003; 
Xanne and de Jonge, 2003) and various individual indices of cardiac (Hayward 
et al., 2000; Moran et al., 2000; Lim et al., 1999; Pines et al., 1993; ) and 
vascular (Majmudar et al., 2000; Scuteri and Ferrucci, 2002) function. These 
conclusions are not universally accepted (Burrows and Bird, 2005; Lebrun et 
al., 1995; Littler et al., 1974), and none of the previous studies have examined 
if there is any effect of female hormones on cardiac power output. Even when 
the women were sub-divided based on their hormonal status this did not 
change any of the data and conclusions drawn. But the number of healthy 
women within each hormonal group was small and generally insufficient to 
draw any meaningful conclusions relating to the possible effects of hormones 
on cardiac power output. 
It would also have been beneficial if we had managed to recruit more 
particularly active endurance-trained women. However, the decision was taken 
not to relax the selection criteria in an attempt to increase the total number of 
subjects, as doing this would have diluted the scientific power of the study. 
After approaching many athletics clubs in North-West England it became 
apparent that there are relatively few habitually active females compared with 
males. This was the major reason for the smaller numbers of female subjects 
within this sub-population. 
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Also with regard to the habitually active populations, attempts were made to 
ascertain their past and present exercise stimulus with as much detail as 
possible. Inevitably although duration and volume could be accurately 
established, it is much more difficult to determine exercise intensity. This is 
due to the fact that many active individuals base their training on qualitative 
factors such as how they feel physically, and seldom use any quantitative 
measure of training intensity, e. g. heart rate monitors. Therefore, an age- 
related decline in exercise intensity cannot be totally discounted, even though 
every possible attempt was made to recruit the most highly trained athletes, 
with as much attention as possible paid to their training volume, duration and 
competitive performance records. 
Despite this study being designed in the most scientific and efficient manner 
possible, there are a number of possible confounding influences. These have 
been recognised and discussed above, as have the ways which the 
investigators have attempted to control and eradicated their impact. Whatever 
the shortcoming or systematic errors, these were the same in all of the 
experiments and were therefore consistent in each and every study 
undertaken. 
The focus of the remainder of the discussion will be on the physiological 
conclusions that can be drawn from the data. Specifically the changes that 
occurred in V02max, CPO max and CR as a consequence of healthy ageing, 
long-term endurance-exercise and heart failure. This is because these are the 
factors which have the most significant impact on an individual's exercise 
capacity, quality of life and their ability to meet everyday environmental 
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demands. The magnitudes of the adaptive changes measured in CPOrest were 
very small in comparison to the changes in CPOmax. Furthermore any 
significant changes in CPOfest are reflected in CR. For the entire healthy male 
group (active and sedentary) CPOrest ranged from 0.43 to 1.92 Watts, in the 
male heart failure patients it ranged from 0.31 to 1.21 Watts, and in healthy 
female population the range of CPOrest was from 0.25 to 1.32 Watts. The lack 
of difference and the considerable overlap between male and female data, 
sedentary and active, healthy and diseased populations shows that CPOrest is 
well maintained in all extreme physiological conditions. But the ability of the 
technique to detect these small changes illustrates its sensitivity. 
10.2 Changes in Maximum Aerobic and Overall Cardiac 
Function in Men 
Three groups of men were recruited, each was subjected to distinctly different 
activity patterns which could significantly affect their overall cardiac function. 
The three groups were: 
1. Healthy sedentary men. 
2. Long-term endurance-trained male athletes. 
3. NYHA class III and IV heart failure patients. 
All of the male subjects were between nineteen and seventy-six years of age. 
10.2.1 The Effects of Healthy Ageing in Men 
Fifty-seven years of healthy ageing in men who had a sedentary lifestyle 
resulted in a 49% decrease in Vo2max (Fig. 12). This decrease is comparable 
to previous research which has found age-related decreases in Vo2max of 
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between 4% and 12% per decade (Hawkins and Wiswell, 2003). Importantly 
though, all the individuals included in this analysis reported as undertaking 
less that ninety minutes of exercise per week. Therefore the age-related 
decrease in Vo2max is more likely to be attributable to the impact of healthy 
ageing rather than a dramatic change in activity patterns. This is in contrast to 
the conclusion of Jackson et al. (1995) who attributed 50% of the age-related 
decrease in aerobic power to a self-reported decrease in activity levels. 
In this same population CPOmax decreased by 23% or 1.1 Watts (Fig. 17). This 
decrease was the result of a 33% reduction in maximum cardiac output (Fig. 
18). Age-related decreases Qmax have been observed in previous studies 
(Ehsani et al, 1991; Fleg et al., 1995; Ogawa et al., 1992). Furthermore in 
agreement with these studies SVmax also decreased by 13% (Fig. 18). Ogawa 
et al. (1992) reported that the age-related decrease in Qmax was equally 
attributable to decreases in SVmax and HRmax. In contrast this study found that 
while SVmax decrease by 13%, HRmax fell by 23% in the same subjects. As 
such these results are in closer agreement with the findings reported by Julius 
et al. (1967) who reported that over a four decade period HRmax decreased by 
18%, whist SVR, ax declined by only 9%. 
What this and all the previous studies do agree on is that HRmax decreases 
with advancing age. Both the contraction and relaxation phases in the cardiac 
cycle are prolonged (Pugh and Wei, 2001) as a result of age-related changes 
in myocardial composition and structure, the loss of pacemaker cells (Lev, 
1954) and a reduced responsiveness to circulating catecholamines (Fleg et 
al., 1985; Kitzman and Edwards, 1990). There is some disagreement though 
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regarding the rate of the decline in HRmax. In this study HRmax decreased by 
0.77 beats per year, this finding is in close agreement with the work of Tanaka 
et al. (2001). They proposed that the traditional equation (HRmax = 220 bpm - 
age) that is widely used to predict maximum heart rate should be amended. 
They found that HRmax = 208 - 0.7 x age was a more accurate equation for the 
prediction of HRmax. The data collected in this study supports this finding. 
With advancing age in sedentary males, this study also measured a 
concomitant 15% increase in maximum mean arterial blood pressure. Mean 
arterial pressure is important when assessing overall cardiac function as it 
represents blood pressure over the duration of the entire cardiac cycle. This 
finding is in agreement with the previous work of Stratton et al. (1994) and 
Ogawa et al. (1992). The increase in the generation of blood pressure 
illustrates the changing characteristic of the male human heart from a flow, to 
a pressure generator. That is, a greater proportion of the energy injected into 
the blood by the contracting heart is diverted from flow generation to pressure 
generation to overcome the age-related increase in systemic vascular 
resistance (Fig. 20). 
However, the increase in the generation of blood pressure was insufficient to 
effectively maintain CR in healthy sedentary men. Hence, overall the 
functional reserve of the male heart decreased by 22% between nineteen and 
seventy-six years of age (Fig. 22). In absolute terms this means that a 
seventy-six year old healthy male possesses a CR of 3.5 Watts. Although this 
figure is significantly lower than that of a younger male, it still represents a 
healthy functional reserve capacity, over the 1 Watt of CPOrest that is needed 
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for basal existence. It is entirely possible that this reduction in the overall 
capacity of the male heart reflects the huge loss (35%) of cardiomyocytes 
which occurs as a consequence of ageing (Olivetti et al., 1995; Fig. 1), despite 
the potential for some compensatory hypertrophy of the existing myocytes. 
It is concluded that healthy age has a detrimental effect on overall cardiac 
function in sedentary men. This change is however over estimated if only 
blood flow is measured as the index of cardiac function. However, in the 
absence of any disease processes a sufficient functional reserve can be 
effectively maintained up to seventy-six years of age to prolong a good quality 
of life. 
10.2.2 The Effect of Habitual Long-term Endurance Exercise in Healthy 
Men 
Individuals habitually engage in endurance exercise for many reasons. The 
benefits in terms of offsetting the age-related accumulation of body fat (Pollock 
et al., 1987) and reduction in Vo2max (Stromme et al., 1977) are widely 
recognised. This study confirms these effects. Each group of habitually active 
males had a significantly higher V02max than their age-matched sedentary 
counterparts (Fig. 23). The adaptation to the training stimulus was such that a 
seventy year old endurance trained male had the same V02max as sedentary 
male fifty years their junior. Despite this there was still an age-related decline 
in the aerobic power of the endurance trained men, which paralleled the 
decline observed in the sedentary population. Therefore, it appears that there 
is an upper ceiling to how much V02max can be increased, and that this ceiling 
is reduced with increasing age. Tanaka and Seals (2003) found that the 
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V02max decreased more steeply in endurance-trained men than in sedentary 
men. They attributed this difference to a greater decline in the habitual activity 
volumes undertaken. This was not the case in this study, and supports the use 
of rigorous inclusion criteria. 
Maximum overall cardiac function was also higher in all the athletic male 
populations, compared to their sedentary age-matched counterparts, even 
though these differences were only statistically significant in the two younger, 
i. e. twenty and fifty year-old, age groups (Fig. 24). Over the range of healthy 
ageing studied the CPOmax of habitually active men still declined, and at a 
greater rate than that of the sedentary subjects. However, the CPOmax of the 
sixty and seventy year old athletic populations was not significantly different 
from that of the twenty year old sedentary group. This shows that the exercise 
stimulus is effective at attenuating the negative effect the ageing process has 
on overall cardiac function. Furthermore, the greater CR possessed by the 
older athletic men in comparison to their sedentary age-matched counterparts 
means they would be better able to withstand a myocardial infarction of the 
same size, and recover to restore a good quality of life. 
In both the sedentary and active men the decline in cardiac function could be 
due to the age-related attrition of cardiomyocytes (Olivetti et al., 1995). If so, 
exercise training does not appear to be protective against the net loss of 
cardiomyocytes, as CPOmax declines with age in both lifestyles. For obvious 
ethical reasons, no cellular study of the endurance-trained human heart has 
been possible to either confirm or deny this superstition. Work in the hearts of 
rats that has looked at both exercise (Kemi et al., 2005) and haemodynamic- 
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induced cardiac overload resulting from either infarction (Anversa et al., 1986) 
or aortic stenosis and hypertension (Lorell and Carabello, 2000) has confirmed 
cardiac remodelling. These studies suggest that the increases in cardiac mass 
are the result of cellular hypertrophy of the existing myocytes, as opposed to 
hyperplasia and new myocyte production. 
In terms of the individual components of maximum cardiac function and the 
effects of habitual endurance exercise, the Amax values for each trained group 
were greater than their sedentary age-matched counterparts (Table 8). This 
occurs in response to an enhanced demand for oxygen, and contributes 
towards the greater Vo2max of the athletes. This increase in the generation of 
maximum blood flow was predominately due to training-induced adaptation in 
SVmax, HRmax did not change significantly and continued to decline with 
increasing age in the trained population. Such an increase in stroke volume is 
supported by other studies which have also found a similar reliance on stroke 
volume (Boutcher et al., 2003; Goodman et al., 2005; Hopkins et al., 1996). 
As with CPOmax, the magnitude of exercise-induced adaptation in blood flow 
generation diminished with advancing age. It is postulated that this could be 
the result of age (Henry et al., 1980; Kitzman and Edwards, 1990) and 
exercise-induced (Spataro et al., 1985) changes in cardiac structure. The 
consequence of these changes is a less compliant myocardium, which results 
in a reduced ability of the Frank-Starling mechanism to respond to the 
exercise stimulus. 
There was no significant change in MAPmax in any of the endurance-trained 
groups when compared to their age-matched sedentary counterparts (Table 
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8). Hence, the age-related increase in MAP,,. was of equal magnitude in both 
the trained and sedentary populations. There have not been many studies 
conducted where blood pressure has been measured at maximum aerobic 
exertion, but the results of this study are in agreement with those of (Ehsani, 
1987). 
Overall the long-term exercise training stimulus resulted in an increase in CR 
in all the endurance trained male groups in comparison to their sedentary 
counterparts. Indeed, if anything the decline over the age range studied was 
greater in the trained groups, and the difference between the trained and 
sedentary population was only statistically significant at twenty and fifty years 
of age. But, as the CR of the endurance-trained seventy year old group was 
not significantly different from that sedentary twenty year old group (i. e. fifty 
years younger), it can be concluded that engaging in long-term endurance 
exercise is effective at attenuating the age-related decline in overall cardiac 
function. This is the first time this has been reported, and adds significant 
weight to the argument that men need to maintain active lifestyles if they wish 
to promote a higher quality of life with advancing age. The age-related 
changes here are similar to those reported by Pearson et al. (2002) for 
skeletal muscle reserve, when comparing competitive and novice weightlifters. 
While force and power generation decreased with age in both populations, the 
resistance exercise had endowed the competitive lifters with a considerably 
greater reserve capacity. 
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10.2.3 The Effect of Heart Failure in Men 
The chronic heart failure patients and the impacts of the disease represented 
the other extreme to the veteran athletes. Neither V02max nor CPOmax changed 
significantly within this group, despite the fact that the age range covered a 
thirty-four year period. This illustrates that the disease process had a 
deteriorative effect on both the aerobic power and cardiac functional reserve 
that was greater than any normal age-related impact. This of itself is important 
as currently cardiologists are unable to distinguish the effects of heart disease 
from the effects of the ageing process. 
The mean V02max for these patients was 14.6 ml/kg/min, which is 45% lower 
than that of healthy age-matched males (Fig. 26b). This figure is in agreement 
with previous studies that have examined patients with a similar severity of 
heart failure (Osada et al., 1998; Wilson et al., 1984). Indeed Vo2max has been 
reported to be as low as 10 ml/kg/min in the most severe cases (Remme and 
Swedberg, 2001). 
Previous research by Tavazzi et al. (2001) has concluded that to fully 
determine and quantify the impacts of heart failure, patients must be assessed 
when the heart is maximally stressed, because under resting conditions 
cardiac function is well maintained. In terms of blood flow generation, the 
mean Qmax measured in the patients in this study was 8.8 I/min (Table 11), this 
is 47% below that of a sedentary but healthy age-matched male. 
Few studies have measured maximum blood pressure generation in heart 
failure patients, and have therefore failed to report changes in overall cardiac 
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function. The MAP,,,,, in our patients was 100.4 mmHg (Table 11), this is also 
significantly below (20%) the figure measured in sedentary but healthy age- 
matched males. In the study by Cooke et al. (1998) MAPmax was 102.3 mmHg 
in a group of similarly classified heart failure patients. Hence, heart failure 
patients have a significantly impaired ability to generate both blood flow and 
blood pressure. 
This impaired ability to generate both blood flow and blood pressure (the result 
of a dyssynchrous cardiac function in all of these patients) resulted in a group 
mean CPOmax of only 1.96 Watts (Fig. 27b). Furthermore, CR was only 1.3 
Watts (Fig. 27c), which is 64% lower than the reserve capacity of an age- 
matched healthy sedentary male, and 71 % below that of a seventy year old 
male veteran athlete. This difference represents a huge reduction in overall 
cardiac functional reserve. And whilst the patients were able to exist under 
basal conditions, the disease severely affected their exercise capacity and 
hence quality of life. 
These data on the effects of heart failure are in close agreement with the 
findings of Bain et al. (1990) and Cooke et al. (1998). In the study by Tan 
(1986) twenty out of twenty-three patients who had a CPOmax below the normal 
resting value of 1 Watt died within one year (Fig. 3). The subjects tested in this 
study were getting very close to this value and clearly had a poor prognosis. 
Fortunately for them a surgical intervention was available which was going to 
be used in an attempt to improve their long-term prognosis. 
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It is evident that all three situations; healthy but sedentary ageing, engaging in 
long-term endurance exercise and chronic heart failure have significant 
impacts on overall cardiac function in men. This is the first time that cardiac 
power output has been used to study such a range and size of different 
populations. These quantitative values of CR clearly illustrate the life/death 
and exercise capacity limitations of men in the general population. 
10.3 Changes in Maximum Aerobic and Overall Cardiac 
Function in Women 
Given the sex-specific differences that have been reported in a few previous 
studies on individual indices of cardiac structure and function, it was logical to 
employ cardiac power output for the first time to measure overall cardiac 
function in women. 
Two groups of healthy women were recruited in which aerobic power, and 
overall cardiac function was measured. They were: 
1. Healthy sedentary women between nineteen and seventy-six 
years of age, and 
2. Long-term endurance-trained athletes who were in three groups 
with mean ages of twenty-six, forty-eight and sixty-one years. 
10.3.1 The Effects of Healthy Ageing in Women 
All the women included in this analysis were thoroughly screened and reported 
to doing less than ninety minutes of activity per week. As with the men the 
V02max values of this group of healthy women showed a significant negative 
correlation to age. In total Vo2max decreased by 40% between nineteen and 
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seventy-six years of age, this equated to a decrease of approximately 7% per 
decade (Fig. 28). The latter is precisely the same as that reported by 
Stathokostas et al. (2004). Other cross-sectional studies have reported the 
aerobic power in women to decline by 9-10% per decade, but their subjects 
were not as rigorously screened, and included moderately-active individuals 
(Drinkwater et al., 1975; Hossack and Bruce, 1982; Toth et al., 1994; Jackson 
et al., 1996; Tanaka et al., 1997). Longitudinal studies have tended to report 
0 
slightly higher rates of decline in Vo2max e. g. 11 % per decade (Astrand et al., 
1973; Plowman et al., 1979). It appears the data collected in this study are in 
close agreement with previous work, and confirmed the self-reported 
information that the cohort was healthy and sedentary in nature. 
Given this decline in aerobic power a similar age-related decline in cardiac 
function might be anticipated. This was not the case. The CPOmax and CR of 
healthy women did not change between nineteen and seventy-six years of age 
(Figs. 33 and 38). On a cellular level the paper by Olivetti et al. (1995) 
indicated that ageing in women did not result in much if any myocyte cell loss 
or reactive hypertrophy (Fig. 1), hence one might predict that the female heart 
has a greater potential to withstand the ageing process, compared with the 
male heart. This is the first time maximal overall cardiac function has been 
reported in healthy women, and leads to a different interpretation, as 
compared to only measuring blood flow. The data illustrates the remarkable 
resistance of the female heart to the effects of ageing. 
There were significant age-related changes in the ability of the female heart to 
generate blood flow and blood pressure. Maximal blood flow decreased by 
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26% (less than the 32% decline in healthy men), and was the result of an age- 
related decrease in HRmax, SVmax did not change significantly (Fig. 34). The 
lack of any age-related change in maximum stroke volume illustrates that the 
female heart retains its distensibility with advancing age. This adds further 
weight to the conclusion that there is an absence of reactive myocyte 
hypertrophy in the female heart. This is not the first time this lack of change in 
stroke volume has been observed in women. Spina et al. (2000) reported a 
similar finding in a longitudinal study. Furthermore, they confirmed a lack of 
any cardiac hypertrophy via echocardiography. However in contrast, the cross- 
sectional study by McCole et al. (1999) reported decreases in stroke volume in 
healthy women. The data in this study were collected using a design more 
akin to the work of McCole et al. (1999). Nonetheless the findings are in 
agreement with those of Spina et al. (2000). 
The 26% decrease in Qmax which occurred in these healthy women over fifty- 
seven years of healthy ageing was offset by a 26% increase in MAPmax (Fig. 
35). Significantly less work has been conducted examining the age-related 
changes in maximum blood pressure generation during dynamic exercise, but 
the data from this study are in agreement with the age-related increases in 
MAPmax reported by Ogawa et al. (1992). 
The female heart over the age-range studied appears to be effective in 
resisting age-related detrimental changes in its overall function, with CR 
unchanged (Fig. 38). It would seem that more of the energy injected into the 
blood is diverted towards pressure generation, and less towards blood flow 
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generation, with increasing age. However the overall power output, as 
opposed to its proportioning, remains unchanged. 
This change in the characteristics of the female heart could be attributed to 
age-related changes in oestrogen levels. But this study cannot provide 
convincing evidence relating to the effect of oestrogen, due to the insufficient 
number of subjects around the menopause, who were taking or abstaining 
from hormone replacement therapy. However, the heart and the major blood 
vessels do possess oestrogen receptors (Grohe et al., 1997) and it is claimed 
that oestrogen is card ioprotective (Channer and Jones, 2003; Grohe et al., 
1998; London et al., 1995; Scuteri et al., 2001) 
10.3.2 The Effects of Habitual Endurance Exercise in Women 
In comparison to healthy sedentary age-matched women, the V02max of the 
female athletic sub-populations were 81%, 60% and 64% greater at twenty- 
five, sixty and seventy years of age, respectively. This data also illustrates that 
the age-related decline in V02max occurs at a faster rate in the athletic women 
(Fig. 39). This finding has been reported by other studies (Fitzgerald et al., 
1997; Hawkins et al., 2001; Tanaka et al., 1997). However the aerobic power 
of an endurance-trained sixty year old was still greater than that of a twenty- 
five year old healthy sedentary woman (Fig. 39). Therefore it can be 
concluded that women who habitually engage in long-term endurance exercise 
do significantly improve their cardiorespiratory fitness and exercise capacity by 
offsetting the normal age-related decline. Nonetheless, ageing still takes its 
toll. 
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The measured improvement in Vo2max which occurred as a consequence of 
endurance-training was not the result of an adaptation in maximum overall 
cardiac function. None of the groups of female athletes showed any significant 
increase in CPOmax or CR in comparison to the age-matched sedentary control 
groups (Figs. 40 and 41). 
In the youngest group of highly trained and competitive women Qmax did show 
a small increase which was the result of a similar sized increase in SVmax. 
Otherwise, none of the measurements of blood flow changed in women in 
response to the exercise stimulus. Therefore both the sedentary and athletic 
groups showed similar age-related decreases in Qmax, SVmax and HRmax (Table 
14). 
In terms of blood pressure generation engaging in long-term endurance- 
training had no effect. Maximum MAP showed a similar age-related increase 
in both the sedentary and trained groups, and there were no age-matched 
differences (Table 14). 
The lack of a cardiac adaptation in women in response to an endurance-based 
exercise stimulus has been suggested by previous studies. Spina et al. (1993) 
reported no increase in Qmax in women, this was confirmed by Ehsani et al. 
(2003) with particular reference to older aged women. With specific reference 
to left ventricular adaptations, such as ejection fraction, end systolic and 
diastolic volume or stroke work index, Fleg et al. (1995) and Higginbotham et 
al. (1984) confirmed that cardiac function in women does not adapt in 
response to exercise, despite measured increases in aerobic power. 
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This increase in aerobic power in the endurance-trained women was primarily 
the result of improvements in the peripheral extraction and consumption of 
oxygen. This was confirmed by calculating the a-V 02diff, ax which was 
significantly augmented in comparison to all the age-matched sedentary 
populations (Fig. 42). This occurred despite the fact that the exercise regimen 
did not significantly increase total lean body mass in the youngest two age 
groups (Table 12). This conclusion is an agreement with that of Spina et al. 
(1993) who also attributed the increased Vo2max in trained-women to a skeletal 
muscle adaptation, in the absence of any improvement in cardiac function. 
Endurance exercise is known to increase the oxidative capacity of muscles. 
Hence, although not different in size, the `trained' muscle possesses more 
mitochondria, and thus a greater capacity to extract and consume oxygen. 
Finally, as with ageing per se CR in the all the groups of trained women was 
unchanged (Fig. 41). Therefore, this data illustrates for the first time that 
overall cardiac function in healthy women is remarkably resilient to both the 
effects of ageing and long-term endurance exercise, and contrasts markedly 
with the changes seen in the hearts of men. 
10.4 Size-Independent Gender Comparison 
As indicated, it appears that healthy male and female hearts respond very 
differently to the effects of ageing and long-term endurance training. However, 
it has been recognised for many years that body size can significantly affect 
heart size and hence the absolute values of cardiac function (Batterham et al., 
1999; Daniels et al., 1995). 
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Over the past sixty years the most frequently used method for normalising the 
affect of body size is simply dividing a physiological variable by the measured 
body size. For example, Vo2max (1/min) divided by total body mass becomes 
Vo2max (ml/kg/min), or in cardiology left ventricular mass is divided by body 
surface area (Deague et al., 1999). Fleg and Lakatta (1988) took this process 
one step further. They recognised the concomitant age-associated loss of 
metabolically active tissue (i. e. muscle) which occurs in tandem with the 
decline in Vo2max. Therefore they used urinary creatinine excretion as an index 
of muscle mass, and subsequently employed it to normalise total body oxygen 
consumption. 
However, this simple division has two major flaws. Firstly it assumes that the 
relationship between the two variables is perfectly linear. Unfortunately such a 
relationship is rarely perfectly linear, and is often much more complex (Nevill 
et al., 1992). Secondly, it assumes a causal relationship exists between the 
two measures. Clearly if a causal relationship doesn't exist then the scaling 
process is meaningless in physiological terms (as opposed to mathematical), 
and will result in erroneous data adjustments and interpretations. 
The allometric scaling method has been shown to be theoretically, and more 
importantly physiologically and statistically superior to the traditionally used 
simple division approach (George et al., 1997; Nevill et al., 1992; Winter, 
1992). Furthermore, previous work by the current investigators has proven this 
method to be effective in controlling the effects of body size and composition 
on CPO (Chantler et al., 2005). This allometric technique was therefore used 
to normalise the impacts of body size and composition on aerobic power and 
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overall cardiac function, and thus allow a more meaningful sex-based 
comparison to be made. 
Lean body mass proved statistically to be the best measure of body 
composition to scale too, both in terms of V02max (Table 15), CPO max and CR 
(Table 17). This made good physiological sense as lean body mass is the 
major consumer of oxygen during exercise, and therefore demands the higher 
supply of blood. Once allometrically scaled, V02max independent of body 
composition still declined significantly in both healthy men and women over 
the course of healthy ageing (Fig. 44c). The difference between the sexes that 
was present in the absolute measures (Fig. 44a) however was removed, and 
the rate of the age-related decline was no longer sex specific over the age 
range studied. These results are in close agreement with those of Fleg and 
Lakatta (1988). They reported that normalising aerobic power to lean body 
mass abolished the difference between the sexes, and reduced the decline 
observed in aerobic power between thirty and seventy years of age from 39% 
to 18%, and from 30% to 14% in men and women, respectively. 
In terms of cardiac function, the sex-dependant difference in CPOmax was 
somewhat reduced by allometrically scaling to LBM. However, the overall 
effect of ageing was still very much sex-dependant. Maximum overall cardiac 
function still declined significantly (22%) as a consequence of healthy ageing 
in sedentary men between nineteen and seventy-six years of age (Fig. 46). In 
contrast, there remained no age-related change in women (Fig. 46). Below 
forty-four years of age the body composition independent measure of CPOmax 
was greater in healthy sedentary men than women. But, at this age point the 
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sexes became indistinguishable, after which healthy women continued to 
maintain their overall maximum cardiac function, whilst the significant decline 
in men continued. 
This is the first time that the overall functional reserve of the human heart has 
been measured in situ, and allometrically scaled, therefore partition out the 
influence of changes in body composition. The result was that a sex- 
dependant difference was still present. The functional reserve capacity of the 
healthy male heart decreased by 19% between nineteen and seventy-six 
years of age (Fig. 47). While the female heart effectively retained its reserve 
capacity, and the heart of a healthy nineteen year old female is functionally 
indistinguishable from that of a healthy seventy-six year old. 
The allometric process was also applied to all the groups of endurance-trained 
male and female athletes, but the process did not enhance or significantly 
change the age-related trends and conclusions already drawn and discussed. 
Therefore, male athletes have the ability to improve their cardiac function in 
response to a sufficient training stimulus independent of the concomitant 
changes in body composition. In contrast, long-term endurance-trained 
females exhibited no change in overall cardiac function when compared to 
healthy sedentary women. 
This data shows that healthy ageing and endurance training have significantly 
different effects on the overall cardiac function of men and women. These 
differences are independent of changes which occur in body size and 
composition suggesting that intrinsically the male and female hearts respond 
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differently to ageing, with important public health and policy making 
implications. By engaging in long-term endurance exercise men improve their 
CR and hence can delay the age-associated decline in overall cardiac 
function. Healthy women show much less capacity to augment their overall 
cardiac function in response to an endurance based exercise stimulus. This 
seems strange considering they retain more cardiomyocytes, and would 
therefore seem to have a greater potential to respond to any such stimulus. 
10.5 Future Research 
As well as providing a new physiological insight into overall cardiac function, 
the data from this study have also confirmed that CPO is the best indicator of 
overall cardiac function (Nicholls and Riley, 2001). If only blood flow 
measurements had been made at maximal exertion, as has traditionally been 
the case in many previous studies on healthy ageing, the decline in function 
would have been overestimated in both healthy men and women, because the 
concomitant increases in blood pressure generation would have been ignored. 
Furthermore, if blood pressure had not been measured in the heart failure 
patients, the extent of the functional impairment which resulted from the 
disease process would have been underestimated. 
Historically CPO has only been used in heart failure patients as a diagnostic 
and prognostic tool. The use of CPO when measuring cardiovascular function 
in healthy and diseased; young and older; trained and sedentary populations 
needs to be promoted and expanded beyond the scope of this study. This 
represents only a start in this direction. The use of this technique would 
provide a clearer picture as to what changes occur in overall cardiac function 
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and cardiac reserve in response to numerous preventative and therapeutic 
interventions in both clinical and exercise physiology. 
Although some research has been done into the cellular mechanisms, and 
changes which occur with healthy ageing in the human heart more work is 
needed in this area. The aim should be to establish a definitive link between 
mechanistic adaptations and their impact on cardiac power output. 
Finally, recent research has focussed on the dose-response relationship 
between endurance training and cardiovascular adaptations (Iwasaki et al., 
2003). Some authors suggesting repeated bouts of high intensity exercise may 
be as effective as longer duration lower intensity exercise in inducing 
cardiorespiratory improvements (Burgomaster et al., 2005). These papers 
though are only focussing on the traditional measurements of individual 
components of cardiac and respiratory function, and tend to involve younger 
fitter individuals. 
This study has established the adaptive changes, or lack of changes, which 
occur in overall cardiac function in long-term highly trained aerobic athletes. It 
would now be advisable to examine whether shorter-term bouts of exercise at 
different intensities could elicit similar adaptations in previously inactive 
individuals. 
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11.0 Conclusion 
The aims of this study were to examine what impact healthy ageing, long-term 
endurance exercise and heart failure had on overall cardiac function, and to do 
this in men and women under identical conditions. Previous studies have 
reported changes in the individual components of cardiac function, such as 
blood flow generation or myocardial contractility. But the main function of the 
heart is to act as a hydraulic pump ensuring adequate circulation of blood. To 
do this the heart generates kinetic energy thereby creating both blood flow and 
blood pressure. Therefore, to accurately measure its overall function 
regardless of the preload and afterload conditions both components must be 
measured in tandem. Cardiac power output does this by measuring and 
integrating both components. For this reason it represents the best measure of 
overall cardiac function (Nicholls and Riley, 2001) and was used throughout 
this study. 
Initially, all the equipment to be used was tested to ensure its accuracy, and 
the protocols developed to ensure that all the data subsequently collected was 
valid and meaningful. Furthermore, all the subjects were thoroughly screened 
and tested to ensure the absence of any diseases, confounding medications 
or food supplements which could affect the measurements. This enabled us to 
study `healthy ageing' in a fairly homogenous group of men and women. 
In healthy sedentary men between seventeen and seventy-six years of age 
the advancing years resulted in the significant (P < 0.001) but progressive 
decline of V02max, CPO max and CR. However, engaging in long-term 
endurance based exercise effectively offset these negative effects by 
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increasing the reserve capacities. Despite this aerobic and overall cardiac 
function still decreased in the long-term endurance trained individuals. Even 
so, a seventy-year old endurance trained male has a Vo2max, CPO max and CR 
which is comparable to that of a twenty-year old healthy sedentary male. 
In contrast, patients who were suffering from chronic heart failure exhibited 
severely impaired aerobic and cardiac function. This was known clinically, but 
it is crucial to quantify the exact levels of deterioration in such patients, i. e. to 
give more objective evidence of the level of dysfunction. Compared to healthy 
sedentary men, the V02max, CPO max and CR of these patients was 
significantly (P < 0.0001) reduced by 45%, 57% and 64% respectively, and 
their long-term prognosis without drastic intervention could be defined as very 
poor. 
In healthy women Vo2ma, also declined significantly (P < 0.0001) as a result of 
healthy ageing between nineteen and seventy-six years of age. But, in the 
same subjects there were no significant (P > 0.05) age-related changes in 
either CPO max or CR. Long-term endurance trained female athletes of twenty- 
five, fifty and sixty years of age significantly (P < 0.05) increased their Vo2max 
by 81%, 60% and 64%, respectively. But the long-term training stimulus had 
no significant (P > 0.05) impact on either CPOmax or CR. Therefore the 
increase in Vo2max had to be attributable to an increased ability to extract and 
consume oxygen at the peripheries by the skeletal muscles. These represent 
very interesting gender differences in response to ageing and exercise that 
warrant greater study and explanation. 
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Previous studies have concluded that body size can significantly affect various 
indices of cardiac function (Batterham et al., 1999; Daniels et al., 1995), and 
that the best method to control for these differences is through the use of 
allometric scaling (George et al., 1997; Nevill et al., 1992; Winter, 1992). This 
scaling method was employed to derive body size and compositional 
independent measurements of overall cardiac function, thereby allowing the 
impact of healthy-ageing and long-term endurance training to be compared 
much more meaningfully between men and women. 
After allometrically scaling the data relating to CPOmax and CR, significant (P < 
0.01) decreases as a consequence of healthy-ageing still existed in healthy 
men. In stark contrast there were still no significant (P > 0.05) changes in 
either CPOmax or CR in healthy women, over the same age range. 
Furthermore, the trends reported in the non-scaled data relating to the effects 
of engaging in long-term endurance exercise remained unchanged. Therefore, 
independent of changes in body size and composition long-term endurance 
trained men were able to significantly improve their overall cardiac function, 
whereas the women showed no overall central cardiac adaptation. 
While our data correlates well with previous work on cardiomyocyte number in 
the hearts of both humans and animals, there is still vast scope for continuing 
research into the cardiovascular dose response relationship, and to establish a 
causal link between cardiac power output and events at the mechanistic 
cellular and molecular level. 
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Annpnriiy 
-- 
Female Partici nt Questionnaire 
Liverpool John Moores University 
Research Institute for 
Sport and Exercise Sciences 
Project: Effects of Ageing on the Power Output of the Heart 
Personal Details 
Medical, Lifestyle and Dietary Assessment Questionnaires 
Please Read Carefully 
The main purpose of this questionnaire is to find out about your health 
status and lifestyle habits. Information that you provide will be used to 
determine your suitability to participate safely and effectively in this study 
Please note: This questionnaire is an important part of the study. We 
request that you answer all questions as accurately and as honestly as 
possible. Most questions can be answered by either placing a circle 
around the appropriate response, a tick in the box provided, or a short 
written response. 
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Section one 
Personal Information 
1. Name: 
2. DOB: 
3. Height: 
_ 
4. Address 
Age: 
Weight: 
5. Telephone number: 
Home: 
Mobile: 
6. Email: 
7. What is your ethnic group (please tick box) 
Caucasian Hispanic Black Asian 
QQQQ 
Section Two 
Personal Medical History Assessment 
Chinese Other 
QQ 
(circle answer) 
8. Has your doctor ever said that you have had a heart condition? Yes No 
If yes, please give details, including dates 
9. Have you ever been instructed to perform physical activity only 
recommended by a doctor? Yes No 
If yes, please give details, including dates 
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10. Have you ever had a real, or suspected, heart attack? 
If yes, when did it occur 
Yes No 
11. Have you ever experienced rapid heart beating or palpitations? Yes No 
If so, please give details, including what you were doing at the time 
12. Have you ever had angina or a sharp heavy pain in your chest as the result 
of physical activity? Yes No 
If so, please circle level of activity: low moderate 
13. Do you lose your balance because of dizziness? 
14. Do you ever lose consciousness? 
15. Have you ever had a resting or exercise ECG taken? 
If yes, was the ECG normal? 
16. Have you ever been severely breathless as a result of 
low / moderate level exercise? 
17. Do you suffer from high or low blood pressure? 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
If yes, which one? Low High 
18. Are you currently taking prescribed medication to control your blood 
pressure? Yes No 
If yes, give name and dosage 
19. Have you ever been told your blood cholesterol is too high? Yes No 
If yes, please state your cholesterol level (if known) 
20. Are you currently taking prescribed medication to control your 
cholesterol ? Yes 
No 
If yes, state name and dosage 
21. Do you suffer from any kidney problems now or in the past? Yes 
No 
If yes please specify condition and medication 
strenuous 
Yes No 
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22. Do you suffer from diabetes? 
If yes, how is it controlled (please tick) 
a) Dietary means b) Insulin injection 
c) Oral medication F-I c) Uncontrolled 1-1 
23. Do you suffer from asthma, or any respiratory disorders? 
Yes No 
Yes No 
Please give details of condition and any medication taken including inhaler 
Is the breathing condition made worse by exercise? Yes No 
If yes, what level of exercise (please circle) low moderate strenuous 
24. Do you have any musculo-skeletal problems that could be made worse by 
a change in physical activity? Yes No 
If so, please give details of condition 
What level of exercise can you do without making your condition worse? 
(please circle) low moderate strenuous 
25. Do you know of any other reason why you should not undertake physical 
activity? Yes No 
If yes, why 
26. Do you suffer from any of the following: - 
HIV/AIDS Yes No 
Hepatitis B or C Yes No 
Or any other disease transmitted by blood Yes No 
Haemophiliac Yes No 
Chron's disease Yes No 
Thyroid Problems Yes No 
Adrenal Problems Yes No 
Pituitary Problems Yes No 
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27. Do you smoke? Yes No 
If yes, 
What do you smoke (please circle) cigarettes cigars pipe 
How long have you smoked for? 
How many per day? 
28. Have you ever smoked? Yes No 
If yes, 
How long did you smoke for? 
How many per day? 
When did you stop? 
Section Three 
Hormonal Status. 
29. Have you ever menstruated (had a period) before? Yes No 
If YES, how old were you when you first menstruated? 
30. Are you using hormone contraceptives? (the pill, progesterone injection, 
patch) Yes No 
If YES, please continue (Q. 31) 
If NO, go to question 33 
If YES, please state what type you use, it's hormonal contents and dosage, if 
known 
31. How long have you been using hormone contraceptives? 
Q Less than 1 year. 
Q 1-2 years. 
Q 3-5 years. 
Q More than 5 years. Please state how long 
32. Why do you use them? 
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Q Contraception alone. 
Q Contraception and regulation of the menstrual cycle. 
Q Contraception and regulation of menstrual cycle symptoms 
(depression, pain, back ache etc. ) 
Q Other reasons, please describe 
33. If you do not currently use hormone contraceptives, have you ever used 
them in the past? Yes No 
If YES, please continue (Q. 34) 
If NO, go to question 37 
34. How long were you using them? 
Q Less than 1 year. 
Q 1-2 years. 
Q 3-5 years. 
Q More than 5 years. Please state how long 
35. How long ago did you stop using hormone contraceptives? 
Q Less than 1 year ago. 
Q 1-2 years ago. 
Q 3-5 years ago. 
Q More than 5 years ago. Please state how long 
36. Why did you stop using them? 
Q Irregular bleeding. 
Q Side effects (cycle irregularities, 
Q Planning a pregnancy. 
Q Other reasons. Please state 
weight gain, mood disturbances). 
37. Have you reached the menopause? 
Q Yes, surgical hysterectomy. 
Q Yes, naturally, confirmed by my doctor. 
Q Yes, naturally, unconfirmed by my doctor. 
Q Unsure. 
Q No. 
If YES, please continue (0.38) 
If NO, go to section four 
38. At what age did you reach the menopause? 
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39. Are you taking any Hormone Replacement Therapy (HRT)? Yes No 
If YES, please continue (Q. 40) 
If NO, go to question 43 
40. Please list what HRT name, hormonal contents and dosage 
41. Why do you use HRT? 
o Treatment of short term symptoms (hot flushes, night sweats, vaginal 
dryness) 
Q Prevention or treatment of osteoporosis. 
Q Prevention of heart disease. 
Q Other. Please describe. 
42. How long have you been taking HRT? 
Q Less than 1 year 
Q 1-2 years 
Q 3-5 years 
Q Longer than 5 years, please state how long 
43. If you are not taking HRT now, have you ever used it in the past? 
Yes No 
If YES, please continue (Q. 44) 
If NO, go to section four 
44. When did you stop taking HRT? 
Q Less than 1 year 
Q 1-2 years 
Q 3-5 years 
Q Longer than 5 years, please state how long 
45. How long did you take HRT for? 
Q Less than 1 year 
Q 1-2 years 
Q 3-5 years 
Q Longer than 5 years, please state how long 
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46. Why did you stop taking HRT? 
Q Side effects (headache, acne, bloating, breast discomfort) 
Q Worried about health risks (cancer, hypertension, blood clots, etc. ) 
Q No longer needed. 
Q Other. Please describe. 
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Section Four 
Physical Activity Assessment 
47. Considering a typical 7-day period (week), how many times do you do 
the following kinds of exercise for during your free time (write on each line the 
appropriate number). 
Times Per Duration 
Week (to the nearest 
5mins) 
a) Strenuous Exercise 
(Heart beats rapidly) 
(e. g. running, jogging, hockey, football, soccer, 
squash, basketball, cross country skiing, judo, 
roller skating, vigorous swimming, vigorous 
longer distance cycling) 
b) Moderate Exercise 
(Not Exhausting) 
(e. g. fast walking, baseball, tennis, easy cycling, 
volleyball, badminton, easy swimming, 
alpine skiing, popular and folk dancing) 
c) Mild Exercise 
(Minimal Effort) 
(e. g. yoga, archery, fishing from river bed, 
bowling, horseshoes, golf, easy walk) 
48. Considering a typical 7-day period (week), during your leisure time, how 
often to do you engage in regular activity long enough to work up a sweat with 
your heart beating rapidly? 
OFTEN SOMETIMES NEVER/RARELY 
El F-1 F1 
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49. Are you currently engaged in moderate or intense training? Yes No 
If yes, over the course of a typical week please could you detail below your 
current training schedule. 
Day Intensity Duration Description 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
How long have you been training for? 
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50. If you compete in any event please could you provide some details 
regarding personal best times. Please list them in chronological order with the 
most recent first. 
Distance / Event Time Date Completed 
(Month & Year) 
51. Have you ever previously engaged in moderate or intense training? 
Yes No 
If yes, please give details of your schedule: 
Intensity Number of times Duration of each session 
per week (to nearest 5mins) 
What year did you start training? 
How long ago did you stop training? 
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Section five 
Diet Assessment 
(please circle) 
52. Are you a vegetarian 
53. During a typical day what do you eat/drink 
Yes No 
54. Do you take any food supplements 
If yes, please specify 
Yes No 
55. Please detail any further information you would like to tell us 
Participant signature: 
Thank you for completing this questionnaire 
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Appendix 2 
Subject Consent Form 
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All Information Given to the Researcher Will Be Treated As Confidential 
I......................................................................... agree to take part in 
the above named project/procedure, the details of which have been fully 
explained to me and described in writing, along with the demands, risks and 
benefits of the study. I am aware of the risks involved and understand that I 
can withdraw from this study at any time without penalty. 
Signed (Subject) .................................... Date ........................ 
I......................................................................... certify that the details 
of this project/procedure have been fully explained and described in writing to 
the subject named above and have been understood by him/her. 
Signed (Researcher) ................................. 
Date ........................ 
I......................................................................... certify that the details 
of this project/procedure have been fully explained and described in writing to 
the subject named above and have been understood by him/her. 
Signed (Witness) .................................... 
Date ........................ 
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